Bayesian Multilevel Models and Medical Applications by Saville, Benjamin Rigby
Bayesian Multilevel Models and Medical Applications
by
Benjamin R. Saville
A dissertation submitted to the faculty of the University of North Carolina at Chapel Hill in
partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Department
of Biostatistics, School of Public Health.
Chapel Hill
2008
Approved by:
Dr. Amy Herring, Committee Chair
Dr. Gary Koch, Committee Member
Dr. Lawrence Kupper, Committee Member
Dr. Lisa LaVange, Committee Member
Dr. Andrew Olshan, Committee Member
c© 2008
Benjamin R. Saville
ALL RIGHTS RESERVED
ii
ABSTRACT
BENJAMIN R. SAVILLE: Bayesian Multilevel Models and Medical Applications.
(Under the direction of Dr. Amy Herring.)
Deciding which predictor effects may vary across subjects is a difficult issue. Standard
model selection criteria are often inappropriate for comparing models with different numbers
of random effects due to constraints on the parameter space of the variance components. We
propose a straightforward approach for testing random effects in the linear mixed model using
Bayes factors. We scale the random effects to the residual variance and introduce parameters
that control the relative contributions of the random effects. The resulting integrals needed to
calculate the Bayes factor are low-dimensional integrals lacking variance components and can
be efficiently approximated with Laplace’s method. Our method incorporates default priors
and can test multiple random effects simultaneously. We illustrate our method on data from a
clinical trial of patients with bipolar disorder and on data from an environmental study of water
disinfection by-products and male reproductive outcomes.
We extend our method for testing random coefficients to multilevel linear models. A major
contribution of our method is the ability to test several variance components from multiple
factors simultaneously, and to do so for nested, non-nested, or cross-nested multilevel designs.
We illustrate our method on a study investigating significant predictors of infant birth weights
in New York City.
Random effects are often used for jointly modeling distributions of correlated longitudinal
and survival outcomes. These methods generally require strong parametric assumptions and
can be difficult to implement. We propose a straightforward approach to evaluate the effect of a
treatment or baseline predictor on both longitudinal and survival outcomes simultaneously. We
define cutpoints of interest in the longitudinal outcome and time-to-event endpoints based on
time to reach a given cutpoint or the survival event, whichever comes first. We use multivariate
time-to-event methods on the resulting endpoints to evaluate the effect of the treatment or
baseline predictor. The method is particularly attractive in clinical trial settings in which the
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primary analysis must be specified a priori. We illustrate the method on data from a study of
chronic lung disease.
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CHAPTER 1
Literature Review
1.1 Introduction
1.1.1 Model uncertainty
Many researchers are interested in finding the “best” statistical model to make scientific in-
ferences. This usually involves determining the model class as well as which predictors to
incorporate in the model. The model class is the general model structure which determines the
relationship between the predictors and the outcome. In generalized linear models, the model
class is determined by the link function, such as the identity link in linear regression, or a logit
link in logistic regression. Although determining the model class may be straightforward for
some applications, there may be other situations in which there is potentially more than one
reasonable model class. For example, two possibilities for modeling a dichotomous outcome
include logistic regression and probit regression. Both model classes may reasonably explain the
data, yet in practice we often choose one model class (e.g. logistic) and ignore the other (e.g.
probit).
After identifying a model class, one must also decide which predictors and interactions to
include in the model. There has been substantial research on this topic. The emphasis on
variable selection in the literature has made the term “model selection” synonymous with the
term “variable selection.” The ideal study would begin with a small number of predictors
specified a priori, or before the data are collected. In practice, however, researchers often collect
data on as many variables as they can afford or manage and use the data to determine which
variables to include in the model used for inference. This may reflect their uncertainty in the
relationship between the outcome and the potential predictors. Due to sample size constraints,
it may not be possible to fit one model that incorporates all variables of interest. Hence one is
forced to determine which of all possible combinations of variables best explains the data.
An important element of choosing a good statistical model is the selection of an appropriate
covariance model. This structure can be implicitly defined by the choice of model class and
predictors or it can be manipulated within the context of a chosen model. In many model
classes there are a large variety of options in choosing a covariance structure. This leads to the
task of formally determining whether a chosen covariance structure is appropriate for the data.
1.1.2 The longitudinal linear mixed model
Covariance model selection can be especially difficult in the context of random coefficient mod-
els. These models incorporate random coefficients that vary by group, introducing intraclass
(i.e. within-group) correlation in the covariance structure. Consider a linear mixed model for
longitudinal data,
yi =Xiβ +Zibi + εi, (1.1)
in which yi = (yi1, . . . , yini)
′ is a ni × 1 vector of responses, Xi = (xi1, . . . ,xip) is a ni × p
design matrix, Zi = (zi1, . . . , ziq) is a ni × q design matrix, β = (β1, . . . , βp)′ is a p × 1 vector
of parameters, and bi = (bi1, . . . , biq)
′ is a q × 1 vector of random coefficients (Laird and Ware,
1982). The matrix Zi is usually considered to be a subset ofXi. It is assumed that εi ∼ N(0,R)
is independent of bi ∼ N(0,ψ), in which ψ is the q× q covariance matrix of the random effects.
A popular choice for R is σ2I, which assumes the observations are independent within a subject
given the random coefficients.
The random coefficients bi, often referred to as random effects, allow the estimated parame-
ters to vary by individual. This introduces intraclass correlation for observations within a given
individual. In the context of model selection, different combinations of random effects lead to
different covariance structures. For situations in which the covariance model is of primary inter-
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est, or the covariance model has a large impact on inference, one must carefully choose random
coefficients for inclusion in a model. This leads to the problem of formally testing whether a
random coefficient should be included in a model.
1.1.3 Frequentist methods for testing variance components
Testing whether a random effect should be included in a model involves the test of whether
the variance of that random effect, say ψ, is equal to 0. This can be written as H0 : ψ = 0
versus H1 : ψ > 0. Because the constrained variance component test lies on the boundary
of the parameter space, classical procedures such as the likelihood ratio test can break down
asymptotically (Pauler et al., 1999; Lin, 1997; Self and Liang, 1987; Stram and Lee, 1994). It
has been shown that tests for a single variance component can be carried out using mixtures of
chi-square distributions (Self and Liang, 1987). For a linear mixed model, Stram and Lee (1994,
1995) show that a likelihood ratio test of q versus q + 1 correlated random effects has a null
distribution of 0.5(χ2q + χ
2
q+1). For example, consider a linear mixed model for a response yij at
time tij, with a random intercept and a random slope for the effect of time,
yij = β0 + bi0 + (β1 + bi1)tij + εij, (1.2)
with bi ∼ N(0,ψ) independent of εij ∼ N(0, σ2). Suppose we wish to test for the presence of
the random slope bi1, or H0 : ψ22 = 0 versus H1 : ψ22 > 0. A model constraint placed by this
hypothesis is that the covariance of the random effects (ψ12) also equals 0. The likelihood ratio
test statistic is equal to twice the difference of the log likelihoods, or
TLR = −2{l(y|H0, θˆ0)− l(y|H1, θˆ1)}, (1.3)
in which l(y|H0, θˆ0) and l(y|H1, θˆ1) are the log likelihoods under the null and alternative hy-
potheses evaluated at their maximum likelihood estimates, respectively. It follows that TLR
asymptotically follows a 50:50 mixture of chi-square distributions with 1 and 2 degrees of free-
dom (Stram and Lee, 1994, 1995). The critical value for an α = 0.05 test using this mixture
distribution is 5.14, indicating one would reject H0 for TLR > 5.14.
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Crainiceanu and Ruppert (2004) show that approximations to the null distribution using the
50:50 mixture of chi-square distributions can perform poorly in simulations. They argue that
the theory of Self and Liang (1987) only applies to linear mixed models in which the data vector
can be partitioned into a large number of independent and identically distributed subvectors
(e.g. subjects). This may be violated when the number of subjects is not sufficient to ensure
an accurate asymptotic distribution. For example, consider a cluster-randomized study with
50 patients randomized within each of 5 different hospitals (250 total patients). In this case
there are only 5 independent and identically distributed clusters (hospitals). Crainiceanu and
Ruppert (2004) and Crainiceanu (2005) derive the finite sample and asymptotic distribution of
the likelihood ratio test, and show that under general conditions the null distribution for testing
a single variance component is different from a 50:50 mixture of chi-square distributions. The
present a restricted likelihood ratio test based on the restricted maximum likelihood (REML),
and derive its exact null distribution. Using eigenvalues based on design matrices, they use a
simulation algorithm to derive the distributions of interest.
Note that these approaches using the likelihood ratio test are only applicable for testing a
single variance component. In more complex model comparisons (i.e. testing more than one
random effect), distributions of test statistics become more complex and are not easily applied
(Pauler et al., 1999; Feng and McCulloch, 1992). For example, a test of k uncorrelated variance
components ψm = 0 versus ψm > 0 (m = 1, . . . , k) has a null distribution that is a mixture of
the form (Molenberghs and Verbeke, 2007; Shapiro, 1988)
k∑
m=0
2−k
 k
m
χ2m. (1.4)
Such mixtures can be calculated from a weighted average of p values corresponding to each of the
χ2 distributions. For a broad number of cases, determining the mixture’s weights is a complex
and possibly numeric task (Verbeke and Molenberghs, 2003). For addressing multiple variance
components, Crainiceanu (2007) suggests using the parametric bootstrap to approximate the null
distribution of the restricted likelihood ratio test. In cases that are computationally demanding,
the author proposes obtaining finite sample approximations according to Greven et al. (2008).
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Some alternative frequentist methods for testing a single variance component include score
tests (Lin, 1997; Commenges and Jacqmin-Gadda, 1997; Verbeke and Molenberghs, 2003; Molen-
berghs and Verbeke, 2007; Zhang and Lin, 2008), Wald tests (Molenberghs and Verbeke, 2007;
Silvapulle, 1992), and generalized likelihood ratio tests (Crainiceanu and Ruppert, 2004). Sim-
ilar to the likelihood ratio test, these alternative tests also have modified null distributions due
to the boundary constraint (i.e. these are modified forms of the usual asymptotic tests). For one
sided variance component tests, Molenberghs and Verbeke (2007) show that the null distribution
of the test statistics for the likelihood ratio, score and Wald tests are asymptotically equivalent.
Zhang and Lin (2008) conduct a simulation in the setting of generalized linear mixed models,
and show that the one-sided score test is slightly more powerful than the likelihood ratio test for
testing a single variance component. Additionally, their simulation showed that the likelihood
ratio test may suffer from numerical instability when the variance component is small and nu-
merical integration is high dimensional. Generally, the score and Wald tests are more difficult
to implement than the likelihood ratio test and require substantial programming in standard
statistical software packages (Molenberghs and Verbeke, 2007). As with the likelihood ratio
test, these alternative approaches are not easily extended for testing multiple random effects
simultaneously.
In more simple settings such as random effects ANOVA with balanced and complete data,
one sided tests of the variance components can be carried out using F tests (Neter et al., 1996,
pg. 959). However, in most applications the assumption of balanced and complete data is not
realistic.
A common frequentist method for choosing between competing random effects models is the
Akaike information criterion (AIC) (Akaike, 1973). Akaike suggested that one should choose
the model that minimizes the quantity
AIC = −2 log{p(y|θˆ)}+ 2d, (1.5)
in which d is the number of parameters and θˆ is the MLE. The AIC is popular because the
models being compared need not be nested (although the test was originally developed for nested
models). Shibata (1976) and Katz (1981) (Kass and Raftery, 1995) show that the AIC tends to
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overestimate the number of parameters needed. In random effects models, the AIC suffers from
ambiguity in the model dimension d.
Hence there are a lack of simple and efficient frequentist-based methods for testing variance
components, especially for testing multiple variance components simultaneously. As an alter-
native to these frequentist-based methods, we consider Bayesian methods for testing random
coefficients. Before we discuss specific challenges associated with such tests, we first introduce
Bayesian methodology in the context of model selection.
1.2 Bayesian methods for model selection
1.2.1 Introduction to Bayesian inference
We introduce Bayesian methods by considering a density function p(y|θ) for observed data y and
a parameter vector θ. The likelihood function in Bayesian inference is any function proportional
to p(y|θ), i.e.
L(θ) ∝ p(y|θ). (1.6)
In contrast to frequentist methods in which θ are fixed and unknown, Bayesian methods assume
that the parameter vector θ has a prior probability distribution pi(θ), reflecting uncertainty in
the parameters θ. The word “prior” is used to denote that pi(θ) is the density before the data
y are observed. The prior distribution allows the researcher to incorporate prior knowledge
about the behavior of θ before data are collected. Bayesian inference is primarily based on
the posterior distribution of θ given the observed data y. Using Bayes’ Theorem, the posterior
distribution can be written as
p(θ|y) = p(θ,y)
p(y)
=
p(y|θ)pi(θ)
p(y)
=
p(y|θ)pi(θ)∫
p(y|θ)pi(θ)dθ , (1.7)
in which
p(y) =
∫
p(y|θ)pi(θ)dθ (1.8)
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is the marginal distribution of y, also known as the normalizing constant. In most inference
problems this quantity is not available in closed form. A common technique is to identify the
kernel density of p(θ|y) by recognizing that the posterior distribution of θ is proportional to
p(y|θ)pi(θ), i.e.
p(θ|y) ∝ p(y|θ)pi(θ). (1.9)
In cases in which the kernel is not identifiable, p(y) must be computed directly, unless more
advanced techniques are used (e.g. Markov chain Monte Carlo methods). If we can calculate
(or estimate) the posterior density p(θ|y), we can use various posterior summaries for inference
on the unknown parameters θ (e.g. the mean, mode, variance, and quantiles).
1.2.2 The Bayes factor
The Bayes factor is the posterior odds of one hypothesis versus another when the prior prob-
abilities of the two hypotheses are equal (posterior odds = Bayes factor * prior odds). From
Bayes’ theorem, we have
p(Hk|D) = p(D|Hk)p(Hk)
p(D|H0)p(H0) + p(D|H1)p(H1) , k = 0, 1, (1.10)
in which p(D|Hk) is the marginal likelihood of the data given hypothesis Hk and p(Hk) is the
prior probability that Hk is true. It follows that
p(H1|D)
p(H0|D) =
p(D|H1)p(H1)
p(D|H0)p(H0) , (1.11)
in which
B10 =
p(D|H1)
p(D|H0) (1.12)
is the Bayes factor, or the ratio of the posterior odds of H1 to its prior odds divided by ratio
of the posterior odds of H0 to its prior odds (Kass and Raftery, 1995; Good, 1958). When the
two hypotheses H1 and H0 are equally probable a priori, (i.e. p(H1) = p(H0)), the Bayes factor
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is equal to the posterior odds in favor of H1 versus H0. The numerator and denominator of
equation (1.12) can be written as
p(D|Hk) =
∫
p(D|θk, Hk)pi(θk|Hk)dθk, (1.13)
in which θk is a vector of parameters and pi(θk|Hk) is the prior distribution of θk. The quantity
p(D|Hk) is known as the marginal likelihood, integrated likelihood, or predictive probability
of the data. One limitation of Bayes factors lies in the influence of the prior distribution. It
can be seen from equation (1.13) that the Bayes factor is a function of the prior distribution
imposed by the investigator. Hence, there are an infinite number of Bayes factors that arise
from different priors. Because only some priors may be appropriate for the data, not all Bayes
factors are scientifically meaningful. In parameter estimation, in which inference is based on the
posterior distribution p(θk|D, Hk), priors are often picked for convenience under the knowledge
that if the sample is large, the effect of the prior on the estimates is small. The same rationale
cannot be applied to hypothesis testing, because Bayes factors tend to be more sensitive to the
priors than estimates based on a posterior distribution (Kass and Raftery, 1995; Kass, 1993).
For an example, see Kass (1993), in which a sensitivity analysis reveals that the Bayes factor
varies more than the posterior mean estimate across a range of possible priors. Kass and Raftery
(1995) point out that choosing “non-informative” priors (as often done in Bayesian inference)
can force the Bayes factor to favor H0. As a result, in practice it is important to implement a
sensitivity analysis to determine the influence of a chosen prior.
The Bayes factor is a summary of evidence provided by the data of one hypothesis versus
another. Jeffreys (1961) suggests interpreting the Bayes factor according to the scale in Table
1.1 (Wasserman, 2000). For example, if B10 = 12, then H1 is 12 times more likely than H0
(given the data), indicating strong evidence for H1 relative to H0. If B10 = .08, then H0 is 12.5
(1/.08) times more likely than H1 (given the data), indicating strong evidence for H0 relative
to H1.
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1.2.3 Bayes factors versus Frequentist hypothesis tests
The common frequentist approach to model selection is to begin with a certain model class
and a potentially large number of predictor variables. Model selection methods (e.g. step-
wise selection) are used to determine which variables are most likely to be associated with the
outcome. A final model is chosen by including only the significant or important predictors
resulting from the selection method. Estimates and inference are based on this “best” model.
One problem with this approach is that the investigator chooses one model out of many
possibilities, and proceeds with inference as if it were the only model ever considered. By
choosing among several models, one is increasing the probability of finding “significant” variables
by chance alone. This can cause the p-values in the final model to be very misleading (Raftery,
1995; Miller, 1984; Freedman, 1983). For example, suppose a researcher collects data on one
outcome and 100 predictors, and the predictors are independent of each other. Suppose also
that the researcher uses a variable selection method to arrive at a final model that includes
5 “significant” predictors, all with p-values less than 0.05. One may want to interpret these
p-values as the probability of observing data as extreme or more extreme than the observed
data, given the null hypothesis of no association between the predictors and outcome. At the
alpha = 0.05 level, this would imply a statistically significant association between each of the five
predictors and the response. However, this interpretation of the p-values is no longer valid. Basic
laws of probability state that even if there is no association between any one of the predictors
and the response, on average 5 out of 100 variables will have p-values less than 0.05 by chance
alone. This suggests one can expect about 5 out of 100 variables to be statistically significant,
even when there is truly no relationship between any one of the predictors and the outcome.
This means that claims of an association between these 5 carefully chosen predictors and the
response may be completely false.
Another difficulty associated with frequentist approaches to model selection involves the
hypothesis test. In frequentist settings, it is assumed that a null hypothesis (H0) is true, and a
p-value indicates the degree of evidence against H0. If one were comparing two nested models,
an appropriate null hypothesis is that the effect of interest in the larger model is equal to 0. It
is generally understood that the effect cannot exactly equal 0, but can be close enough to 0 to
9
be clinically meaningless. Raftery (1993, 1986a) argues that p-values ask the wrong question.
Instead of asking “Is the null model true?”, a better question is “Which model predicts the data
better?” A Bayesian approach using Bayes factors is designed to answer the latter question. The
Bayes factor is the ratio of posterior to prior odds, and measures how well one model predicts
the data compared to another model. This can be advantageous in the above example because
one does not need to assume that an effect is arbitrarily close to 0. In addition, if a frequentist
approach yields a non-significant p-value, it can be unclear whether there is evidence for the
null hypothesis or whether there are not enough data. In contrast, Bayes factors allow one to
assess the evidence for a null hypothesis versus the alternative hypothesis. In cases in which
there are not enough data, the evidence using Bayes factors is unlikely to be strong in either
direction, reflecting the uncertainty present in the data.
The differences between p-values and Bayes factors become more apparent in large samples.
Frequentist methods tend to reject H0 almost systematically in large samples while Bayes factors
do not. Frequentist approaches to this problem include adjusting the level of significance (e.g.
0.01 instead of 0.05) or simply ignoring the p-values and basing inference on other criteria that
appeal to common sense (Kass and Raftery, 1995). Because Bayes factors measure how well one
model predicts the data versus another, no adjustments are needed for large samples. In the
case of small samples, frequentist methods based on asymptotic theory may not be valid. Of
course exact methods, if they can be used, do not rely on asymptotics. Bayes factors, however,
do not require asymptotics for valid inference.
Frequentist approaches often assume there are only two possible hypotheses to entertain,
even though there may be additional hypotheses of interest. When multiple hypotheses are
compared, frequentist methods must make adjustments to the significance level in order to
correctly interpret the p-values, due to the independence assumed between each of the tests.
Additional complications arise if the hypotheses are non-nested. Bayes factors are well suited
for comparing many models, nested or non-nested. The interpretation of a Bayes factor does
not change in the presence of multiple testing, although one still may need to control for an
increased rate of false positives. To limit false positives that may arise in Bayesian multiple
testing, one can build information about correlated hypotheses into the prior distribution (e.g.
setting the probability that β = 0 in the prior).
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Bayes factors follow the likelihood principle, which says that if two distinct sampling designs
yield proportional likelihood functions, then inference about the parameters of interest will be the
same between the two designs. In other words, all of the information in a sample is contained in
the likelihood function. This provides flexibility in studies in which data are accrued sequentially
(e.g. clinical trials), in which certain aspects of the study can be modified without changing the
likelihood function. For example, one can conduct an unscheduled analysis of the data without
affecting the interpretation of the final analysis. This can allow one to modify the sample
size or even stop a clinical trial according to pre-specified criteria. In contrast, frequentist
methods generally do not follow the likelihood principle. As an example (taken from Ibrahim,
2005), consider 12 independent coin tosses, in which one observes 9 heads and 3 tails. We are
interested in testing the hypothesis H0 : θ = 1/2 versus H1 : θ > 1/2, in which θ is the true
probability of heads. Depending on the experiment, one could base the likelihood either on the
binomial distribution or the negative binomial distribution. If we let n = 12 be fixed beforehand,
and define x as the number of heads in 12 tosses, then x follows a binomial distribution. The
likelihood function in this experiment is
L1(θ) =
 12
9
 θ9(1− θ)3. (1.14)
As an alternative experiment, suppose one continues flipping the coin until the third tail appears,
and x equals the number of heads required to complete the experiment, then x follows a negative
binomial distribution. In this case, the likelihood function is
L2(θ) =
 11
9
 θ9(1− θ)3. (1.15)
The two likelihoods differ by a constant, meaning they are proportional to each other. From a
Bayesian perspective, the posterior distribution of θ is the same for both experimental designs,
i.e.
p(θ|x) ∝ θx(1− θ)12−xpi(θ) (1.16)
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for a chosen prior pi(θ). Hence Bayesian inference (including those based on Bayes factors) will
be the same regardless of the experimental design. From a frequentist perspective, inferences
about θ are different under each design. The p-value for the binomial design is
p1 =
12∑
j=9
 12
j
 θj(1− θ)12−j = 0.075, (1.17)
while the p-value for the negative binomial design is
p2 = 1−
8∑
j=1
 2 + j
j
 θj(1− θ)3 = 0.0325. (1.18)
At a significance level of 0.05, we make two different conclusions depending on the distribution
of x. We reject H0 in the negative binomial design, yet fail to reject H0 in the binomial design.
Now suppose that interim analyses (both Bayesian and frequentist) were conducted before
all the coin flips were completed under the first experimental design. The complete likelihood
based on all the observed data would not be altered by this interim analysis (as long as the
experimental design is not changed). Hence conclusions based on Bayesian inference would not
be affected by the interim analysis. However, the frequentist p-value based on the complete
data would now have a different interpretation, because the type I error rate has been inflated
by performing two tests on the same data.
Many critics of Bayesian methods argue that Bayesian inference (and hence model selec-
tion) is subjective due to the elicitation of prior distributions on the unknown parameters.
These subjective prior distributions can have a large influence on inference through the poste-
rior distribution. When there is prior knowledge about a parameter, a Bayesian approach is
advantageous because it can incorporate the prior knowledge. In cases in which there is no prior
knowledge, it is desirable to formulate “non-informative” (i.e. well-spread out) priors that allow
the observed data likelihood to dominate the posterior distribution. There is a large literature
on challenges with prior selection as the prior distributions must be carefully defined.
Another major criticism of Bayesian methodology lies in the computational challenges associ-
ated with estimating posterior distributions and Bayes factors. There are only a few statistical
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software packages that offer Bayesian inference (e.g. WinBUGS, limited capabilities in SAS
PROCs BGENMOD, BLIFEREG, and BPHREG), meaning many Bayesian applications must
be programmed by the user. This requires a higher level of knowledge and more user time than
standard frequentist approaches. Frequentist methods do not incorporate prior distributions
and hence do not rely on subjective information. They also are straightforward to implement in
standard statistical software packages. Hence, despite some advantages of Bayesian approaches
to model selection, frequentist methods are most commonly implemented in practice.
1.2.4 Approximating the Bayes factor
The main limitation of Bayes factors is that the marginal likelihood (1.13) can be difficult to
calculate, especially when θk has many dimensions. For example, consider a simple logistic
regression model. Suppose yi, . . . , yn are independent Binomial(1, pi) random variables
pi =
exp{x′iβ}
1 + exp{x′iβ}
(1.19)
in which xi is a vector of predictors with corresponding parameters β. Suppose we specify an
non-informative improper prior pi(β) ∝ 1. This suggests that β has a uniform prior distribution
on the entire real line, and that the odds ratio φ = eβ has a prior distribution p(φ) ∝ 1/φ on
the positive real line (which is not necessarily non-informative). Then the marginal likelihood
is
p(y) =
∫
p(y|x,β)dβ (1.20)
=
∫
exp
[
n∑
i=1
{yix′iβ − log (1 + exp{x′iβ})}
]
dβ, (1.21)
which does not have a closed form solution. Hence an alternative strategy is needed to compute
the marginal likelihood. Numerical methods of computing complex marginal likelihoods are not
efficient nor useful in most cases. However, there are some useful approximations that perform
well in certain settings.
Laplace’s approximation to the marginal likelihood (Tierney and Kadane, 1986) is derived
by assuming the posterior density, which is proportional to p(D|θ, H)pi(θ, H), is highly peaked
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about its maximum θ˜ (the posterior mode). This is usually the case when the likelihood function
p(D|θ, H) is peaked near its maximum, as in large samples. Using the notation of Kass and
Raftery (1995), let l˜(θ) = log{p(D|θ, H)pi(θ|H)}. Expanding l˜(θ) as a quadratic about θ˜ and
exponentiating gives the approximation
p(D|Hk) ≈ exp[l˜(θ)]
∫
exp{[1/2(θ − θ˜)T [−D2l˜(θ˜)](θ − θ˜)]}dθ. (1.22)
The integral in (1.22) takes the form of a normal density with mean θ˜ and covariance matrix
Σ˜ = [−D2l˜(θ˜)]−1, in whichD2l˜(θ˜) is the Hessian matrix of second derivatives. After integrating
with respect to θ, the Laplace approximation is given by
p̂(D|Hk) = (2pi)d/2|Σ˜|1/2p(D|θ˜, Hk)pi(θ˜|Hk). (1.23)
The relative error of the Laplace approximation is of the order O(n−1). For adequate accuracy
using the Laplace approximation, Kass and Raftery (1995) recommend a sample size greater
than 20d, in which d is the dimension of θ. This will be sufficient in most “reasonable” problems,
in which the likelihoods are well-behaved and a good parameterization is used. A modification
of (1.23) is
p̂(D|Hk) = (2pi)d/2|Σˆ|1/2p(D|θˆ, Hk)pi(θˆ|Hk), (1.24)
in which θˆ is the maximum likelihood estimate (MLE) of θ and Σˆ−1 is the observed information
matrix (Kass and Raftery, 1995; Kass and Vaidyanathan, 1992). This approximation also has a
relative error of order O(n−1), but may be less accurate than (1.23) when the prior is somewhat
informative relative to the likelihood. The advantage of (1.24) is that it is easily computed from
standard statistical output, because it only requires the MLE, the observed information matrix,
and the maximized likelihood.
A popular approximation to the log Bayes factor is the Schwarz Criterion (Schwarz, 1978;
Kass and Raftery, 1995), given by
S = log{p(D|θˆ0, H0)} − log{p(D|θˆ1, H1)} − 1
2
(d0 − d1) log(n), (1.25)
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in which θˆk is the MLE under hypothesis Hk, dk is the dimension of θk, and n is the sample
size. This approximation is also known as the Bayesian information criterion (BIC) (Weakliem,
1999; Raftery, 1986a; Raftery, 1986b), formally defined as
BIC01 = −2S. (1.26)
The BIC approximation assumes an implied non-informative prior pi(θ), and suggests that the
log marginal likelihood of a model can be approximated by
log{p̂(D|Hk)} = log{p(D|θˆ, Hk)} − d
2
log(n). (1.27)
It follows that the Bayes factor B10 can be approximated as
B10 ≈ exp
{
1
2
BIC01
}
. (1.28)
The Bayesian information criterion approximates the log Bayes factor with a relative error of
order O(1). Although the error of O(1) implies a crude approximation, empirical experience
has found the BIC to be more accurate in practice than the error term O(1) suggests (Raftery,
1995, 1996) . In fact, it has been shown that under certain conditions the BIC approximation
has a relative error of O(n−1/2) (Kass and Wasserman, 1995).
One argument against the BIC is that the Bayes factor derived from the BIC may not be close
to the Bayes factor derived from an appropriate prior set by the investigator (Weakliem, 1999).
The Bayes factor from the BIC corresponds closely to that derived from the unit information
prior, which is a prior with the amount of information equal to the amount of information
contained in one observation. More specifically, the unit information prior is a multivariate
normal prior with mean at the maximum likelihood estimate and variance equal to the inverse
of the expected information matrix for one observation. A simple example, taken from Raftery
(1999), illustrates the idea. Let Yi ∼ N(µ, σ2), iid for i = 1, . . . , n, with σ known, and consider
the test H0 : µ = 0 versus H1 : µ 6= 0. Then a unit information prior is µ ∼ N(y¯, σ2), in which
y¯ is the mean of the data. Raftery (1999) points out that the unit information prior is usually
a well spread out prior as it covers the range of the data. It seems unlikely that an investigator
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would specify a prior outside the range of the data; hence any alternative prior imposed by an
investigator is likely to be less spread out than the unit information prior. The more spread out
a prior, the more it favors the null hypothesis of no effect. If the BIC favors an effect, then it is
likely that any alternative prior will also find evidence for the effect. If the BIC does not favor
an effect, then there still may be a justifiable prior that would show evidence for an effect. One
can still use the BIC as a baseline reference even when the unit information prior is not the
same as the prior chosen by the investigator (Raftery, 1999).
The BIC and Laplace approximations are based on the assumption that the dimension d
is fixed as the sample size n goes to infinity. However, in random coefficient models the di-
mension increases as the sample size increases. For example, consider a linear mixed model
with a subject-specific random intercept. For every additional subject added to the data, an
additional parameter is added for the subject-specific random coefficient. Stone (1979) observed
that the BIC can be inconsistent when the dimension of the parameter vector goes to infinity.
Berger et al. (2003) used Stone’s example to show that the BIC and Laplace approximation
may not be good approximations to the Bayes factor as the dimension and sample size both
tend to infinity. The authors propose a generalized Bayesian information criterion (GBIC) and
a Laplace approximation to the log Bayes factor as alternatives to approximating the Bayes
factor. Chakrabarti and Ghosh (2006) generalize the methods of Berger et al. (2003) to allow
distributions from the exponential family and show derivations that clarify the structure of the
GBIC.
For an excellent summary of other approximations available, see Kass and Raftery (1995).
These include a simple Monte Carlo method, in which the marginal likelihood in (1.13) is
estimated by averaging p(D|θ) over sampled values of θ, in which the samples are taken from
the prior distribution of θ. This method has been shown to be inefficient when the posterior
is concentrated relative to the prior (McCulloch and Rossi, 1991). The precision of the simple
Monte Carlo estimate can be improved by using importance sampling, which generates samples
of θ from a more complex density (Geweke, 1989). Another option is Gaussian quadrature, which
uses numerical analysis to evaluate integrals that are peaked around a dominant mode (Genz and
Kass, 1993). Other approaches discussed by Kass and Raftery (1995) involve simulating from the
posterior distribution. Such methods include direct simulation, rejection sampling, a weighted
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likelihood bootstrap (Newton and Raftery, 1994), and Markov chain Monte Carlo (MCMC)
methods, such as the Gibbs sampler or Metropolis-Hastings algorithm. Several variations of the
above methods have been proposed. See Han and Carlin (2001) for a more thorough review of
MCMC methods to approximate the Bayes factor. More recently, Raftery et al. (2007) proposed
a modified BIC approximation to the marginal likelihood based on MCMC output. Using the
harmonic mean identity and the fact that the posterior distribution of the log likelihood is
approximately a shifted gamma distribution, they introduce BICM (where M stands for Monte
Carlo), a posterior-based version of the BIC. One major disadvantage of this approach is the
need to fit each model with MCMC methods, which can be computationally demanding.
Several methods of approximating the Bayes factor are compared by Raftery (1996) in gen-
eralized linear models. Raftery concludes that exact analytic evaluation is the most accurate
approach, but is only useful for a limited class of models. The Laplace method gives accurate
approximations and is usually computationally efficient. In cases of modest dimensionality, the
adaptive quadrature method of Genz and Kass (Kass and Raftery, 1995; Genz and Kass, 1993)
is effective. Monte Carlo integration and importance sampling are less accurate and more com-
putationally intensive, but there may be few other options in complex models. MCMC methods
seem promising, but may be difficult to use because they can require large numbers of likeli-
hood evaluations. The Schwarz criterion (BIC) is the easiest approximation to use, and has the
advantage of not depending on a prior distribution imposed by the investigator. However, it
can perform poorly when the number of degrees of freedom is large (Kass and Raftery, 1995;
McCulloch and Rossi, 1991).
1.2.5 Bayes factors and prior distributions
An additional challenge to model selection via Bayes factors lies in the choice of prior distribu-
tions. It is well known that Bayes factors are sensitive to the choice of priors (Kass and Raftery,
1995; Kass, 1993). This is problematic in situations in which one has no prior information on
the parameters, and the goal is to choose the best model based on the data. In these situations,
it is common to use default “noninformative” priors, or prior distributions that accommodate
a wide range of choices for the prior mean. However, one must choose these default prior vari-
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ances with care, because as the prior variance increases toward infinity the Bayes factor will
increasingly favor the null model (Bartlett, 1957). It has been documented that normal priors
lead to aberrant behavior in model selection problems, leading Jeffreys (1961) to suggest the
Cauchy prior as a heavy-tailed and more robust alternative. This early work by Jeffreys was
extended by Zellner and Siow (1980) to develop a robust class of multivariate Cauchy priors
for variable selection problems. Zellner’s g-prior (Zellner, 1986) has been widely adopted in
linear models, and only requires the specification of one hyperparameter. Liang et al. (2008)
generalized Zellner’s g-prior by implementing a fully Bayes approach using mixtures of g-priors.
1.2.6 Latent variable methods
Random effects can be viewed as special cases of latent variables, generally defined as variables
not directly observed. Latent variables are commonly used in the social sciences to model
underlying characteristics such as self-esteem. In latent variable models, the BIC and Laplace
approximations to the Bayes factor can suffer in performance due to ambiguity of the model
dimension d. This can be especially problematic in Bayesian analyses and hierarchical models.
For example, in a Bayesian analysis one can increase the number of parameters of a given
model by incorporating hyperpriors, even though the marginal distribution of interest may
be unchanged. As a result, the model dimension d is not clearly defined for computing the
BIC and Laplace approximations. As a result, researchers have suggested using the “effective
model dimension” in place of the standard model dimension (Berger et al., 2003). The effective
model dimension is a measure of the complexity of the model that takes into account the latent
variables and unknown parameters. Defining the “effective model dimension” is a non-trivial
task, as the relationship between the latent variables influences the effective dimension of the
model. Additionally, the sample size n used to compute the BIC must be defined carefully. In
hierarchical models, this may depend on which parameters are being tested (Kass and Raftery,
1995).
Some alternative methods of Bayesian model selection have been developed for latent vari-
able models and show promise for random effects models. One such method is the deviance
information criterion (DIC), which is based on the posterior distribution of the deviance statis-
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tic,
D(θ) = −2 log{p(y|θ)}, (1.29)
in which p(y|θ) is the likelihood function for the observed data vector y given the parameter
vector θ (Spiegelhalter et al., 2002). The effective number of parameters is defined as
pD = D(θ)−D(θ˜), (1.30)
in which D(θ) = Eθ|y[D(θ)] is the posterior mean deviance, and θ˜ = θ˜(y) is an estimate of θ
based on the data (generally taken to be E(θ|y)). The measure pD is the difference between
the posterior mean of the deviance and the deviance at the posterior means of the parameters.
The deviance information criterion (DIC) is
DIC = D(θ) + pD (1.31)
= 2D(θ)−D(θ¯),
which is a measure of model fit penalized by the complexity of the model. The DIC can be
thought of as a Bayesian analogue to the AIC. Assuming that D(θ) is available in closed form,
the DIC is calculated after an MCMC run by taking twice the sample mean of the simulated
values of D(θ), minus the plug-in estimate of the deviance using the sample means of the
simulated values of θ. Celeux et al. (2006) introduce variations of the DIC that allow flexibility
in whether the latent variables are regarding as missing data or as parameters in the model.
One poor property of the DIC discussed by Spiegelhalter et al. (2002) is that pD can take on
negative values. Additionally, pD is not invariant to a model’s parameterization as it involves
the posterior mean θ¯. As a result, restructuring of the data can lead to different values of the
DIC. Another drawback of the DIC is the need to fit each model with MCMC methods, which
can be difficult when the number of models being compared is large.
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1.3 Multilevel linear models
1.3.1 Introduction
Many studies collect data that have hierarchical or clustered structures. Examples include
randomized studies in which patients are clustered within practices, educational studies in which
students are clustered in schools, or environmental studies in which individuals are clustered
in homes which are clustered in counties. An analysis that ignores the clustering in these
examples regards all observations as independent, resulting in incorrect model-based standard
errors that can lead to misleading scientific inferences. Multilevel models are used to account
for the correlation of observations within a given group by incorporating group-specific random
effects. These random effects can be be nested (e.g. repeated observations of students nested
in schools, with random effects at the student and school levels), cross-nested (e.g. repeated
observations of students nested in schools and neighborhoods, with random effects at the school
and neighborhood levels), or even non-nested (e.g. individuals clustered within job categories
and states, with random effects at the job and state level). For an introduction to multilevel
models, see Gelman and Hill (2007) or Fitzmaurice et al. (2004).
1.3.2 Nested models
There can be many levels to a data hierarchy in nested multilevel modeling. A longitudinal linear
mixed model is an example of a two-level model, in which the level 1 units are the repeated
observations and the level 2 units are the subjects. A two-level model can be expressed as
Yij = x
′
ijβ + z
′
ijbj + εij, (1.32)
in which i indexes the the first level (e.g. repeated observations) and j indexes the second
level (e.g. individuals), xij is a p × 1 vector of predictors with corresponding parameters β,
and zij is q × 1 vector of predictors with corresponding random effects bj. The vector zij is
formed as a subset of the vector xij. It is assumed that the bj ∼ N(0,ψ) are independent
of εij ∼ N(0, σ2). This notation can be generalized to accommodate a three-level model (e.g.
repeated measurements clustered within patients which are clustered within practices). Let k
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index the third level, and let
Yijk = x
′
ijkβ + z
′(3)
ijk b
(3)
k + z
′(2)
ijk b
(2)
jk + εijk, (1.33)
in which xijk is a p × 1 vector of predictors with corresponding fixed effects β, z(3)ijk is q3 × 1
vector of predictors with corresponding random effects b
(3)
k , and z
(2)
ijk is q2×1 vector of predictors
with corresponding random effects b
(2)
jk . Independence is assumed between b
(3)
k , b
(2)
jk , and εijk
with distributions b
(3)
k ∼ N(0,ψ(3)), b(2)jk ∼ N(0,ψ(2)), and εijk ∼ N(0, σ2). The predictors z(3)ijk
vary across level 2 and level 1 units, while the z
(2)
ijk vary across level 1 units. The superscripts
attached to b
(3)
k and b
(2)
jk denote the levels at which the random effects vary (levels 3 and 2 in
this case, respectively). Models with more than 3 levels can be written using similar notation.
A key feature of multilevel modeling is the incorporation of covariates xijk that can be
measured at any level of the hierarchy. This allows one to address the effect of a given covariate,
say at the individual level, while controlling for the effect of a higher level covariate, say at the
school level. However, greater care is required in the interpretation of regression parameters,
because some covariates can operate at many different levels.
For example, consider a multi-center study of 229 male patients from 3 sites (Raleigh, NC;
Memphis, TN; and Galveston, TX), in which investigator’s are interested in evaluating the
effect of disinfection by-products (DBP’s) in drinking water on male reproductive outcomes
in presumed fertile men. DBP exposure was measured using water system samples and data
collected on individual water usage. Three exposure variables of interest for the outcome percent
normal sperm are brominated haloacetic acids (HAA-Br), brominated trihalomethanes (THM-
Br), and total organic halides (TOX). Our focus is to evaluate the DBP exposure effects on
sperm quality (% normal sperm) using a multilvel model. In assessing the impact of DBPs on
sperm quality, it is of interest to assess the heterogeneity among study sites with respect to
the overall mean of percent normal sperm (i.e. intercept) and each DBP effect (i.e. slope). It
may be the case that study site is a surrogate for unmeasured aspects of water quality or other
unmeasured factors of interest.
We can analyze these data using a two-level model, in which the level-1 units are the male
subjects (indexed by i), and the level-2 units are the study sites (indexed by j), which are
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Raleigh, Memphis, and Galveston. Let Yij denote the response for subject i in study site j. For
a given water exposure xij, a random intercepts model can be written as
Yij = β0 + β1xij + b
(2)
j + εij, (1.34)
in which b
(2)
j represents the random intercept of study site j. It is assumed that b
(2)
j ∼ N(0, σ22)
is independent of ²ij ∼ N(0, σ2), such that the correlation of two observations within study site
j is given by ρ = σ22/(σ
2
2 + σ
2). Note that in the longitudinal linear mixed model, we used i
to index the subjects, or the level-2 units. In multilevel models, we change this notation and
let i index the level-1 units, j index the level-2 units, k index the level-3 units, etc., even when
individuals are at higher levels in the hierarchy.
Suppose that we also collect information on the county that each subject lives in, and we
think that the sperm morphology may vary by county within a given study site. Reasons for
this may be different environmental risk factors or demographics in each of the different counties
for a given site. We extend our notation to a 3-level model by incorporating random intercepts
at the county and site level, where counties are nested within sites. In this setup, i indexes the
subject, j indexes the county, and k indexes the study site. Let n3 equal the number of level-3
units (i.e. n3 = 3 study sites). Each of the sites (for k = 1, ..., n3) is composed of n2k level-2
clusters (i.e. counties), and each of the level-2 clusters is composed of n1jk level-1 units (i.e.
subjects). Let Yijk denote the response for subject i in county j in study site k. The model can
be written as
Yijk = β0 + β1xijk + b
(3)
k + b
(2)
jk + εijk, (1.35)
in which b
(2)
jk is the random intercept for county j (nested within the kth study site), b
(3)
k is the
random intercept for site k, and xijk is the water exposure predictor for subject i in county j
in site k. It is assumed that b
(3)
k ∼ N(0, σ23), b(2)jk ∼ N(0, σ22), and ²ijk ∼ N(0, σ2), such that the
correlation of two observations within county j in site k is given by ρ = (σ23+σ
2
2)/(σ
2
3+σ
2
2+σ
2).
We can extend this model to allow the water exposure effect (i.e. slope) to vary by county
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and by study-site. Let
Yijk = β0 + b
(3)
k0 + b
(2)
jk0 + (β1 + b
(3)
k1 + b
(2)
jk1)xijk + εijk, (1.36)
in which b
(2)
jk0 and b
(2)
jk1 are the random intercept and slope for county j (nested within study site),
and b
(3)
k0 and b
(3)
k1 are the random intercept and slope for study site k, respectively. It is assumed
that b
(3)
k = (b
(3)
k0 , b
(3)
k1 )
′ ∼ N(0,ψ(3)), b(2)jk = (b(2)jk0, b(2)jk1)′ ∼ N(0,ψ(2)), and ²ijk ∼ N(0, σ2). This
model allows the intercept and water exposure effect to vary at both the county and site levels.
1.3.3 Non-nested models
In multilevel linear models, it is also possible to have non-nested random coefficients. For
example, suppose investigators are interested in modeling grade point average (GPA), Yi, for
subjects (i) nested in types of extra-curricular activities (j) and schools (k). Possible categories
for extra-curricular activities are sports, band, drama, debate, student council, etc. In this case
the subjects are nested within activities and schools, but neither activities nor schools are nested
within each other.
To illustrate, we consider a simple model with no predictors, and the focus is to determine
whether there is variability in GPA across schools and across extra-curricular activities. We
modify our notation somewhat to account for the non-nested structure. The model can be
written in terms of Yi as
Yi = β0 + αj[i] + bk[i] + εi, (1.37)
with αj[i] ∼ N(0, σ2α), bk[i] ∼ N(0, σ2b ), and εi ∼ N(0, σ2). The random effects in this example
(αj[i] and bk[i]) are non-nested because neither activities (j) nor schools (k) are subsets of the
other. We use the notation j[i] and k[i] to denote that the level-1 units (i) are nested in the
level-2 units (j and k).
Now suppose that investigators conduct an assessment test prior to the school year, and are
interested in assessing the effect of the test score on the students’ GPA, and whether hetero-
geneity exists across schools for this effect. Let xi be the test score for subject i. We can fit the
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model
Yi = β0 + αj[i] + b0k[i] + (β + b1k[i])xi + εi, (1.38)
in which bk[i] = (b0k[i], b1k[i])
′ denotes the random intercept and random slope for the kth school
corresponding to subject i (respectively), and bk[i] ∼ N2(0,ψb). This model has a random
intercept and slope for school as well as a random intercept for activity, allowing heterogeneity
in the mean GPA among activities and schools and heterogeneity in the effect of the test score
among schools.
1.3.4 Notation
Because multilevel linear models can have nested, cross-nested, and non-nested random coeffi-
cients, we need notation that encompasses these various types of data structures. We define the
general multilevel linear model with q factors as
Yi = x
′
iβ + z
′
ib[i] + εi, (1.39)
= x′iβ +
q∑
h=1
z′ihbh[i] + εi,
in which Yi is the response for observation i, i = 1, . . . ,m, xi is a p× 1 vector of predictors with
corresponding fixed effects β, b[i] = (b
′
1[i], . . . , b
′
q[i])
′, zi = (z′i1, . . . , z
′
iq)
′, zih is a dh × 1 vector
of predictors with corresponding random effects bh[i] in which [i] indexes the group in factor h
pertaining to the ith observation, and bh[i] ∼ N(0,ψh) independent of ε ∼ N(0, σ2), with bh[i]
independent of bh′[i] for h 6= h′.
To illustrate, consider the water exposure study and the nested model given in (1.36). This
model can be written as
Yi = β0 + b10[i] + b20[i] + (β1 + b11[i] + b21[i])xi + εi, (1.40)
in which b10[i] and b11[i] are the random intercept and slope for the study site corresponding to
subject i, and b20[i] and b21[i] are the random intercept and slope for the county corresponding
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to subject i. It is assumed that b1[i] = (b10[i], b11[i])
′ ∼ N(0,ψ1), b2[i] = (b20[i], b21[i])′ ∼ N(0,ψ2),
and εi ∼ N(0, σ2).
For a non-nested illustration, consider the GPA example with non-nested random coefficients.
We can express model (1.38) as
Yi = β0 + b1[i] + b20[i] + (β1 + b21[i])xi + εi, (1.41)
in which b1[i] is the random intercept for the activity corresponding to subject i, b2[i] = (b20[i], b21[i])
′
denotes the random intercept and random slope for the school corresponding to subject i. We
assume b2[i] ∼ N2(0,ψ2), b1[i] ∼ N(0, ψ1), and εi ∼ N(0, σ2).
1.3.5 Model selection in multilevel models
Testing whether a random coefficient should be included in a multilevel model involves the test
of whether the variance of that random coefficient is equal to 0. This is problematic because the
null hypothesis lies on the boundary of the parameter space. Such issues are addressed in the
literature in the context of linear mixed models (e.g. Stram and Lee, 1994), but there is very little
research specifically for testing variance components in the broader class of multilevel models.
Berkhof and Snijders (2001) proposed three score tests for variance components in multilevel
models and compare their method via simulation to the likelihood ratio test, fixed F test, and
Wald test. However, their simulations only consider two level models and it is not clear whether
generalizations to a larger number of levels are possible. Fitzmaurice et al. (2007) proposed a
permutation test for variance components in multilevel generalized linear mixed models. They
apply their method to two-level generalized mixed models and suggest strategies for multilevel
models with greater than two levels. However, their strategy cannot be directly applied to
multilevel models with crossed random effects and can only test one variance component at
a time. Frequentist methods for testing variance components in the linear mixed model are
useful to some extent in nested multilevel models for testing single variance components (e.g.
Crainiceanu and Ruppert, 2004; Verbeke and Molenberghs, 2003), but the null distributions are
not easily obtained for testing multiple variance components, and it is not clear whether these
methods can be applied to non-nested variance components. Also, Bayesian MCMC methods for
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testing variance components in the linear mixed model (e.g. Cai and Dunson, 2006; Kinney and
Dunson, 2008) may be generalizable to multilevel models, but these methods generally suffer
from computational constraints and rely on subjective choice of hyperparameters.
1.4 Joint modeling of longitudinal and time-to-event out-
comes
1.4.1 Introduction
Many clinical trials evaluate the efficacy of a treatment on correlated longitudinal and time-to-
event outcomes. For example, consider a randomized clinical trial evaluating the effectiveness
of a treatment drug versus a control in 2,000 patients with a chronic respiratory disorder. The
investigators recorded the time to death within 3 years of randomization, as well as repeated
measurements at 6 month intervals of respiratory lung function FEV, or postbronchodilator
forced expiratory volume at 1 second. Because these patients suffer from a chronic condition,
lung function is expected to deteriorate over time and ultimately result in death. Clearly,
lung function and survival are expected to be highly correlated. There are well-established
methods for analyzing these longitudinal and survival outcomes separately, including the linear
mixed model for longitudinal data (Laird and Ware, 1982) and the Cox proportional hazards
model for survival data (Cox, 1972). However, the analysis of these longitudinal and survival
outcomes separately may be inefficient or even inappropriate when the longitudinal variable is
correlated with the survival endpoint (Guo and Carlin, 2004). Such approaches ignore important
information in the other outcome as well as potentially informative dropout in the longitudinal
process. This has led to a growing literature on jointly modeling distributions of correlated
longitudinal and survival endpoints. For additional reviews of joint modeling methods, see
Hogan and Laird (1997b), Tsiatis and Davidian (2004), and Yu et al. (2004).
There are many reasons to consider a joint model of longitudinal and event outcomes. Such
reasons include describing the trajectory of the longitudinal process over time subject to infor-
mative censoring and how this is affected by baseline covariates; determining how the probability
of an event outcome is influenced by the longitudinal process; evaluating whether the longitudi-
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nal process can be used as a surrogate endpoint for the event outcome; or making predictions of
future event times for subjects who are censored. Whatever the purpose is, a general strategy
of joint models is to base inference on the joint distribution of the longitudinal and survival
outcomes.
Hogan and Laird (1997b) discuss joint models from the perspective of repeated measures
with missing, possibly non-ignorable, observations. They broadly classify the joint models as
either selection models or mixture models (see also Little, 1993). A selection model is obtained
by specifying the joint density function fy,d as a product of the conditional distribution of the
failure time di given the longitudinal measure yi, and the unconditional distribution of yi (i.e.
fy,d = fd|yfy). A mixture model is given by by first conditioning yi on di, such that fy,d = fy|dfd.
Hogan and Laird (1997b) point out that modeling the joint distribution of longitudinal and
survival outcomes is a global strategy that does not depend on which outcome is the primary
endpoint. Another broad view classifies joint model approaches as either a two-stage approach
or a likelihood-based approach (Yu et al., 2004). In a two-stage approach, estimates are imputed
for the longitudinal process at all time points, and the estimates are treated as true values of the
longitudinal process for the event outcome model. As an alternative, a likelihood-based approach
bases estimation and inference on the likelihood from a joint model of both the longitudinal
and event outcomes. The likelihood approaches simultaneously estimate parameters from both
outcome models, and are generally more accurate and efficient at estimating the relationship
between the longitudinal and event outcomes compared to two-stage approaches (Yu et al.,
2004).
We adopt the notation of Hogan and Laird (1997b) such that yoi and y
m
i denote the vectors
of observed and missing outcomes in yi, respectively. Let di be the time at which subject i
experiences an event, which may be right censored by Ci (independent of di). The time-to-event
data for subject i is given by (d˜i, δi), in which d˜i = min(di, Ci), and δi = I(di ≤ Ci). Let Xi
be additional (and complete) covariate information for subject i. The observed data are then
given by the set {(yoi , d˜i, δi,Xi) : i = 1, . . . , N}.
From a repeated measures perspective, a joint model should take into account the nature of
the missing data on the longitudinal process. Little and Rubin (1987) discuss various definitions
of missing data mechanisms. Missing data in a response yi is missing completely at random
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(MCAR) when the probability of missing does not depend on yi. It is missing at random
(MAR) when the probability of missing depends on the observed data yoi but not on the missing
data ymi . Under MCAR and MAR, one can obtain unbiased parameter estimates based on the
likelihood of the observed data. Hence the missing data mechanisms are said to be ignorable. In
contrast, missing not at random (MNAR) mechanisms are non-ignorable, because the probability
of missing depends on the unobserved data ymi . Diggle and Kenward (1994) define informative
dropout as that which induces MNAR. In the context of joint models for longitudinal and
event outcomes, we focus on models that account for informative dropout in the longitudinal
process but not in the survival endpoints. In other words, it is assumed that the censoring Ci
is independent of the event time di given the covariates in the model.
1.4.2 Mixture models
A mixture model is given by by first conditioning yi on di, such that fy,d = fy|dfd. Two types
of mixture models are pattern mixture models and random effects mixture models. In pattern
mixture models, each possible outcome of di corresponds to a different model for the longitudinal
process. Little (1993) proposes modeling the longitudinal process as a multivariate normal
distribution conditional on dropout time. The marginal distribution f(yi) is straightforward
to estimate, but informative dropout can be difficult to detect using this formulation. As an
alternative, random effects mixture models assume the conditional distribution of yi given di
can be modeled using a linear mixed model with di as a (possibly censored) covariate. This is
done by specifying distributions for (yi|bi, di), (bi|di), and (di|θd), such that the event outcome
is related to the longitudinal outcome through the random effects bi. The joint distribution
p(yi, di) is obtained by integrating over the random effects bi.
Wu and Bailey (1988, 1989) propose a random effects mixture model by specifying the
random slope as a linear function of dropout time, and calculate ordinary least squares estimates
using weighted least squares methodology. Wu et al. (1994) extend this approach to provide
robust variance estimation using bootstrap methods. Mori et al. (1992) modify the approach of
Wu and Bailey (1989) to estimate the adjusted slope using empirical Bayes methodology. These
mixture model approaches can be implemented in software with linear mixed model capabilities.
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However, a drawback of these approaches is that the dropout times must be fully observed
(i.e. no censored events). Hogan and Laird (1997a) propose maximum likelihood estimation
(MLE) that allows censoring in di. Their model assumes p(yi|di) is multivariate normal and
can accommodate non-parametric and semi-parametric forms for the cumulative distribution
function Fd of d. The authors regard the distinct outcomes of di as categories in a multinomial
distribution and use the EM algorithm to obtain maximum likelihood estimates.
Mixture models are useful when the primary goal is inference about the unconditional sur-
vivor rates or the association between the survival time and the longitudinal process. A limi-
tation of these models is there must be enough observed events (i.e. high levels of dropout) to
reliably estimate the parameters in the longitudinal model. It can also be difficult to account
for non-ignorable missing data in the longitudinal process.
1.4.3 Selection models
The majority of the literature on joint models for longitudinal and event outcomes can be classi-
fied as selection models, in which one first conditions di on yi, such that fy,d = fd|yfy. One type
of selection model is an outcome-dependent selection model (Hogan and Laird, 1997b), in which
di depends on both the observed data y
o
i and the missing data y
m
i . For example, an AIDS clini-
cal trial may define death as the event outcome and CD4 counts as the longitudinal measure. A
person experiencing death at time tk will not have observed values for CD4 counts at tk, although
the probability of death may depend on the unobserved CD4 count at tk. Diggle and Kenward
(1994) define the probability of dropout at time tk as a function of both outcome history prior
to tk, Hik = (yi1, . . . , yi,k−1), and the unobserved yik. The longitudinal outcomes are modeled
with a linear model and the probability of dropout is modeled via a logistic regression model.
Diggle and Kenward (1994) suggest that one can formally test for MAR, MCAR, and MNAR
structures by testing the coefficients in the dropout model (although this is controversial).
In some cases the missing data may be more directly related to a trend over time as opposed
to the actual longitudinal data. In these situations it is reasonable to relate the missing data
mechanism to an underlying disease or illness progression related to yi. For example, in an
AIDS clinical trial we may be interested in modeling the relationship of CD4 cell count and
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survival times. One can use subject-specific random effects to model this underlying process.
Consider the linear mixed model of Laird and Ware (1982), with the complete data y subset
into observed yoi and missing y
m
i data. In this setting, we can define the probability of dropout
as a function of yoi and y
m
i through the unobserved random effects bi, i.e.
f(di|yi, bi,θd|y) = f(di|bi,θd|y). (1.42)
Informative dropout, or non-ignorable missing data, occurs when di depends on y
m
i , conditional
on yoi . If the probability of missing depends on the random effects bi, then
f(di|yoi ,ymi ) =
∫
bi
f(di|bi,yoi ,ymi )f(bi|yoi ,ymi )dbi (1.43)
=
∫
bi
f(di|bi)f(bi|yoi ,ymi )dbi. (1.44)
Note that f(di|yoi ,ymi ) only depends on ymi because f(bi|yoi ,ymi ) depends on ymi . In other words,
the probability of missing only depends on the missing data ymi through the random effects bi.
A more general class of selection models that incorporates random effects is a shared param-
eter model (Hogan and Laird, 1997b). These models treat the random effects bi as parameters
in the model for yi, and as predictors in the model for the event outcome. Follman and Wu
(1995) discuss shared parameter models in the setting of generalized linear models and use
likelihood-based estimates that can accommodate right-censored values of di. Wu and Carroll
(1988) develop a less general shared parameter model that assumes a multivariate normal model
for the longitudinal data and a probit regression model for the probability of dropout.
Other approaches to shared parameter selection models include that of Schluchter (1992) and
DeGrutolla and Tu (1994), who specify a multivariate normal distribution on (bi, di). Schluchter
(1992) is motivated by a longitudinal study with dropouts and considers a monotone transfor-
mation h(di) on the event outcome, such that a transformation of event time is modeled as a
linear combination of the random effects. The authors assume that the subject-specific slopes
are linear functions of dropout time (see also Wu and Bailey, 1988, 1989). DeGrutolla and Tu
(1994) is motivated by using CD4 cell counts as a marker for survival in AIDS patients. The
authors model the survival time di as a linear function of the random effects, in which a non-zero
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coefficient of the random effects indicates a longitudinal process can serve as a biomarker of the
event process.
Tsiatis et al. (1995) use a similar AIDS study motivation to propose a semiparametric pro-
portional hazards model on the survival data as a function of individual trends in the progression
of CD4 cell counts. The authors use a linear mixed model on the longitudinal data, and then use
empirical Bayes (EB) estimates of the random effects as predictors in the proportional hazards
model. This is referred to as a two-stage approach (Yu et al., 2004), in which the strategy is to
impute estimates of the longitudinal process at all time points, and treat the estimates as true
values of the longitudinal process for the event outcome model. In Tsiatis et al. (1995), the
hazard of death at time t takes the form
λ(t|bi) = λ0(t) exp{φ(b0i + b1it)}, (1.45)
in which λ0(t) is the baseline hazards at time t, and φ quantifies the relationship between the
the event time and the CD4 counts. Bycott and Taylor (1998) propose a two-stage approach
similar to Tsiatis et al. (1995), in which they incorporate a Browning motion error term in
the longitudinal model. Dafni and Tsiatis (1998) investigate the two-stage approach of Tsiatis
et al. (1995) by simulation and find that the use of empirical Bayes estimators in the survival
model may exhibit bias due to violated normality assumptions of the yi (see also Tsiatis and
Davidian, 2001). Dafni and Tsiatis (1998) propose an alternative two-stage approach that allows
a different random intercept and slope model for k different treatments.
Wulfsohn and Tsiatis (1997) use an EM algorithm for a joint model that uses a mixed model
on the longitudinal data and a proportional hazards model on the survival data. Henderson et al.
(2000) use a related approach, but incorporate a mean-zero stochastic process independent of
the random effects and baseline covariates. Their longitudinal model takes the form
yij = x
′
1i(t)β1 +W1i(tij) + εij (1.46)
for times ti1, . . . , tini , in which x
′
1i(t)β1 is the mean response (with possibly time-varying pre-
dictors), W1i(t) = z
′
1i(t)bi incorporates subject-specific random effects, and εij ∼ N(0, σ2). The
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event outcome model for a proportional hazards model takes the form
λi(t) = λ0(t) exp{x′2iη2 +W2i(t)}, (1.47)
in which λ0(t) is the baseline hazards at time t, x
′
2i(t) may be a subset of x
′
1i(t), and W2i(t)
is specified similar to W1i(t). The authors assume Wi(t) = (W1i(t),W2i(t))
′ to be a non-zero
Gaussian process independent across subjects with distribution N(0,Σ). For their application,
they recommend a longitudinal process with a random intercept and slope,
W1i(t) = bi0 + bi1t, (1.48)
and a survival model
W2i(t) = γ0bi0 + γ1bi1 + γ2(bi0 + bi1t) + bi2, (1.49)
in which the bi2 are independent frailty terms, modeled as N(0, σ
2
2) variables, independent of
the (bi0, bi1)
′, which have variances σ20 and σ
2
1 and correlation ρ. The parameters γ0, γ1, and γ2
in the survival model measure the association between the two models induced by the random
intercepts, slopes, and fitted longitudinal value W1i(t). Guo and Carlin (2004) develop a fully
Bayesian version of Henderson et al. (2000) via Markov chain Monte Carlo (MCMC) methods.
They implement their methods using the software WinBUGS and compare their results to a
frequentist implementation of Henderson et al. (2000).
Lin et al. (2002) use a similar framework to Henderson et al. (2000), but employ shared
dependency in the models through a latent class variable. The latent class membership is
determined through a multinomial logistic model, and allows underlying population heterogene-
ity. The longitudinal and survival outcomes are modeled independently given the latent class
membership. Song and Davidian (2002) consider Wulfsohn and Tsiatis (1997), but relax the
assumption of normality of the random effects. They instead assume that the random effects
have a distribution with a “smooth” density.
Faucett and Thomas (1996) specify a joint model similar to Wulfsohn and Tsiatis (1997)
using a Bayesian approach via Monte chain Monte Carlo (MCMC) methods. They assume
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the baseline hazards function is a step function, and employ Gibbs sampling to sample from
the posterior distributions of the unknown parameters. Xu and Zeger (2001a) generalize this
approach to allow a stochastic process in the longitudinal model. Wang and Taylor (2001) use
a similar framework to implement a Bayesian MCMC approach. Brown and Ibrahim (2003b)
suggest a semiparametric Bayesian joint model in which the random effects are modeled non-
parametrically. Brown and Ibrahim (2003a) and Law et al. (2002) propose Bayesian joint
models that account for cured fraction. For a more thorough review of Bayesian joint models,
see Ibrahim et al. (2001).
Tsiatis and Davidian (2001) focus on estimation of the parameters in the hazards model.
They use a set of unbiased estimating equations that yield consistent and asymptotically normal
estimators without specifying distributional assumptions on the random effects. Faucett et al.
(2002) and Xu and Zeger (2001b) focus on inference on the marginal event time distribution,
incorporating the longitudinal data as auxiliary information. More recent developments include
Tseng et al. (2005), in which the authors propose an accelerated failure time model on the
event outcome. They use a Monte Carlo EM algorithm to estimate the unknown parameters
and the baseline hazard function. Hsieh et al. (2006) examine the robustness of maximum
likelihood estimates against departure from the normal random effects assumption. They also
discuss a profile likelihood approach, and suggest using bootstrap methods to obtain reliable
variance estimates. Yu et al. (2004) formulate a joint model to account for the cured fraction,
and consider estimates from the Monte Carlo EM algorithm and MCMC methods.
1.4.4 Limitations of joint models
Joint modeling methods can be computationally demanding, difficult to implement, and may
require specialized software (Hogan and Laird, 1997b). Many of the joint model approaches
make strong parametric assumptions regarding the longitudinal and survival processes (Tsiatis
and Davidian, 2004; Yu et al., 2004). These assumptions may not be obvious and can be difficult
to validate.
One strong assumption commonly made in joint models, though not required, is that the
missing data ymi are ignorable (Yu et al., 2004). However, in many instances this assumption
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is not reasonable and may lead to biased inference. For example, consider the study of chronic
lung disease, in which investigators are interested in assessing the effect of treatment on FEV
and survival. A person with rapidly decreasing FEV values may die at time tij, but as a result
of death will not have an FEV measurement at time tij. It may even be the case that the last
FEV measurement prior to death showed reasonably good values and provided no indication
of decreasing lung function. In this case the probability of death depends on the unobserved
FEV value at time tij, resulting in non-ignorable missing data. If one is interested in evaluating
baseline covariates as predictors of FEV measurements and survival, a joint model would be
appropriate. However, it would need to account for the non-ignorable missing data in the FEV
measurements.
In many settings such as clinical trials, the primary effect of interest may be a baseline
covariate such as a treatment effect. Fitting a marginal model on either the longitudinal or
survival outcomes separately ignores important information in the other outcome. Many joint
models are too complex and computationally demanding to implement in practice, and make
strong assumptions regarding the longitudinal and survival outcomes. An ideal joint model
would incorporate information from both longitudinal and survival outcomes in a simple manner
that is straightforward to implement and makes limited distributional assumptions.
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TABLE 1.1: Grades of evidence of Bayes factors
Bayes factor Interpretation
B10 < 1/10 Strong evidence for H0
1/10 < B10 < 1/3 Moderate evidence for H0
1/3 < B10 < 1 Weak evidence for H0
1 < B10 < 3 Weak evidence for H1
3 < B10 < 10 Moderate evidence for H1
B10 > 10 Strong evidence for H1
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CHAPTER 2
Testing Random Effects in the Linear
Mixed Model Using Approximate
Bayes Factors
2.1 Introduction
The linear mixed model with random effects (Laird and Ware, 1982) is a popular method for
fitting longitudinal data. In such models it is often of interest to test whether certain random
effects should be included the model. Testing whether a random effect should be included
in the model involves the test of whether the variance of that random effect is equal to 0.
Because this test lies on the boundary of the parameter space, classical procedures such as
the likelihood ratio test can break down asymptotically (Pauler et al., 1999; Lin, 1997; Self
and Liang, 1987; Stram and Lee, 1994). It has been shown that tests for a single variance
component can be carried out using mixtures of chi-square distributions (Self and Liang, 1987;
Stram and Lee, 1994). In more complex model comparisons (i.e. testing more than one random
effect), distributions of test statistics are more complex and are not easily applied (Pauler et al.,
1999; Feng and McCulloch, 1992; Shapiro, 1988). Some alternative frequentist methods include
score tests (Lin, 1997; Commenges and Jacqmin-Gadda, 1997; Verbeke and Molenberghs, 2003;
Molenberghs and Verbeke, 2007; Zhang and Lin, 2008), Wald tests (Molenberghs and Verbeke,
2007; Silvapulle, 1992), and generalized likelihood ratio tests (Crainiceanu and Ruppert, 2004),
but these methods also require modified asymptotic null distributions for tests on the boundary
of the parameter space.
Bayesian sampling-based estimation approaches for calculating Bayes factors can also en-
counter numerical problems on the boundary of the parameter space. Markov chain Monte
Carlo (MCMC) methods such as the Gibbs sampler or data augmentation can fail for certain
choices of default priors on the random effects (Gilks and Roberts, 1996). Some MCMC methods
have been suggested to test variance components (Sinharay and Stern, 2001; Chen and Dunson,
2003; Cai and Dunson, 2006; Kinney and Dunson, 2008), but these methods are generally time
consuming to implement, require special software, and rely on subjective choice of hyperpa-
rameters which are difficult to elicit. The most widely used approximation to the Bayes factor
is based on the Laplace approximation (Tierney and Kadane, 1986), resulting in the Bayesian
information criterion (BIC) (Schwarz, 1978) under certain assumptions. However, the required
regularity conditions of the Laplace approximation fail when the parameter lies on the boundary
(Pauler et al., 1999; Hsiao, 1997; Erkanli, 1994). Pauler et al. (1999) proposed estimating Bayes
factors for model comparison using an importance sampling approach and a boundary Laplace
approximation. Their methods are relatively complex and are only applied in the context of
simple variance component models.
Because random effects involve a distinct parameter for every individual, linear mixed models
can have a very large number of dimensions. This is problematic in calculating Bayes factors,
because high dimensional integrals are needed to calculate marginal likelihoods. Generally these
integrals are not available in closed form, and one must consider approximations. Numerical
integration methods are not efficient nor useful in such high-dimensional integrals (Kuonen,
2003). Monte Carlo integration and importance sampling methods are generally recommended
for approximating high-dimensional integrals, but these methods lack accuracy and are compu-
tationally demanding. The Laplace and BIC approximations also suffer in performance from
high-dimensionality (Kass and Raftery, 1995). In addition, it is not entirely clear how to define
the dimensional penalty, or “effective dimension”, in the BIC approximation (Spiegelhalter et
al., 2002).
An additional challenge to model selection via Bayes factors lies in the choice of prior dis-
tributions. It is well known that Bayes factors are sensitive to the choice of priors (Kass and
37
Raftery, 1995). This is problematic in situations in which one has no prior information on the
parameters, and the goal is to choose the best model based on the data. In these situations, it is
common to use default priors, which can be chosen based on the data without subjective inputs
and that result in good frequentist and Bayesian operating characteristics. However, one must
choose these default prior variances with care, because as the prior variance increases toward
infinity the Bayes factor will increasingly favor the null model (Bartlett, 1957). It has been
documented that normal priors lead to aberrant behavior in model selection problems, leading
Jeffreys (1961) to suggest the Cauchy prior as a heavy-tailed and more robust alternative. This
early work by Jeffreys was extended by Zellner and Siow (1980) to develop a robust class of
multivariate Cauchy priors for variable selection problems. Zellner’s g-prior (Zellner, 1986) has
been widely adopted in linear models, and only requires the specification of one hyperparameter.
Liang et al. (2005) generalized Zellner’s g-prior by implementing a fully Bayes approach using
mixtures of g-priors.
We propose a simple approach for conducting approximate Bayesian inferences on testing
whether to include random effects in the linear mixed model using Bayes factors. Our approach
involves a re-parameterization of the linear mixed model, and allows for accurate approximations
to the Bayes factor via Laplace’s approximation. In Section 2 we introduce our method in
the context of a repeated measures ANOVA model, and conduct a simulation to evaluate its
performance in testing a subject-specific intercept. In Section 3 we generalize our approach to
the linear mixed model, and in Section 4 we illustrate our method using two data examples. We
conclude with a discussion in Section 5.
2.2 Testing a random intercept
2.2.1 ANOVA model
We start by considering a simple ANOVA model with a random subject effect
M
(1)
1 : Yij = µ+ λbi + εij, (2.1)
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in which Yij is the jth response for subject i, µ is an intercept, bi ∼ N(0, σ2) is a scaled
random effect multiplied by a parameter λ > 0, and εij ∼ N(0, σ2) is the disturbance term for
i = 1, . . . , n and j = 1, . . . , ni. This is an ANOVA model with a random effect variance equal to
λ2σ2, in which λ is a parameter controlling the level of within subject correlation. The utility of
this variance component decomposition will later become clear. The notation M
(a)
k represents
parameterization (a) for model k. We distinguish models parameterized in different ways in order
to consider the impact of parameterization on the accuracy of the Laplace approximation to the
marginal likelihood. The implied covariance matrix of yi = (Yi1, . . . Yini)
′ is σ2(Ini + λ
21ni1
′
ni
),
in which Ini is the ni × ni identity matrix, and 1ni is a ni × 1 vector of 1’s. It follows that the
implied correlation between Yij and Yis for j 6= s is
ρ(Yij, Yis) =
λ2
1 + λ2
. (2.2)
Our initial focus is to compare the ANOVA model to a model with no random subject effect,
M0 : Yij = µ+ εij, (2.3)
in which µ is an overall mean and εij ∼ N(0, σ2). We are interested in estimating Bayes factors
to determine which model has the largest posterior odds given equal prior odds, given by
B
(a)
10 =
p(Y |M (a)1 )
p(Y |M0) , (2.4)
in which Y = (y′1, . . . ,y
′
n)
′. Estimating the Bayes factor implies deriving estimates of p(Y |M (a)k ),
or
p(Y |M (a)k ) =
∫
p(Y |θ(a)k ,M (a)k )pi(θ(a)k |M (a)k )dθ(a)k , (2.5)
in which p(Y |θ(a)k ,M (a)k ) is the data likelihood, θ(a)k is the vector of model parameters, and
pi(θ
(a)
k |M (a)k ) is the prior distribution of θ(a)k . For clarity, let M (a)0 = M0, i.e. only one parame-
terization ofM0 will be considered. ForM
(a)
1 andM0, the marginal likelihoods are not generally
not available in closed form for common choices of prior distributions. Let θ
(a)
1 = (ζ
′(a)
1 , b
′, σ2)′
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and θ
(a)
0 = (ζ
′(a)
0 , σ
2)′, such that the vector ζ(a)k denotes all parameters other than the random
effects b and residual variance σ2. We specify an inverse gamma prior on σ2 with parameters
v, w, in which the mean of σ2 is w/(v− 1) for v > 1. By marginalizing out b and σ2 in M (1)1 and
σ2 in M0, it can be shown that (Y |µ, λ,M (1)1 ) and (Y |µ,M0) follow multivariate t-distributions
with the general form
p(Y |ζ(a)k ,M (a)k ) =
Γ
(
2v+m
2
)∏n
i=1 |wvΣi|−1/2
(pi2v)m/2Γ(2v/2)
(2.6)
×
{
1 +
1
2v
n∑
i=1
(yi − µi)′
(
w
v
Σi
)−1
(yi − µi)
}− 2v+m
2
,
in which m =
∑n
i=1 ni is the total number of observations. In our ANOVA setup, µi = µ1ni
in both M0 and M
(1)
1 , Σi = Ini in M0, and Σi = (Ini + λ
21ni1
′
ni
) in M
(1)
1 . After specifying a
suitable prior on µ, the Laplace method can be used to integrate over (µ, λ) inM
(1)
1 and µ inM0.
We then use the resulting marginal likelihood estimates to estimate the Bayes factor B
(1)
10 . Note
that the vector µi and the matrix σ
2Σi are the mean and covariance matrix of yi marginalized
over the random effect bi. For additional details regarding these multivariate t-distributions, see
the Appendices.
The Laplace approximation is based on a linear Taylor series approximation of l˜(ζ
(a)
k ) =
log{p(Y |ζ(a)k ,M (a)k )pi(ζ(a)k |M (a)k )}. The marginal likelihood p(Y |M (a)k ) for model k and parame-
terization (a) is estimated by
p̂(Y |M (a)k ) = (2pi)d/2|Σ˜(a)k |1/2p(Y |ζ˜(a)k ,M (a)k )pi(ζ˜(a)k |M (a)k ), (2.7)
in which Σ˜
(a)
k is the Hessian matrix of l˜(ζ
(a)
k ) evaluated at the posterior mode ζ˜
(a)
k . Because
the Laplace approximation is based on a linear Taylor series approximation, it requires certain
regularity conditions. When the posterior mode lies on the boundary of the parameter space
these regularity conditions fail. The Laplace method can perform poorly even if the mode is
close to the boundary of the parameter space; hence estimating the marginal likelihood in M
(1)
1
via Laplace can be problematic because of the restricted parameter space of λ > 0. If the
posterior mode λ˜ is close to 0, this can cause problems with the accuracy of the approximation.
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Hence we consider an alternate parameterization of equation (2.1),
M
(2)
1 : Yij = µ+ e
φbi + εij, (2.8)
in which φ = log(λ). Note the parameter space of φ is unrestricted, ensuring that the posterior
mode falls within the boundaries of the parameter space. Because the posterior mode of φ
will not violate the regularity conditions of the Laplace approximation, the estimated marginal
likelihoods based on M
(2)
1 may be more accurate than those based on M
(1)
1 . Following the steps
outlined previously, it can be shown that (Y |µ, φ,M (2)1 ) follows a multivariate t-distribution with
density (2.6), with µi = µ1ni and Σi = (Ini + e
2φ1ni1
′
ni
). We use the Laplace approximation to
integrate over (µ, φ), and use the resulting estimate of the marginal likelihood to estimate the
Bayes factors B
(2)
10 .
2.2.2 Prior choice
It is well understood that a Bayes factor is sensitive to the choice of prior distributions (Kass and
Raftery, 1995). As the prior variance of the random effect increases toward infinity, the Bayes
factor will increasingly favor M0 over the random effects model. It is therefore of interest to
suggest default priors that yield robust tests with respect to model selection. In our model, we
have introduced a parameter λ (or eφ) that controls the contribution of the random effect, free of
the scale of the data. We propose default priors of λ ∼ logN(κ = 0, τ = 1) and φ ∼ N(0, 1), in
which κ and τ denote the mean and variance of the log-normal distribution on the log scale. The
priors on λ and φ are “equivalent” priors, meaning they lead to the same marginal likelihood.
Any differences in the estimated marginal likelihoods between M
(1)
1 and M
(2)
1 should be a result
of differences in the accuracy of the Laplace approximation under different parameterizations.
In choosing a prior distribution for λ(> 0), we want to avoid a prior that is concentrated
around the null value of 0. Given that the the random effects are scaled to the residual error,
a logN(0, 1) prior on λ is a reasonable default prior for model selection. After marginalizing
out σ2, this log normal prior is heavy-tailed and covers most reasonable mean values of the
parameter.
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2.2.3 Simulation study
We conducted a simulation study to evaluate the performance of parameterization M
(2)
1 and
M
(1)
1 in correctly identifying models with or without random effects. We simulated 100 data
sets based on parameterization (2.1), with n = 25, 50, 100, 500, 1000, 5000, ni = 3 and σ
2 = 1.
The parameter λ was varied to allow different degrees of correlation in the simulated data, or
correlations of 0, 0.14, 0.33, 0.5, 0.69. In order to implement the Laplace approximation, we
estimated the posterior mode using an algorithm by Nelder and Mead (1965). We used prior
distributions µ ∼ N(0, 1) and σ2 ∼ InvGam(1, 1). Estimates of the Bayes factors B(1)10 and B(2)10
were calculated for each data set for a given correlation, and were interpreted according to the
scale given by Wasserman (2000) and Jeffreys (1961). Table 2.1 includes the percent of times
that the estimated Bayes factors fell into the respective categories, indicating weak, moderate,
or strong evidence in favoring a given model.
Both parameterizations performed well in favoring the correct model, but accuracy depended
on both the sample size and the simulated correlation. In general, as ρ increased our method
increasingly favored M
(a)
1 over the null model. As the sample size increased, our method more
accurately detected the absence of a random slope for ρ = 0, and more accurately detected the
presence of a random slope for ρ > 0. For small sample sizes, we observed reasonably good
performance with zero or moderate correlation (ρ = 0, ρ ≥ 0.33). However, larger sample sizes
were needed in order to detect smaller correlations close to the boundary. Figure 2.1 shows
box plots of log Bˆ
(1)
10 for ρ = 0, 0.33. The dotted black line represents a log Bayes factor of 0
(i.e. Bayes factor equal to 1). As n goes toward infinity the estimated log Bayes factor B
(1)
10
goes to infinity for ρ = 0.33, and goes to negative infinity for ρ = 0, showing that our method
increasingly favors the correct model as n increases.
The estimated Bayes factors comparing M
(a)
1 to M0 were very similar across parameteriza-
tions, even close to the boundary. We also considered the use of numerical integration to more
effectively compare the parameterizations. For finite integrals of low dimension, adaptive nu-
merical integration is an accurate and efficient method for calculating integrals. We employed
transformations on the parameters (λ, φ, µ) to map the infinite integral in (2.5) to a finite
integral, and implemented Genz’ (1991) adaptive numerical integration routine for sample sizes
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n = 25, 50. We did not find either parameterization to outperform the other. In fact, the Laplace
approximations from the two parameterizations were so close that it was difficult to compute
a numerical integration approximation with enough precision to distinguish between the two
parameterizations. Hence, given the similarities between the two parameterizations, it is fairly
evident that the boundary issue of λ is not a major problem with the Laplace approximation in
this model.
2.3 Testing a random slope
2.3.1 Linear mixed model
We generalize our approach for testing random effects by considering a linear mixed model
(Laird and Ware, 1982) of the form
yi =Xiβ +Zibi + εi, (2.9)
in which yi = (Yi1, . . . , Yini)
′ is a ni × 1 vector of responses, Xi = (xi1, . . . ,xip) is a ni × p
design matrix, Zi = (zi1, . . . , ziq) is a ni × q design matrix, β = (β1, . . . , βp)′ is a p × 1 vector
of parameters, and bi = (bi1, . . . , biq)
′ is a q × 1 vector of random coefficients. The matrix Zi
is usually considered to be a subset of Xi. It is assumed that εi ∼ N(0,R) is independent of
bi ∼ N(0,ψ), in which ψ is the q× q covariance matrix of random effects. A popular choice for
R is σ2I, which assumes the observations are independent within a subject given the random
coefficients.
We choose bih ∼ N(0, σ2), and introduce a parameter λh that controls the relative contri-
bution of the hth random effect of subject i. Let M
(a)
k refer to model k and parameteriza-
tion a. Similar to the approach of Chen and Dunson (2003) (but without the assumption of
b0,i ∼ N(0, I)), our reparameterized model takes the form
M
(1)
0 : yi =Xiβ +Z0,iΛ
(1)
0 Γ0b0,i + εi, (2.10)
in which Z0,i = (zi1, . . . , ziq), b0,i = (bi1, . . . , biq)
′, Λ(1)0 is a positive diagonal matrix with
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diagonal elements λ
(1)
0 = (λ1, . . . , λq)
′, and λ(1)0 ∼ logN(0q, Iq) as an extension of the “default”
prior suggested in 2.2.2. Let Γ0 be a lower triangular matrix with 1q along the diagonal, and
lower off-diagonal elements γ0 which induce correlation between the respective random effects.
Our focus is to test whether to include an additional random effect bi(q+1). Let Z1,i, Λ
(1)
1 , Γ1,
and b1,i be equal to their counterparts from (2.10), but including the elements corresponding
to the additional random effect bi(q+1). The full model including the additional random effect
takes the form
M
(1)
1 : yi =Xiβ +Z1,iΛ
(1)
1 Γ1b1,i + εi, (2.11)
in which Z1,i = (zi1, . . . , zi(q+1)), b1,i = (bi1, . . . , bi(q+1))
′, Λ(1)1 is a positive diagonal matrix
with diagonal elements λ
(1)
1 = (λ1, . . . , λq+1)
′ and λ(1)1 ∼ logN(0q+1, Iq+1), and Γ1 is a lower
triangular matrix with 1q+1 along the diagonal and lower off-diagonal elements γ1.
As demonstrated with the ANOVA model, we also consider an alternate parameteriza-
tion of (2.10) and (2.11), by setting λ
(2)
k = φk = logλ
(1)
k , with λ
(2)
0 ∼ N(0q, Iq) and λ(2)1 ∼
N(0q+1, Iq+1). We define Λ
(2)
0 as a diagonal matrix with diagonal elements e
λ
(2)
0 = (eφ1 , . . . , eφq),
and Λ
(2)
1 as a diagonal matrix with diagonal elements e
λ
(2)
1 = (eφ1 , . . . , eφq+1). Let M
(2)
0 denote
the reduced model and M
(2)
1 denote the full model under this parameterization.
2.3.2 Approximating the marginal likelihoods
In order to implement the Laplace approximation, we first marginalize out b and σ2. Let
σ2 ∼ InvGam(v, w). It can be shown that the marginal distribution p(Y |β,λ(a)k ,γk,Mk) fol-
lows a multivariate t-distribution with density (2.6), in which µi = Xiβ and Σi = (Ini +
Zk,iΛ
(a)
k ΓkΓ
′
kΛ
′(a)
k Z
′
k,i). Integrating out all random effects simultaneously dramatically decreases
the dimension of the integral needed for the marginal likelihoods. After specifying suitable pri-
ors for β and γk, we use the Laplace method to integrate over (β,λ
(a)
k ,γk) to approximate the
marginal likelihoods p(Y |M (a)k ) used to evaluate the Bayes factor B(a)10 . For additional details
regarding these multivariate t-distributions, see the Appendices.
As previously discussed, many of the existing methods for testing variance components are
only applicable in simple settings, e.g. testing a single variance component. One major ad-
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vantage of our approach is we can test multiple random effects simultaneously by modifying
equation (2.11) such that the Z1,i, Λ
(a)
1 , Γ1, and b1,i correspond to a model with several addi-
tional random effects. Incorporating default priors on the β coefficients, one can simultaneously
compare models with varying numbers of both fixed and random effects.
2.3.3 Simulation study
We conduct a simulation study to test for the presence of a random slope. We define one
predictor based on time, such that xi = (1, 2, . . . , J)
′,Xi = (1,xi), and β = (β0, β1)′. Consistent
with our previous notation, let M1 refer to the random intercept model and M2 refer to the
random intercept and slope model. Letting Z1,i = 1J , λ
(a)
1 = λ
(a)
0 , and b1,i = bi0, we have
M
(a)
1 : yij = β0 + λ
(a)
0 bi0 + β1xij + εij (2.12)
for the random intercepts model. Letting Z2,i = (1J ,xi), λ
(a)
2 = (λ
(a)
0 , λ
(a)
1 )
′, and b2,i = (bi0, bi1)′,
we have
M
(a)
2 : yij = β0 + (λ
(a)
0 + γ12xijλ
(a)
1 )bi0 + (β1 + λ
(a)
1 bi1)xij + εij (2.13)
for the random intercept and slope model. Our focus is to compare model M
(a)
2 to M
(a)
1 . After
integrating out b and σ2 to produce marginal multivariate t-distributions, the integrals needed
to calculate the marginal distributions p(Y |M (a)1 ) and p(Y |M (a)2 ) only have 3 or 5 dimensions,
respectively. Hence the Laplace method can effectively be used to integrate over (β0, β1, λ
(a)
0 ) in
M
(a)
1 and (β0, β1, λ
(a)
0 , λ
(a)
1 , γ12) in M
(a)
2 .
We simulated 100 data sets based on a random intercept and slope model under the standard
notation of Laird and Ware (1982) as shown in (2.9), i.e.
Yij = β0 + bi0 + (β1 + bi1)xij + ²ij. We set β0 = 0, β1 = 0.5, J = 10, σ
2 = 1, and we generated
the random effects from a multivariate normal distribution bi ∼ N2(0,ψ), in which ψ11 = 1
and ψ12 = ρ(bi0, bi1)
√
ψ11ψ22 = −0.3. We considered different combinations of the random
slope variance component and sample size by varying
√
ψ22 = 0, 0.04, 0.08, 0.15, 0.25 across
n = 25, 50, 100, 500, 1000, 5000. For implementing the Laplace approximation to the marginal
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likelihoods, we used prior distributions β ∼ N(0, I), σ2 ∼ InvGam(1, 1), and γ12 ∼ N(0, 1).
As illustrated in Table 2.2, our method performed well in favoring the correct model, but
accuracy depended on both the sample size and the simulated variance of the random slope.
In general, as the standard deviation of bi1 increased, our method increasingly favored M
(a)
2
over M
(a)
1 . As the sample size increased, our method more accurately detected the absence of
a random slope for
√
ψ22 = 0, and more accurately detected the presence of a random slope
for
√
ψ22 > 0. For smaller sample sizes, our method generally detected the random slope for
√
ψ22 ≥ 0.15, indicating our method is useful even for small sample sizes with moderate to large
random effects. Figure 2.2 shows box plots of log Bˆ
(1)
21 for
√
ψ22 = 0 and
√
ψ22 = 0.08. As n
goes to infinity the estimated log Bayes factor Bˆ
(1)
21 goes to infinity for
√
ψ22 = 0.08, and goes
to negative infinity for
√
ψ22 = 0. This indicates the estimated Bayes factor increasingly favors
the correct model as n increases.
As noted previously, the approximations to the marginal likelihoods do not seem to vary
a great deal across parameterizations. Similar patterns were found in this simulation, with
most differences extremely small. Occasionally we did observe large differences between the
marginal likelihood estimates of M
(2)
2 and M
(1)
2 for simulated variances close to the boundary
for n = 5000. It appears that this situation was due to occasional poor convergence of the
maximization routine for the λ
(2)
k parameterization, and not due to the Laplace approximation
itself.
2.4 Illustrative examples
2.4.1 Hamilton Rating Scale for Depression
To illustrate our method, we consider a clinical trial of patients with bipolar I disorder (Cal-
abrese et al., 2003), GlaxoSmithKline study SCAB2003. The investigators concluded that the
treatment drug, lamotrigine, significantly delays the time to intervention for a depressive episode
compared to placebo. The investigators also collected repeated measurements on the Hamil-
ton Rating Scale for Depression (HAMD), a numerical measure of the severity of depressive
symptoms. As a secondary analysis, we wish to determine if lamotrigine is effective in reducing
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depressive symptoms during the first year after randomization as measured by the HAMD-17
summary score. Larger HAMD-17 scores reflect higher levels of depression.
We consider 275 patients (160 lamotrigine 200/400 mg/day, 115 placebo) with at least one
outcome measurement and complete covariate data. The number of repeated measurements per
subject ranges from 1 to 17, and HAMD-17 scores range from 0 to 35, with a mean value of
7. To better approximate normality, we used a square root transformation of HAMD-17 (sqrt-
HAMD-17). We fit a linear mixed model with sqrt-HAMD-17 as the response, predicted by
sqrt-HAMD-17 at screening and baseline, time (in years), treatment, gender, age (< 30, 30-40,
40-50, ≥ 50), and the number of depressive or mixed episodes in the last year (1-2 vs. ≥ 3).
Screening refers to the time at enrollment, and baseline refers to the time of randomization
(after stabilization).
In assessing the impact of lamotrigine on HAMD-17 scores, it is also interesting to assess
the variability among patients with regards to the overall mean and slope. One might expect
patients to have different patterns of depressive episodes across time, perhaps resulting from
biological mechanisms or individual responses to drug treatment. This leads to the task of
testing whether to include random effects in our model. Our focus is to compare models with
varying combinations of a random intercept and slope, i.e. M0: a model without random effects;
M1: a model with a random intercept; and M2: a model with a random intercept and slope.
Based on the scale of both the response and the explanatory variables, we use vague priors on
the fixed effects β and residual variance σ2 that accommodate a wide range of reasonable mean
values. We define these priors as β ∼ N9(0, 10I) and σ2 ∼InvGamma(0.01, 0.01).
The estimated log Bayes factors for the respective comparisons are log βˆ21 = 61.0, log βˆ20 =
348.5, log βˆ10 = 287.5. These estimates show strong evidence for M2 versus the other models,
indicating the intercepts and slopes vary significantly by individual. We fit the preferred model,
M2, using MCMC methods based on 15,000 samples, with a burn-in of 10,000. Figure 2.3 shows
the predicted overall mean for each treatment group and the predicted individual sqrt-HAMD-
17 for 50 random subjects. The predicted overall mean is based on a 40-50 year old female with
1-2 depressive episodes in the past year, and average values of sqrt-HAMD-17 at screening and
baseline (2.2 and 4.8, respectively). There is large variability in the subject specific intercepts
and slopes. Lamotrigine use, age, and sqrt-HAMD-17 at screening and baseline all appear to
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be significant predictors of the outcome. A one unit increase in sqrt-HAMD-17 at baseline is
associated with a 0.63 (95% CI = 0.51, 0.74) increase in mean sqrt-HAMD-17, and a one unit
increase in sqrt-HAMD-17 at screening is associated with a 0.22 (95% CI = 0.02, 0.48) increase
in mean sqrt-HAMD-17. On average, patients 30-40 years old have sqrt-HAMD-17 values 0.18
(95% CI = −0.20, 0.56) units greater than patients < 30 years old, patients 40-50 years old have
sqrt-HAMD-17 values 0.47 (95% CI = 0.13, 0.82) units greater than patients < 30 years old, and
patients ≥ 50 years old have sqrt-HAMD-17 values 0.39 (95% CI = 0.05, 0.73) units greater than
patients < 30 years old. As the main association of interest, sqrt-HAMD-17 values for subjects
on lamotrigine are on average 0.33 units lower (95% CI = −0.54,−0.10) than sqrt-HAMD-17
values for subjects on placebo. The 95% credible interval does not contain 0, indicating that
lamotrigine may be effective at reducing depressive symptoms. These conclusions reinforce the
time-to-event analysis of Calabrese et al. (2003).
2.4.2 Exposure of disinfection by-products in drinking water and
male fertility
A multi-center study of 229 male patients from 3 sites (A, B, C) was conducted to evaluate
the effect of disinfection by-products (DBP’s) in drinking water on male reproductive outcomes
in presumed fertile men. DBP exposure was measured using water system samples and data
collected on individual water usage. Three exposure variables of interest for the outcome percent
normal sperm are brominated haloacetic acids (HAA-Br), brominated trihalomethanes (THM-
Br), and total organic halides (TOX).
Our focus is to model the response (% normal sperm) using the three DBP exposure vari-
ables. Because we are interested in each exposure’s effect independent of the other exposure
variables, we fit three separate models, one for each DBP exposure. In each model we control
for the following baseline covariates using indicator variables: male age (< 25, 25-30, 30-35,
> 35), education (high school or less, some college, graduated college), and the abstinence in-
terval before taking the sample (2-3 days, 4-8 days, or > 8 days). We scale each predictor by
subtracting the overall mean of the predictor and dividing by a constant c (c = 10 for HAA-Br
and THM-Br, and c = 100 for TOX) to allow for better computational efficiency. We use a
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probit transformation of percent normal sperm and multiply the result by 5, so the tranformed
response has a range of -10.5 to -1.8, a mean of -5.6, and a variance of 1.8.
In assessing the impact of DBP’s on sperm quality, it is also of interest to assess the variability
among study sites with regards to the overall mean of percent normal sperm (i.e. intercept) and
each DBP effect (i.e. slope). It may be the case that study site is a surrogate for unmeasured
aspects of water quality or other unmeasured factors of interest. For each DBP exposure,
we define three models based on the inclusion of random effects, i.e. M0 : a model without
random effects; M1 : a model with a random intercept; and M2 : a model with a random slope
and intercept. Based on the scale of both the response and the explanatory variables, we use
vague priors on the fixed effects β and residual variance σ2 that accommodate a wide range of
reasonable mean values. We define these priors as β ∼ N9(µ,Σ) and σ2 ∼InvGamma(0.01, 0.01),
with µ = (−5.5,0′8)′ and Σ a diagonal matrix with diagonal elements (100, 10× 1′8).
For HAA-Br, we observe moderate evidence for M1 versus M2 (Bˆ12 = 6.9) and strong
evidence for M1 versus M0 (log Bˆ10 = 15.3). For THM-Br, we observe strong evidence for M1
versus both M2 (Bˆ12 = 10.5) and M0 (log Bˆ10 = 19.2). For TOX, we observe weak evidence for
M1 versus both M2 (Bˆ12 = 1.1) and strong evidence for M1 versus M0 (log Bˆ10 = 12.9). Hence
the random intercepts modelM1 is favored by the Bayes factor for all three DBP exposures. For
comparison, we fit both models M1 and M2 using MCMC methods based on 40,000 samples,
with a burn-in of 40,000 for each model. We plot the predicted mean response based on M2, for
a 30-35 year old male who has graduated college and has abstained for 2-3 days (Figure 2.4). For
each of the three exposure models, one can see that there is some separation of the intercepts
and varying degrees of agreement between the slopes. Although the point estimates of the slopes
(based on the posterior means) appear to be quite different, the large variability associated with
these estimates suggests that the slopes do not vary by study site. Hence we conclude that M1
is the preferred model for each of the predictors. Based onM1, both HAA-Br and THM-Br have
posterior distributions centered near 0, indicating little association between these DPB’s and
percent normal sperm. The posterior distribution of TOX tends to be centered below 0, with a
posterior mean of -1.20 (95 % CI = -3.67,0.47); however, the 95% credible interval contains 0.
49
2.5 Discussion
We recommend our approach as a simple and efficient method in testing random effects in the
linear mixed model. Our approach avoids issues with testing on the boundary of the param-
eter space, uses low-dimensional approximations to the Bayes factor, and incorporates default
priors on the random effects. We have shown Laplace’s method to be an effective approach to
estimating Bayes factors, even in cases in which the variance of the random effect lies on the
boundary. By scaling the random effects to the residual variance and introducing a parame-
ter that controls the relative contribution of the random effects, we can effectively integrate
out the random effects and reduce the dimensionality of the marginal likelihood. The scaling
of the random effects to the residual variance makes the logN(0, I) and N(0, I) distributions
reasonable default priors for λ
(1)
k and λ
(2)
k , respectively. Simulations suggest that these priors
have good small sample properties and consistency in large samples. Incorporating reasonable
default priors on the fixed effects, our method can be used for comparing a large class of random
effects models with varying fixed and random effects.
Alternative procedures for allowing default priors for model selection via Bayes factors are
discussed by Berger and Pericchi (1996). These include the authors’ proposed intrinsic Bayes
factors, the Schwarz approximation (Schwarz, 1978), and the methods of Jeffreys (1961) and
Smith and Spiegelhalter (1980). Gelman (2006) discusses various approaches to default pri-
ors specifically for variance components. Common approaches include the uniform prior (e.g.
Gelman, 2007), the half-t family of prior distributions, and the inverse-gamma distribution
(Spiegelhalter et al., 2003). These prior distributions can encounter difficulties when the vari-
ance components are close to 0. Other discussions of selecting default priors on variance compo-
nents include Natarajan and Kass (2000), Browne and Draper (2006), and Kass and Natarajan
(2006).
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TABLE 2.1: Testing a random intercept, Bˆ
(a)
10
Parameterization (1) Parameterization (2)
Favor null Favor random int. Favor null Favor random int.
n ρ < 0.1 0.1-0.33 0.33-1 1-3 3-10 > 10 < 0.1 0.1-0.33 0.33-1 1-3 3-10 > 10
25 0 6 67 22 4 0 1 7 71 18 3 0 1
0.14 0 31 35 22 9 3 0 36 31 21 9 3
0.33 0 1 12 20 25 42 0 1 14 18 25 42
0.5 0 0 0 4 7 89 0 0 1 3 7 89
0.69 0 0 0 0 0 100 0 0 0 0 0 100
50 0 23 50 18 7 2 0 27 51 13 7 2 0
0.14 2 22 34 16 14 12 4 25 30 18 11 12
0.33 0 0 7 4 8 81 0 0 7 5 8 80
0.5 0 0 0 0 0 100 0 0 0 0 0 100
0.69 0 0 0 0 0 100 0 0 0 0 0 100
100 0 43 43 12 2 0 0 52 36 10 2 0 0
0.14 3 12 18 21 15 31 6 13 15 22 15 29
0.33 0 0 1 0 3 96 0 0 1 0 4 95
0.5 0 0 0 0 0 100 0 0 0 0 0 100
0.69 0 0 0 0 0 100 0 0 0 0 0 100
500 0 75 18 7 0 0 0 82 14 4 0 0 0
0.14 0 0 0 1 1 98 0 0 0 1 1 98
0.33 0 0 0 0 0 100 0 0 0 0 0 100
0.5 0 0 0 0 0 100 0 0 0 0 0 100
0.69 0 0 0 0 0 100 0 0 0 0 0 100
1000 0 84 14 2 0 0 0 86 12 2 0 0 0
0.14 0 0 0 0 0 100 0 0 0 0 0 100
0.33 0 0 0 0 0 100 0 0 0 0 0 100
0.5 0 0 0 0 0 100 0 0 0 0 0 100
0.69 0 0 0 0 0 100 0 0 0 0 0 100
5000 0 96 3 1 0 0 0 96 3 1 0 0 0
0.14 0 0 0 0 0 100 0 0 0 0 0 100
0.33 0 0 0 0 0 100 0 0 0 0 0 100
0.5 0 0 0 0 0 100 0 0 0 0 0 100
0.69 0 0 0 0 0 100 0 0 0 0 0 100
* Table includes the percent of times that the estimated Bayes factors fell into
the respective categories
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TABLE 2.2: Testing for a random slope, Bˆ
(a)
21
Parameterization (1) Parameterization (2)
Favor null Favor random slope Favor null Favor random slope
n
√
ψ22 < 0.1 0.1-0.33 0.33-1 1-3 3-10 > 10 < 0.1 0.1-0.33 0.33-1 1-3 3-10 > 10
25 0 97 2 1 0 0 0 97 2 1 0 0 0
0.04 98 1 1 0 0 0 98 1 1 0 0 0
0.08 85 6 5 3 1 0 85 6 5 3 1 0
0.15 11 5 6 4 9 65 12 4 7 3 9 65
0.25 0 0 0 0 1 99 0 0 0 0 1 99
50 0 100 0 0 0 0 0 100 0 0 0 0 0
0.04 97 2 1 0 0 0 98 1 1 0 0 0
0.08 65 11 8 7 1 8 65 11 8 7 1 8
0.15 0 3 0 0 4 93 0 3 0 0 5 92
0.25 0 0 0 0 0 100 0 0 0 0 0 100
100 0 99 1 0 0 0 0 100 0 0 0 0 0
0.04 98 2 0 0 0 0 98 2 0 0 0 0
0.08 37 11 14 10 9 19 37 11 15 9 10 18
0.15 0 0 0 0 0 100 0 0 0 0 0 100
0.25 0 0 0 0 0 100 0 0 0 0 0 100
500 0 100 0 0 0 0 0 100 0 0 0 0 0
0.04 93 2 2 0 2 1 93 2 2 0 2 1
0.08 0 0 1 1 0 98 0 0 1 1 0 98
0.15 0 0 0 0 0 100 0 0 0 0 0 100
0.25 0 0 0 0 0 100 0 0 0 0 0 100
1000 0 100 0 0 0 0 0 100 0 0 0 0 0
0.04 77 11 8 2 1 1 78 11 7 2 1 1
0.08 0 0 0 0 0 100 0 0 0 0 0 100
0.15 0 0 0 0 0 100 0 0 0 0 0 100
0.25 0 0 0 0 0 100 0 0 0 0 0 100
5000 0 100 0 0 0 0 0 100 0 0 0 0 0
0.04 2 4 3 3 4 84 2 5 2 3 4 84
0.08 0 0 0 0 0 100 0 0 0 0 0 100
0.15 0 0 0 0 0 100 0 0 0 0 0 100
0.25 0 0 0 0 0 100 0 0 0 0 0 100
* Table includes the percent of times that the estimated Bayes factors fell into
the respective categories
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CHAPTER 3
Testing Variance Components in
Multilevel Linear Models using
Approximate Bayes Factors
3.1 Introduction
Many studies collect data that have hierarchical or clustered structures. Examples include ran-
domized studies in which patients are clustered within practices, educational studies in which
students are clustered in schools, or environmental studies in which individuals are clustered in
homes clustered in counties. An analysis that ignores such clustering assumes all observations
are independent, resulting in incorrect model-based standard errors that can lead to misleading
scientific inferences. Multilevel models are used to account for the correlation of observations
within a given group by incorporating group-specific random coefficients. These random coeffi-
cients can be be nested (e.g. repeated observations of students nested in schools, with random
coefficients at the student and school levels), cross-nested (e.g. repeated observations of students
nested in schools participating in different extra-curricular activities, with random coefficients
at the school and activity levels), or even non-nested (e.g. individuals clustered within job cat-
egories and states, with random coefficients at the job and state level). For an introduction to
multilevel models, see Gelman and Hill (2007), Fitzmaurice et al. (2004), Sullivan et al. (1999),
and Bryk and Raudenbush (1992).
Birth records were obtained for all live births in New York City in 2003 and linked to
the hospital discharge data from the Statewide Planning and Research Cooperative System
by the New York State Department of Health. These data include information on mother’s
demographic characteristics, previous births, smoking, weight gain during pregnancy, maternal
birth outside the U.S., and infant’s gender, birth weight, and gestational age (Savitz et al.,
2008), all collected from the birth certificate. These data were also linked to U.S. Census
data to obtain additional demographic information at the census tract level. Investigators are
interested in identifying significant predictors of birth weight among term births adjusting for
gestational age. To address this, we use a multilevel linear model of infant’s birth weight,
predicted by infant gestational age, gender, maternal race, parity, smoking status, age, weight
gain, nativity, and the neighborhood deprivation index. The neighborhood deprivation index
(NDI) is a standardized score of various socioeconomic factors in which higher scores represent
higher levels of deprivation, and is measured at the census tract level rather the individual level.
In New York City, it is common for individuals with similar demographic characteristics to live
in close proximity, resulting in social as well as biological similarities between subjects. Because
of these shared characteristics, we consider random coefficients for census tracts in our model.
Research has shown a persistent racial disparity in birth outcomes in the United States
(Osypuk and Acevedo-Garcia, 2008). Although individual and community-level covariates have
been shown to account for some of the racial risk in low birth weight (Buka et al., 2003; Roberts,
1997; Rauh et al., 2001; OCampo et al., 1997), much of this disparity remains unexplained.
Howard et al. (2006) found substantial variability in the risk of preterm birth and low birth
weight among black race subgroups defined by maternal ancestry (African, American, Asian,
Cuban, European, Puerto Rican, South and Central American, and West Indian and Brazilian).
They also found nativity (U.S. or foreign born) to be a significant predictor that varied by
ancestry. In addition to race, the NYC birth data has additional information available on
maternal country of origin and nativity. We consider random coefficients in our model to allow
heterogeneity in birth weights across ethnic ancestries (62 categories), and to allow the effect
of race to vary by ancestry. For example, the effect of black race may depend on whether the
mother has North African or Jamaican ancestry. In order to determine whether heterogeneity
exists in birth weights across ancestries and census tracts, one must be able to test whether
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these random coefficients should be included in the model.
Testing whether a random coefficient should be included in a multilevel model involves the
test of whether the variance of that random coefficient is equal to 0. This is problematic because
the null hypothesis lies on the boundary of the parameter space. Such issues are addressed in
the literature in the context of linear mixed models (e.g. Stram and Lee, 1994), but there is
very little research specifically for testing variance components in multilevel models. Berkhof
and Snijders (2001) proposed three score tests for variance components in multilevel models
and compared their method via simulation to the likelihood ratio test, fixed F test, and Wald
test. However, their simulations only considered two level models, and it is not clear whether
generalizations to a larger number of levels are possible. Fitzmaurice et al. (2007) proposed a
permutation test for variance components in multilevel generalized linear mixed models. They
applied their method to two-level generalized mixed models and suggested strategies for mul-
tilevel models with greater than two levels. However, their strategy cannot be directly applied
to multilevel models with crossed random effects and can only test one variance component at
a time. Frequentist methods for testing variance components in the linear mixed model are
useful to some extent in nested multilevel models for testing single variance components (e.g.
Crainiceanu and Ruppert, 2004; Verbeke and Molenberghs, 2003), but the null distributions are
not easily obtained for testing multiple variance components, and it is not clear whether these
methods can be applied to non-nested variance components. Also, Bayesian MCMC methods for
testing variance components in the linear mixed model (e.g. Cai and Dunson, 2006; Kinney and
Dunson, 2008) may be generalizable to multilevel models, but these methods generally suffer
from computational constraints and rely on subjective choice of hyperparameters.
The potential complexity of multilevel linear models with multiple nested or non-nested ran-
dom coefficients makes an approach using Bayes factors particularly challenging. In particular,
one must address issues arising from testing on the boundary of the parameter space, poor
performance of approximations to the Bayes factor resulting from high-dimensionality, and the
specification of default non-informative priors on the random coefficients. We propose to extend
the approach of Saville and Herring (2008) by scaling the random coefficients to the residual
variance and introducing parameters that control the relative contribution of the random coef-
ficients. After integrating over the random coefficients and variance components, the resulting
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integrals needed to calculate the Bayes factor can be efficiently approximated with Laplace’s
method. The method also incorporates default prior distributions that were shown to have good
frequentist properties in the linear mixed model (Saville and Herring, 2008).
We present the multilevel model and Bayesian model selection problem in Section 2. We
discuss methods for approximating the marginal likelihoods in Section 3. We conduct simulation
studies in Section 4 and apply our method to the NYC birth data in Section 5. We conclude
with a discussion in Section 6.
3.2 Testing random coefficients in multilevel linear mod-
els
We define the general multilevel linear model with q random factors as
Yi = x
′
iβ + z
′
ib[i] + εi, (3.1)
= x′iβ +
q∑
h=1
z′ihbh[i] + εi,
in which Yi is the response for observation i, i = 1, . . . ,m, xi is a p× 1 vector of predictors with
corresponding fixed effects β, b[i] = (b
′
1[i], . . . , b
′
q[i])
′, zi = (z′i1, . . . , z
′
iq)
′, zih is a dh × 1 vector
of predictors with corresponding random effects bh[i] in which [i] indexes the group in factor h
pertaining to the ith observation, and bh[i] ∼ N(0,ψh) independent of εi ∼ N(0, σ2), with bh[i]
independent of bh′[i] for h 6= h′. A key feature of multilevel modeling is the incorporation of
covariates xi that can be measured at any level of the hierarchy. This allows one to address the
effect of a given covariate, say at the individual level, while controlling for the effect of a higher
level covariate, say at the census level. However, greater care is required in the interpretation
of regression parameters, because some covariates can operate at many different levels.
To illustrate, consider the NYC birth data for 2003, in which there are 104,710 observations
within 62 ethnic ancestries and 2,128 census tracts. The aims of our analysis are to identify
significant predictors of infant birth weight and to determine whether there is heterogeneity
across ancestry groups and census tracts. To start, we will consider the predictor maternal
weight gain during pregnancy, which has been linked to infant birth weight. Because of social
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and biological characteristics shared by persons of the same ancestry, the effect of maternal
weight gain may vary by ancestry. This can be evaluated with a non-nested multilevel linear
model, with a random intercept and slope (for weight gain) at the ancestry level and a random
intercept at the census level. The model is
Yi = β0 + xiβ1 + b10[i] + b11[i]xi + b20[i] + εi, (3.2)
in which Yi is the weight of infant i, xi is the weight gain of the ith mother, β0 is the model
intercept, β1 is the parameter corresponding to weight gain, b10[i] is the random intercept and b11[i]
the random slope corresponding to the ancestry of mother i, and b20[i] is the random intercept
corresponding to the census tract of mother i. There are a total of 2 × 62 = 124 random
coefficients at the ancestry level and 2,128 random coefficients at the census level. In order to
test whether there is heterogeneity in birth weights across ancestries (h = 1) or census tracts
(h = 2), one can conduct a test of whether the variance of the respective random coefficients
is equal to 0. This corresponds to a test of H0 : ψh = 0, which lies on the boundary of the
parameter space.
3.2.1 Bayes factors
From a Bayesian perspective, we can test H0 : ψh = 0 by calculating the Bayes factor, or
posterior odds of M1 versus M0 given equal prior odds, given by
B10 =
p(Y |M1)
p(Y |M0) , (3.3)
in which M0 is model corresponding to the null hypothesis and M1 is the model corresponding
to the alternative hypothesis. Calculating the Bayes factor requires the marginal likelihood
p(Y |Mk) =
∫
p(Y |θk,Mk)pi(θk|Mk)dθk, (3.4)
in which p(Y |θk,Mk) is the data likelihood for model Mk, θk is the vector of model parameters,
and pi(θk|Mk) is the prior distribution of θk. Multilevel models typically have a large number
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of parameters due to the inclusion of random coefficients. This is problematic in calculating
Bayes factors because high dimensional integrals are needed to calculate marginal likelihoods.
Generally these integrals are not available in closed form, and one must consider approximations.
Monte Carlo integration and importance sampling provide alternatives, but these methods lack
accuracy and are computationally demanding. The Laplace and Bayesian Information Criterion
(BIC) (Schwarz, 1978) approximations also suffer in performance from high-dimensionality (Kass
and Raftery, 1995), and it is not clear how to define the penalty for dimensionality in the BIC
(Spiegelhalter et al., 2002).
It is well known that Bayes factors can be sensitive to the choice of prior distributions (Kass
and Raftery, 1995). This is challenging in model selection problems in which one has no prior
information on the parameters. In these situations it is common to use default priors that
do not require subjective inputs. However, one must choose these default priors with care,
because as the prior variance increases the Bayes factor will increasingly favor the null model
(Bartlett, 1957). Our goal is to propose a method that incorporates default priors on the random
coefficients that result in good frequentist properties with respect to power and Type I error.
Also, we aim to avoid issues with the boundary of the parameter space and high-dimensional
approximations to the Bayes factor.
3.3 Approximating the marginal likelihood
3.3.1 Reparameterization
To introduce our method, we first give a modified notation for the multilevel linear model. Let
Yi = x
′
iβ +w
′
ib+ εi (3.5)
= x′iβ +
q∑
h=1
w′ihbh + εi
in which wi = (w
′
i1, . . . ,w
′
iq)
′, wih is an (rh×1) vector of predictors with corresponding random
effects bh, and rh = dhch is the total number of random coefficients for factor h (dh is the
number of random coefficients for one observation for factor h, and ch is the total number of
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classifications for factor h). More specifically, wih = [δi ⊗ zih], in which δi is a (ch × 1) vector
of indicator variables (equals 1 if yes, 0 if no) for group membership of observation i in each of
the ch classifications, and ⊗ denotes the left Kronecker product. The dimension of wi is (r× 1),
with r =
∑q
h=1 rh the total number of random coefficients in the model. Also, b = (b
′
1, . . . , b
′
q)
′,
in which bh = (b
′
h1, . . . , b
′
hch
)′ is the vector of all random coefficients for factor h. We assume
bhl ∼ Ndh(0dh ,ψh) independent of εi ∼ N(0, σ2).
Extending the work of Saville and Herring (2008), we scale the random coefficients to the
residual variance such that b˜hl ∼ N(0, σ2I). We then express the model as
Yi = x
′
iβ +w
′
iΦΓb˜+ εi, (3.6)
in which b˜ is the vector of scaled random coefficients, Φ = diag(exp(φ′∗1 , . . . ,φ
′∗
q )) with φ
∗
h =
(1ch ⊗ φh), and φh = (φh1, . . . , φhdh)′ are parameters that control the relative contribution of
the random coefficients. Also, Γ = blockdiag(Γ∗1, . . . ,Γ
∗
q) with Γ
∗
h = (Ich ⊗ Γh), in which Γh is
a lower triangular matrix with 1dh along the diagonal, and lower off-diagonal elements γh that
induce correlation between the random coefficients within factor h. We can also express the
model in the form
Y =Xβ +WΦΓb˜+ ε, (3.7)
in which Y = (Yi, . . . , Ym)
′, W = (w1, . . . ,wm)′, X = (x1, . . . ,xm)′, and ε = (ε1, . . . , εm)′.
Let σ2 ∼ InvGam(v, w). By integrating out b˜ and σ2 from the posterior distribution, the
marginal posterior p(Y |β,φ,γ) can be shown to have the multivariate t-distribution given by
p(Y |β,φ,γ) = Γ
(
2v + p
2
)
(pi2v)−p/2|Σ|−1/2
Γ(2v/2)
{
1 +
1
2v
(Y −Xβ)′Σ−1(Y −Xβ)
}− 2v+p
2
, (3.8)
in which Γ() denotes the gamma function and Σ = (WΦΓΓ′Φ′W ′ + Im). We assume the
default prior φhl ∼ logN(log(0.3), 2) suggested by Saville and Herring (2008), and use the
Laplace method to integrate over (β,φ,γ) to obtain the marginal density p(Y ). This default
prior was shown to have good frequentist properties in simulation studies in the linear mixed
model.
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3.3.2 Computational considerations
Product of likelihoods
For studies with large sample sizem, the covariance matrix Σmay be too large to handle compu-
tationally. For example, in applying model (3.2) to the complete 2003 NYC data (m =104,710),
the covariance matrix Σ is (104,710 × 104,710). We note that this matrix has the potential to
be extremely sparse, and even with very large m may be computationally feasible using sparse
matrix computations. However, when the matrix is large and not sufficiently sparse, it may be
advantageous to work with the product of independent likelihoods (conditional on the random
coefficients) as opposed to the likelihood of the vector of response variables. To illustrate, the
marginal distribution can be written as
p(Y |β,φ,γ) =
∫
p(Y |β,φ,γ, b˜, σ2)pi(b˜)pi(σ2)db˜dσ2 (3.9)
=
∫ [ m∏
i=1
p(Yi|β,φ,γ, b˜, σ2)
]
pi(b˜)pi(σ2)db˜dσ2
=
Γ
(
2v+m
2
)
|A|−1/2
(pi2v)m/2Γ(2v/2)
{
1 +
1
2v
(
f(Y )−C ′A−1C
)}− 2v+m2
with A = {Ir + Γ′Φ′ (∑mi=1wiw′i)ΦΓ}, C = Γ′Φ′ {∑mi=1wi(Yi − x′iβ)}, and f(Y ) = ∑mi=1(Yi −
x′iβ)
2, in which Ir denotes the identity matrix with dimension (r × r).
Using this approach, it should be computationally possible to approximate the marginal
likelihood regardless of the size of m. The computation is limited, however, by the total number
of random coefficients r. If r is very large, it may not be feasible to compute the inverse and
determinant of the (r× r) matrix A (or may be very computationally expensive). For example,
in applying (3.2) to the NYC data, r = 2, 252. Although it may be possible to compute the
inverse and determinant of A in this example, computations are likely to be very slow. Hence,
an alternative computational approach is to write the data likelihood as products of marginal
likelihoods for lower-dimensional response vectors or scalars.
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Alternative for non-nested models
Consider the NYC data in which there are two non-nested factors, ancestry and census tracts.
We denote the factor with fewer groups as h = 1 (ancestry) and the factor with a larger number
of groups as h = 2 (census tracts). We can write the marginal likelihood as
p(Y |β,φ,γ) =
∫
p(Y |β,φ, b˜2, b˜1, σ2)pi(b˜2)pi(b˜1)pi(σ2)db˜2db˜1dσ2, (3.10)
=
∫ { c2∏
k=1
p(Yk|β,φ, b˜2k, b˜1, σ2)
}
pi(b˜2)pi(b˜1)pi(σ
2)db˜2db˜1dσ
2,
=
∫ { c2∏
k=1
∫
p(Yk|β,φ, b˜2k, b˜1, σ2)pi(b˜2k)db˜2k
}
pi(b˜1)pi(σ
2)db˜1dσ
2
=
∫ { c2∏
k=1
∫ [mk∏
i=1
p(Yki|β,φ, b˜2k, b˜1, σ2)
]
pi(b˜2k)db˜2k
}
pi(b˜1)pi(σ
2)db˜1dσ
2,
in which c2 is the number of groups in factor 2, Yk is the vector of responses for group k in factor
2, b˜2 are the random coefficients for factor 2, b˜2k are the random coefficients corresponding to
group k in factor 2, b˜1 are the random coefficients for factor 1, mk is the number of subjects in
group k of factor 2 and Yki is the response of the ith subject in group k of factor 2. This approach
allows one to integrate out the random coefficients for factor 2 in smaller dimensions, as b˜2k is
only a (d2 × 1) vector. For model (3.2) applied to the NYC data, b˜2k is a scalar (representing a
random intercept for census tract k) and results in matrices with smaller dimensions than those
obtained from (3.9).
Alternative for nested models
Although not of particular interest in the NYC data, one could consider a 3-level nested design
with subjects nested within census tracts nested within boroughs (there are 5 boroughs in NYC).
In such cases one can use the nested structure for easier computation. Let h = 1 denote the
census tract factor and h = 2 denote the borough factor. Then
p(Y |β,φ,γ) =
∫
p(Y |β,φ, b˜2, b˜1, σ2)pi(b˜2)pi(b˜1)pi(σ2)db˜2db˜1dσ2 (3.11)
=
∫ { c2∏
k=1
p(Yk|β,φ, b˜2k, b˜1k, σ2)
}
pi(b˜2)pi(b˜1)pi(σ
2)db˜2db˜1dσ
2
=
∫ { c2∏
k=1
∫
p(Yk|β,φ, b˜2k, b˜1k, σ2)pi(b˜2k)pi(b˜1k)db˜2kdb˜1k
}
pi(σ2)dσ2
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=
∫ 
c2∏
k=1
∫  c1k∏
j=1
p(Ykj|β,φ, b˜2k, b˜1kj, σ2)
pi(b˜2k)pi(b˜1k)db˜2kdb˜1k
pi(σ2)dσ2
=
∫ 
c2∏
k=1
∫  c1k∏
j=1
∫
p(Ykj|β,φ, b˜2k, b˜1kj, σ2)pi(b˜1kj)db˜1kj
pi(b˜2k)db˜2k
pi(σ2)dσ2
=
∫ 
c2∏
k=1
∫  c1k∏
j=1
∫ (mkj∏
i=1
p(Ykji|β,φ, b˜2k, b˜1kj, σ2)
)
pi(b˜1kj)db˜1kj
pi(b˜2k)db˜2k
 pi(σ2)dσ2,
in which c1k is the number of groups for factor 1 within group k of factor 2, mkj is the number of
subjects in group j of factor 1 within group k of factor 2, Ykj is the response vector for subjects
in group j of factor 1 within group k of factor 2, Ykji is the response of subject i within group j
of factor 1 within group k of factor 2, b˜1k are the random coefficients for factor 1 within group
k of factor 2, and b˜1kj are the random coefficients corresponding to group j of factor 1 within
group k of factor 2. This approach allows one to integrate out the random coefficients b˜1kj and
b˜2k which have smaller dimensions equal to (d1 × 1) and (d2 × 1), respectively. For the NYC
data with a random intercept for census tracts and boroughs, b˜1kj and b˜2k are both scalars.
If there are non-nested random coefficients in addition to nested random coefficients (i.e.
cross-nested) and either m or r is too large for computational feasibility, then similar strategies
can be used to decrease the dimensions of the required integrals. For example, such strategies
could be used on the NYC data with factors for ancestry and census tracts nested within
boroughs. However, given there are only 5 boroughs in the NYC data, incorporating random
coefficients at the borough level is not of particular interest for this example.
3.4 Simulation study
3.4.1 Testing random intercepts
We conducted a simulation study to evaluate the performance of our method in correctly iden-
tifying models with or without random intercepts. We consider a simple setting with two
non-nested factors with 30 classifications each. We simulated b10[i] ∼ N(0, 1), b20[i] ∼ N(0, 1),
εi ∼ N(0, 1), and calculated
Yi = λ1b10[i] + λ2b20[i] + εi, (3.12)
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for various combinations of m = (100, 500, 1000), λ1 = (0, 0.1, 0.2, 0.3), and λ2 = (0, 0.1, 0.2, 0.3)
for 1,000 datasets. Using prior distributions β0 ∼ N(0, 1), σ2 ∼ InvGam(.1, .1) (which are non-
informative given the simulation settings), and φh ∼ N(log(0.3), 2), we approximated marginal
likelihoods for the following models:
M0 : Yi = β0 + εi, (3.13)
M1 : Yi = β0 + e
φ1b10[i] + εi,
M2 : Yi = β0 + e
φ2b20[i] + εi,
M3 : Yi = β0 + e
φ1b10[i] + e
φ2b20[i] + εi,
in which φh = log(λh) for λh > 0 and h = 1, 2. Estimates of the Bayes factors Bˆ30, Bˆ10, Bˆ20
were calculated for each data set and interpreted according to the scale given by Wasserman
(2000) and Jeffreys (1961). For comparison with frequentist methods, we chose to reject H ′k
if an estimated Bayes factor Mkk′ was greater than 1, in which model k was preferred over
model k′. In this simple setting, we can use the restricted likelihood ratio test for testing M1
and M2 versus M0, in which the null distributions follow a 50:50 mixture of a point mass at 0
and a chi-square distribution with 1 degree of freedom (denoted as LR10 and LR20) (Self and
Liang, 1987; Stram and Lee, 1994). We can also test M1 and M2 versus M0 using the ANOVA
F-test (denoted as AOV10 and AOV20). For testing M3 versus the other models, we implement
an ad-hoc restricted likelihood ratio test, in which the standard test statistic is compared at
the α = 0.10 level to a chi-square distribution with degrees of freedom equal to the difference
in the number of variance components in the models being compared (denoted as LR∗30, LR
∗
31,
and LR∗32). Although this approach may not be recommended from a theoretical perspective
(Fitzmaurice et al., 2004), it is known to be used in practice.
In the absence of random effects, the Bayes factor approach, likelihood ratio tests, ANOVA
F-tests, and ad-hoc tests all preserved the nominal Type I error rate at 0.05 for all model
comparisons and all sample sizes (Table 3.1). The power for Bˆ10 and Bˆ20 in detecting a random
effect was very similar to the likelihood ratio tests LR10 and LR20 and the ANOVA F-tests. For
testing M3 versus M0, the performance of Bˆ30 was similar to the ad-hoc LR
∗
30, with slighter
greater power for small sample sizes and slightly less power for larger sample sizes. A similar
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pattern was seen comparing Bˆ31 versus LR
∗
31 and B32 versus LR
∗
32. These results support the
claim that our method has good frequentist properties with respect to power and Type I error.
Tables 3.2-3.4 shows a more complete breakdown of the estimated Bayes factors according
to the scale of Wasserman (2000) and Jeffreys (1961). As λ1 and λ2 increased, the estimated
Bayes factor displayed greater evidence for the model with random intercepts. As the sample
size increased, the estimated Bayes factors increasingly favored the null model in the absence
of random intercepts, and increasingly favored the random intercept models in the presence of
random intercepts. This shows large sample consistency in our method under these simulation
settings.
3.4.2 Testing a random slope
We extend our simulation to test for the presence of a random slope in a two-factor non-nested
multilevel model. To simulate the data, we include random intercepts for each factor as done
previously, but also incorporate a random slope for one of the factors. We simulated xi ∼
N(0, .25), b20[i] ∼ N(0, 0.04), εi ∼ N(0, 1), b1[i] ∼ N2(0,ψ), with ψ11 = 0.04, ψ12 = ρ
√
ψ11ψ22,
and ρ = −0.3, which induces a negative correlation between the random intercept and slope.
The variances of the random intercepts (0.04) were chosen to match the variances from the
previous simulation corresponding to λ1 = λ2 = 0.2. We calculated
Yi = b10[i] + b20[i] + b11[i]xi + εi, (3.14)
for various combinations of m = (100, 500, 1000) and
√
ψ22 = (0, 0.1, 0.2, 0.3, 0.6, 1.0) for 1,000
datasets. Using prior distributions β0 ∼ N(0, 1), σ2 ∼ InvGam(.1, .1) (which are non-informative
given the simulation settings), and φh ∼ N(log(0.3), 2), we approximated marginal likelihoods
for the following models:
M3 : Yi = β0 + β1xi + e
φ1b10[i] + e
φ2b20[i] + εi (3.15)
M4 : Yi = β0 + β1xi + e
φ10b10[i] + e
φ20b20[i] + e
φ11b∗11[i]xi + εi,
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in which b∗11[i] = γ1b10[i] + b11[i]. Model M3 incorporates random intercepts for both factors
with a fixed effect for the covariate, and model M4 includes the additional random slope on
the covariate for factor 1. Table 3.5 gives the power and Type I error of our approach using
approximate Bayes factors and the ad-hoc restricted likelihood ratio test. Our method preserves
the Type I error rate at α = 0.05 and has similar power to the ad-hoc RLRT. Table 3.6 shows
the estimated Bayes factors according to the scale of Wasserman (2000) and Jeffreys (1961). As
√
ψ22 increased, the estimated Bayes factor displayed greater evidence for the model with the
random slope. As the sample size increased, the estimated Bayes factor increasingly favored M3
in the absence of a random slope, and increasingly favoredM4 in the presence of a random slope.
These simulation results support the claim that our method has good frequentist properties and
large sample consistency.
3.4.3 Choice of prior distributions
Saville and Herring (2008) considered several alternative prior distributions for this method in
the context of the linear mixed model. More specifically, the authors conducted simulations with
priors of the form φhl ∼ N(h, ζ), with various combinations of h = log(1), log(0.3), log(0.15) and
ζ = 1, 2, 3. Additionally, they considered a t-distribution for φhl with 2 and 10 degrees of free-
dom, as well as prior distributions σ2 ∝ σ−2, σ2 ∼InvGamma(0.1,0.1), σ2 ∼InvGamma(0.01,0.01),
and β ∝ c in which c is a constant. They found that alternative priors on σ2 and β did not have
notable influence on the estimated Bayes factors, but the priors for φhl did have some influence.
More specifically, values of h = log(0.30) and ζ = 2 resulted in power and Type I error rates
that closely aligned with standard frequentist methods. Smaller values of h or ζ led to increased
Type I error rates and larger values of h or ζ led to more conservative Type I error rates. Given
that simulation results for the multilevel linear model using the default prior are similar to those
obtained from the linear mixed model, we would expect to observe similar patterns based on
alternative prior distributions in the multilevel linear model.
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3.5 Application
We are interested in fitting a multilevel linear model to infant’s birth weight, predicted by
infant gestational age, gender, maternal race, parity, smoking status, age, weight gain, maternal
nativity, and the neighborhood deprivation index, with random coefficients for census tracts and
ethnic ancestries. We focus on singleton term births with a gestational age ≥ 37 weeks and a
birth weight between 900 g and 5300 g. After exclusions, we have a total of 93,938 subjects with
complete data available for the analysis.
The first model we investigate allows a random intercept for ancestry, defined as
M1 : Yi = x
′
iβ + b1[i] + εi, (3.16)
with
x′iβ = β0 + β1Blacki + β2Hispi + β3Asiani + β4Otheri + β5Gesti (3.17)
+ β6Gest
2
i + β7Pbirthi + β8Femalei + β9Smokei + β10NDIi
+ β11Age2i + β12Age3i + β13Age4i + β14Age5i + β15Nativityi +
+ β16Wtgaini + β17Wtgain
2
i + β18Wtgain
3
i ,
in which b1[i] is the random intercept corresponding to the ancestry of subject i. The explanatory
variables Blacki, Hispi, Asiani, and Otheri are indicator variables for race corresponding to
black, Hispanic, Asian or Pacific Islander, and other (white as the referent group). Gesti is the
gestational age of the infant for subject i and Gest2i is the corresponding quadratic variable.
The variables Pbirthi, Femalei, Smokei, and Nativityi are indicator variables for any previous
births, female infant gender, maternal smoking, and maternal birth outside of the United States,
respectively. Maternal age was categorized into the following groups: < 25yrs (referent group),
26-30 yrs (Age2i), 31-35 yrs(Age3i), 36-40 yrs (Age4i), and > 40 yrs (Age5i). The variable
NDIi is the neighborhood deprivation index corresponding to the census tract of subject i,
and Wtgaini is the difference in maternal pre-pregnancy weight and weight at delivery. The
continuous variables NDIi, Gesti, and Wtgaini are centered and standardized by 2 standard
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deviations to place the regression coefficients on the same scale as the binary indicators (Gelman,
2008).
We also consider a model with a random intercept for census tracts but without random
coefficients for ancestries,
M2 : Yi = x
′
iβ + b2[i] + εi, (3.18)
in which b2[i] is the random intercept corresponding to the census tract of subject i. Incorporating
random intercepts for both ancestries and census tracts, a two-factor non-nested model takes
the form
M3 : Yi = x
′
iβ + b1[i] + b2[i] + εi. (3.19)
As discussed previously, the effect of race may depend on maternal ancestry. Hence we consider
a variation of M3 with random intercepts for both ancestry and census tract, but we allow the
effect of race to vary by ancestry. This model can be written as
M4 : Yi = x
′
iβ + b1p[i] + b2[i] + εi, (3.20)
in which b1p[i] is the random intercept corresponding to the ancestry (factor 1) of subject i within
race p. This model assumes that two persons of the same ancestry with different races have
different random intercepts. Similarly, it may be the case that the effect of ancestry varies by
nativity. Hence we consider
M5 : Yi = x
′
iβ + b1s[i] + b2[i] + εi, (3.21)
in which b1s[i] is the random intercept corresponding to the ancestry (factor 1) of subject i within
nativity s. This model assumes that two persons of the same ancestry with opposite nativity
have different random intercepts. Additionally, it may be the case that the effect of maternal
weight gain on infant birth weight is affected by ancestry. This may result from either biological
or social factors that are correlated with a given ancestry. We can model this heterogeneity by
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including a random slope for weight gain for the ancestry factor. Adding this component to
model M3, we have
M6 : Yi = x
′
iβ + b10[i] + b2[i] + b11[i]Wtgaini + εi, (3.22)
in which b11[i] is the random slope for weight gain corresponding to the ancestry of subject i.
Finally, we consider a model without random effects,
M0 : Yi = x
′
iβ + εi. (3.23)
Our goal is to identify the preferred model using approximate Bayes factors, and to proceed
with inference using this chosen model.
The mean value for infant birth weight is 3,362 grams with a standard deviation of 460
g. Converting to kilograms for computational convenience, we use prior distributions β0 ∼
N(3.36, 1), β ∼ N(0, I), and σ2 ∼ N(0.1, 0.1), which are non-informative priors given the scale
of the response and predictors. We found very strong evidence for heterogeneity in birth weights
across census tracts and across ancestries (log Bˆ10 = 280, log Bˆ20 = 32, and log Bˆ30 = 284), with
birth weights tending to vary across maternal ancestries in greater magnitude than across census
tracts. We found that the effects of race (log Bˆ43 = −6), nativity (log Bˆ53 = −11) and maternal
weight gain (log Bˆ63 = −1) do not vary by ancestry.
We fit the preferred model, M3, using MCMC methods and base inference on 20,000 samples
after discarding 5,000. The posterior means and 95% credible intervals of the fixed effects
are given in Table 3.7. Results are presented in grams for better interpretability. Predictors
with 95% credible intervals greater than 0 include parity (99,111), maternal age 26-30 (45,60),
maternal age 31-35 (64,80), maternal age 36-40 (75,94), maternal age >40 (60,92), and maternal
nativity (3,18). Hence, previous live births, greater maternal age, and maternal birth outside the
U.S. are all associated with greater infant birth weights. Predictors with 95% credible intervals
that are less than 0 include maternal Asian race (-91,-24), black race (−74,−7), infant female
gender (-126,-115), maternal smoking (-186,-143), and higher neighborhood deprivation (95%
CI=(-23,-9) for a 2 sd increase). Hence, Asian and black race (compared to white), female
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infants (compared to males), smokers (compared to non-smokers), and greater NDI values are
associated with lower infant birth weights. Both maternal weight gain and infant gestational
age showed non-linear associations with infant birth weight. The linear effect for a 2 sd increase
in maternal weight gain is significant in a positive direction (95% CI=(175,190)), the quadratic
effect is significant in a positive direction (95% CI: (40,58)), and the cubic effect is significant in
the negative direction (95% CI=(-41,-30,)). As shown in Figure 3.2, this implies greater maternal
weight gain in the range of 8-78 lbs. is associated with greater infant birth weights, but greater
maternal weight gain in the ranges of 0-8 lbs. and 78-98 lbs. is associated with smaller infant
birth weights. The linear effect for a 2 sd increase in infant gestational age is highly significant
in a positive direction (95% CI: (278,289)) while the quadratic effect is significant in a negative
direction (95% CI: (-71,-54)). As shown in Figure 3.2, this implies greater gestational age is
associated with greater infant birth weights, but this association flattens as gestational age
nears the right tail of its distribution (44 weeks). The variables with the largest effects on infant
birth weight are smoking (βˆ9 = −165), female infant gender (βˆ8 = −120), maternal weight gain
(non-linear), and infant gestational age (non-linear). Variables with weaker yet “significant”
associations include a 2 sd increase in NDI (βˆ10 = −16), maternal nativity (βˆ15 = 11), and black
versus white race (βˆ1 = −40). One must consider whether the magnitude of each of these effects
is considered clinically relevant, as the statistical significance may be a result of the large sample
size. The effects of Hispanic (95% CI=(−25, 56)) or “other” (95% CI=(-80,75)) races are not
significantly associated with infant birth weight at the α = 0.05 level. The non-significant result
for Hispanic race may be due to the nature in which the variable was constructed. Data were not
initially collected for Hispanic race, and investigators therefore constructed a Hispanic indicator
variable using the ethnic ancestry variable. Hence this predictor may lack the precision of the
other race indicator variables. The “Other” race group suffered from small sample size.
The frequency counts for ancestry by race are given in Table 3.8. We note that most an-
cestries correspond to predominantly one race. We give the posterior means of the random
intercepts corresponding to the 62 ancestries in Table 3.9, as well as the predicted means for
each of the ancestries by race for a typical subject with mean gestational age (39.3 weeks), NDI
equal to 0, mean weight gain (31.2 lbs.), no previous births, male infant, non-smoker, < 25
years old, and maternal birth in the United States (with missing values for non-observed race
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by ancestry classifications). 95% credible intervals for the ancestry random intercepts are given
in Table 3.10 and plotted in Figure 3.1. Ancestries with the greatest estimated infant birth
weights include Peru, Morocco, and Nigeria, while ancestries with the lowest estimated infant
birth weights include Guyana, Bangladesh, Gambia, and Ivory Coast. There were no notable
trends for certain geographical regions with respect to the ancestry effects. Also, we did not
observe patterns between nativity and the ancestry random coefficients (Table 3.10), supporting
the claim (based on the Bayes factors) that nativity does not modify the effect of ancestry.
In conclusion, we found heterogeneity in birth weights across maternal ancestries and census
tracts. The heterogeneity in maternal ancestry exists within subgroups that Howard et al.
(2006) considered homogeneous, and may be due to any of a large number of unmeasured social
and biological factors. Further research is needed to determine why certain ancestries tend to
have lower or higher birth weights. The effect of race was significant for Asian and black versus
white race (although perhaps not clinically significant) and non-significant for Hispanic versus
white race, while adjusting for the effects of ancestry and census tracts. Additionally, effects for
race, nativity, and maternal weight gain did not vary by ancestry.
3.6 Discussion
We recommend our approach as a straightforward and efficient method for testing random coef-
ficients in multilevel linear models. Our approach avoids issues with testing on the boundary of
the parameter space, uses low-dimensional approximations to the Bayes factor, and incorporates
a default prior on the random coefficients. The scaling of the random coefficients to the residual
variance makes φhl ∼ N(log(0.3), 2) a reasonable default prior distribution. Simulations suggest
that this prior has good frequentist properties and large sample consistency. A major contri-
bution of our method is the ability to test several variance components from multiple factors
simultaneously, and to do so for nested, non-nested, or cross-nested multilevel designs.
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TABLE 3.1: Testing non-nested random intercepts, power and Type I error
M1 vs. M0 M2 vs. M0 M3 vs. M0 M3 vs. M1 M3 vs. M2
m λ1 λ2 Bˆ10 LR10 AOV10 Bˆ20 LR20 AOV20 Bˆ30 LR∗30 Bˆ31 LR
∗
31 Bˆ32 LR
∗
32
100 0 0 0.05 0.05 0.05 0.04 0.03 0.04 0.03 0.03 0.04 0.03 0.06 0.05
0.1 0.06 0.04 0.05 0.06 0.04 0.04 0.04 0.03 0.06 0.04 0.06 0.04
0.2 0.05 0.04 0.05 0.12 0.1 0.09 0.07 0.06 0.12 0.1 0.05 0.04
0.3 0.06 0.04 0.05 0.26 0.22 0.2 0.16 0.14 0.27 0.21 0.05 0.04
0.1 0 0.07 0.06 0.06 0.04 0.03 0.04 0.04 0.03 0.04 0.03 0.08 0.06
0.1 0.07 0.06 0.06 0.06 0.04 0.04 0.05 0.04 0.06 0.04 0.07 0.06
0.2 0.07 0.06 0.06 0.12 0.1 0.09 0.08 0.07 0.12 0.09 0.07 0.06
0.3 0.08 0.06 0.06 0.26 0.22 0.19 0.18 0.15 0.27 0.22 0.08 0.06
0.2 0 0.14 0.12 0.1 0.04 0.03 0.04 0.08 0.06 0.04 0.03 0.14 0.12
0.1 0.14 0.12 0.1 0.06 0.05 0.04 0.08 0.07 0.06 0.04 0.15 0.11
0.2 0.14 0.11 0.1 0.12 0.1 0.09 0.12 0.1 0.12 0.1 0.14 0.11
0.3 0.13 0.11 0.1 0.26 0.22 0.19 0.22 0.19 0.26 0.22 0.14 0.11
0.3 0 0.27 0.24 0.22 0.05 0.03 0.04 0.18 0.16 0.04 0.03 0.28 0.23
0.1 0.26 0.23 0.22 0.06 0.05 0.04 0.2 0.17 0.06 0.04 0.27 0.23
0.2 0.26 0.23 0.22 0.12 0.09 0.09 0.23 0.19 0.12 0.09 0.27 0.22
0.3 0.25 0.21 0.21 0.25 0.21 0.18 0.29 0.27 0.25 0.21 0.26 0.22
500 0 0 0.04 0.04 0.05 0.05 0.06 0.07 0.02 0.04 0.05 0.05 0.04 0.04
0.1 0.04 0.04 0.05 0.14 0.15 0.17 0.06 0.09 0.15 0.15 0.04 0.04
0.2 0.04 0.04 0.05 0.64 0.65 0.66 0.42 0.52 0.64 0.64 0.04 0.04
0.3 0.03 0.04 0.05 0.95 0.95 0.95 0.87 0.91 0.94 0.94 0.04 0.04
0.1 0 0.13 0.13 0.14 0.05 0.06 0.07 0.06 0.09 0.05 0.06 0.12 0.13
0.1 0.13 0.13 0.15 0.14 0.15 0.18 0.1 0.15 0.14 0.15 0.13 0.13
0.2 0.13 0.13 0.15 0.62 0.63 0.64 0.48 0.57 0.62 0.63 0.13 0.13
0.3 0.12 0.13 0.14 0.95 0.95 0.95 0.89 0.92 0.94 0.94 0.12 0.13
0.2 0 0.6 0.61 0.63 0.05 0.06 0.07 0.41 0.49 0.06 0.06 0.61 0.61
0.1 0.59 0.6 0.62 0.14 0.15 0.17 0.48 0.56 0.14 0.15 0.59 0.6
0.2 0.58 0.6 0.6 0.61 0.62 0.63 0.75 0.8 0.62 0.63 0.58 0.59
0.3 0.57 0.58 0.58 0.94 0.94 0.95 0.95 0.96 0.94 0.94 0.57 0.59
0.3 0 0.95 0.95 0.95 0.05 0.06 0.06 0.89 0.92 0.06 0.06 0.95 0.95
0.1 0.95 0.95 0.95 0.14 0.15 0.17 0.91 0.93 0.14 0.14 0.95 0.95
0.2 0.95 0.95 0.95 0.56 0.57 0.58 0.95 0.96 0.58 0.59 0.94 0.95
0.3 0.93 0.93 0.94 0.93 0.93 0.93 0.99 0.99 0.94 0.94 0.94 0.95
1000 0 0 0.04 0.06 0.06 0.03 0.04 0.05 0.01 0.04 0.03 0.04 0.04 0.06
0.1 0.04 0.05 0.06 0.24 0.29 0.31 0.1 0.2 0.24 0.29 0.04 0.05
0.2 0.03 0.05 0.06 0.92 0.93 0.94 0.8 0.88 0.92 0.93 0.04 0.05
0.3 0.03 0.05 0.06 1 1 1 1 1 1 1 0.04 0.05
0.1 0 0.24 0.29 0.32 0.03 0.04 0.05 0.12 0.21 0.03 0.04 0.24 0.28
0.1 0.24 0.29 0.31 0.24 0.3 0.32 0.24 0.39 0.24 0.29 0.24 0.28
0.2 0.23 0.28 0.3 0.92 0.93 0.94 0.86 0.92 0.91 0.93 0.25 0.28
0.3 0.23 0.26 0.28 1 1 1 1 1 1 1 0.24 0.28
0.2 0 0.92 0.94 0.94 0.03 0.05 0.05 0.81 0.89 0.03 0.04 0.92 0.93
0.1 0.92 0.94 0.94 0.23 0.28 0.3 0.87 0.93 0.23 0.28 0.92 0.93
0.2 0.92 0.93 0.94 0.9 0.92 0.94 0.98 1 0.91 0.93 0.92 0.93
0.3 0.9 0.93 0.93 1 1 1 1 1 1 1 0.91 0.93
0.3 0 1 1 1 0.03 0.04 0.05 0.99 1 0.03 0.04 1 1
0.1 1 1 1 0.21 0.27 0.28 1 1 0.23 0.28 1 1
0.2 1 1 1 0.88 0.91 0.92 1 1 0.9 0.93 1 1
0.3 1 1 1 1 1 1 1 1 1 1 1 1
Table gives percent of times the null hypothesis was rejected out of 1000 simulations
Type I error is given by λ1 = 0 or λ2 = 0
βˆkk′ : estimated Bayes factor for Mk vs. Mk′
LRk0: restricted likelihood ratio test for Mk vs. M0 using a mixture of chi-square distributions
AOVk0: ANOVA F-test for Mk vs. M0
LR∗
kk′ : Ad-hoc restricted likelihood ratio test for Mk vs. Mk′ using α = 0.10
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TABLE 3.2: Estimated Bayes factors for comparing M1 and M2 versus M0
Bˆ10 Bˆ20
Favor M0 Favor M1 Favor M0 Favor M2
m λ1 λ2 < 0.1 0.1-0.33 0.33-1 1-3 3-10 > 10 < 0.1 0.1-0.33 0.33-1 1-3 3-10 > 10
100 0 0 0 2 92 4 1 0 0 2 94 3 0 0
0.1 0 2 92 4 1 0 0 2 92 5 1 0
0.2 0 2 93 4 1 0 0 1 88 9 2 1
0.3 0 1 93 4 1 1 0 0 73 17 6 3
0.1 0 0 1 91 6 1 0 0 2 93 4 1 0
0.1 0 1 92 6 1 1 0 2 92 5 1 0
0.2 0 1 91 6 1 1 0 1 87 9 2 1
0.3 0 1 91 6 1 1 0 0 73 17 6 3
0.2 0 0 1 85 10 3 1 0 2 93 3 1 0
0.1 0 1 85 10 2 1 0 2 92 5 1 0
0.2 0 1 85 11 2 1 0 1 87 10 2 1
0.3 0 1 86 10 2 1 0 0 74 18 5 3
0.3 0 0 0 72 17 6 4 0 2 93 4 1 0
0.1 0 0 73 16 7 4 0 2 92 5 1 0
0.2 0 0 74 16 7 3 0 1 87 9 2 1
0.3 0 0 74 17 6 3 0 0 75 17 5 2
500 0 0 0 67 29 3 1 0 0 62 33 4 1 0
0.1 0 67 29 3 0 0 0 39 47 9 4 2
0.2 0 66 30 3 1 0 0 8 28 21 16 26
0.3 0 66 31 3 1 0 0 0 5 7 10 78
0.1 0 0 42 45 9 2 1 0 62 33 4 1 0
0.1 0 43 44 9 2 1 0 40 46 9 4 2
0.2 0 44 43 9 3 1 0 8 30 21 16 26
0.3 0 45 43 9 2 1 0 0 5 8 9 78
0.2 0 0 7 32 20 16 25 0 63 32 4 1 0
0.1 0 7 33 19 15 25 0 41 45 9 4 1
0.2 0 8 33 20 15 23 0 9 30 21 17 23
0.3 0 9 34 21 15 21 0 0 5 9 8 77
0.3 0 0 0 4 6 10 79 0 63 32 4 1 0
0.1 0 0 5 6 10 78 0 42 43 10 3 1
0.2 0 0 5 9 12 73 0 10 33 22 16 18
0.3 0 1 6 8 13 72 0 1 7 9 9 74
1000 0 0 0 82 13 3 1 0 0 83 14 2 1 0
0.1 0 82 13 3 1 0 0 43 31 12 7 5
0.2 0 81 15 2 0 1 0 2 5 8 12 71
0.3 0 81 14 2 1 1 0 0 0 0 1 99
0.1 0 0 41 33 10 8 6 0 83 14 2 1 0
0.1 0 42 33 10 7 7 0 43 31 12 7 5
0.2 0 43 32 10 7 6 0 2 5 9 13 69
0.3 0 46 29 11 7 6 0 0 0 0 1 99
0.2 0 0 2 6 8 12 72 0 83 13 2 1 0
0.1 0 2 6 8 11 72 0 45 30 13 6 4
0.2 0 3 5 9 12 70 0 2 7 10 14 67
0.3 0 3 6 10 13 66 0 0 0 0 1 99
0.3 0 0 0 0 0 1 99 0 83 14 2 0 0
0.1 0 0 0 0 1 99 0 47 29 12 6 3
0.2 0 0 0 0 1 98 0 2 9 10 14 63
0.3 0 0 0 1 1 98 0 0 0 0 1 98
Table includes the percent of times that the estimated Bayes factors fell into the respective categories
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TABLE 3.3: Estimated Bayes factors for comparing M3 versus M1 and M2
Bˆ31 Bˆ32
Favor M1 Favor M3 Favor M2 Favor M3
m λ1 λ2 < 0.1 0.1-0.33 0.33-1 1-3 3-10 > 10 < 0.1 0.1-0.33 0.33-1 1-3 3-10 > 10
100 0 0 0 2 94 3 1 0 0 2 92 5 1 0
0.1 0 1 93 5 1 0 0 2 93 4 1 0
0.2 0 1 87 10 2 0 0 1 93 4 1 1
0.3 0 0 73 18 7 1 0 1 93 4 1 1
0.1 0 0 1 94 3 1 0 0 1 91 6 1 0
0.1 0 1 93 5 1 0 0 1 92 6 1 1
0.2 0 0 87 10 2 0 0 1 92 5 1 1
0.3 0 0 73 18 7 1 0 1 92 6 1 1
0.2 0 0 2 94 3 1 0 0 1 85 10 3 1
0.1 0 1 93 4 1 0 0 1 84 11 2 1
0.2 0 0 87 9 2 0 0 0 85 11 2 1
0.3 0 0 73 18 7 1 0 0 85 11 2 1
0.3 0 0 1 94 4 1 0 0 0 72 17 6 4
0.1 0 1 93 4 1 0 0 0 72 16 7 4
0.2 0 0 87 10 2 0 0 0 73 16 7 3
0.3 0 0 75 17 7 1 0 0 74 16 7 3
500 0 0 0 61 33 4 1 0 0 67 29 3 1 0
0.1 0 38 47 9 5 1 0 67 29 3 0 0
0.2 0 8 28 21 27 16 0 66 30 3 0 0
0.3 0 0 5 6 19 69 0 66 30 3 1 0
0.1 0 0 63 32 4 1 0 0 42 45 9 3 1
0.1 0 40 46 9 5 0 0 43 44 9 3 1
0.2 0 8 29 20 26 15 0 44 43 9 3 1
0.3 0 0 5 7 18 69 0 44 43 8 3 1
0.2 0 0 63 31 5 1 0 0 7 32 20 16 25
0.1 0 41 45 9 5 0 0 7 33 19 15 25
0.2 0 9 29 20 27 15 0 8 34 19 15 25
0.3 0 0 6 8 18 68 0 8 34 19 16 23
0.3 0 0 63 32 5 1 0 0 0 4 7 10 79
0.1 0 41 45 9 5 0 0 0 5 6 10 79
0.2 0 9 33 22 25 11 0 0 5 9 12 74
0.3 0 0 6 8 19 67 0 0 5 6 12 76
1000 0 0 0 83 14 2 1 0 0 82 13 3 1 0
0.1 0 43 31 12 9 3 0 83 13 3 1 0
0.2 0 2 6 9 25 58 0 83 13 3 1 0
0.3 0 0 0 0 1 98 0 83 13 3 1 0
0.1 0 0 84 13 2 1 0 0 41 33 10 8 6
0.1 0 44 30 13 9 2 0 42 32 10 8 6
0.2 0 2 6 8 25 58 0 43 31 11 7 6
0.3 0 0 0 0 1 98 0 43 31 10 7 6
0.2 0 0 84 12 2 1 0 0 2 6 8 12 73
0.1 0 44 30 13 8 2 0 2 5 9 11 73
0.2 0 2 6 8 25 57 0 2 6 9 12 71
0.3 0 0 0 0 1 98 0 2 6 8 12 71
0.3 0 0 84 12 2 1 0 0 0 0 0 1 99
0.1 0 45 30 13 8 2 0 0 0 0 1 99
0.2 0 2 7 8 26 57 0 0 0 0 1 99
0.3 0 0 0 0 1 98 0 0 0 0 1 99
Table includes the percent of times that the estimated Bayes factors fell into the respective categories
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TABLE 3.4: Estimated Bayes factors for comparing M3 versus M0
Favor M0 Favor M3
m λ1 λ2 < 0.1 0.1-0.33 0.33-1 1-3 3-10 > 10
100 0 0 0 68 29 2 0 1
0.1 0 65 31 3 1 1
0.2 0 57 35 5 1 1
0.3 0 41 42 11 3 2
0.1 0 0 65 31 3 1 1
0.1 0 62 33 4 1 1
0.2 0 53 39 5 2 1
0.3 0 40 42 12 4 2
0.2 0 0 55 37 5 2 1
0.1 0 53 38 6 2 1
0.2 0 47 41 8 3 1
0.3 0 34 44 15 4 3
0.3 0 0 43 39 12 4 3
0.1 0 40 40 13 4 3
0.2 0 34 43 14 5 3
0.3 0 23 47 17 8 5
500 0 0 55 38 4 2 0 0
0.1 37 47 11 3 2 1
0.2 10 26 22 15 11 15
0.3 1 5 7 8 9 69
0.1 0 38 46 11 4 1 1
0.1 25 48 17 7 2 2
0.2 5 24 23 17 14 18
0.3 0 4 7 8 9 72
0.2 0 8 31 20 14 12 15
0.1 5 25 21 16 15 18
0.2 1 11 13 15 17 43
0.3 0 2 3 5 7 83
0.3 0 1 5 6 9 12 68
0.1 1 4 5 8 12 70
0.2 0 2 3 7 9 79
0.3 0 0 1 2 3 95
1000 0 0 79 16 3 1 0 0
0.1 47 31 11 5 3 2
0.2 3 8 8 9 15 56
0.3 0 0 0 1 1 98
0.1 0 48 30 10 5 3 3
0.1 23 33 19 10 7 7
0.2 1 6 7 7 12 66
0.3 0 0 0 0 1 98
0.2 0 3 8 8 9 12 59
0.1 1 5 6 8 13 66
0.2 0 0 1 1 4 93
0.3 0 0 0 0 0 100
0.3 0 0 0 0 1 1 98
0.1 0 0 0 1 1 98
0.2 0 0 0 0 0 100
0.3 0 0 0 0 0 100
Table includes the percent of times that the estimated
Bayes factors fell into the respective categories
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TABLE 3.5: Testing a random slope, power and Type I error
m
√
ψ22 Bˆ43 LR
∗
43
100 0 0.05 0.03
0.1 0.05 0.04
0.2 0.07 0.05
0.3 0.09 0.07
0.6 0.26 0.2
1 0.66 0.56
500 0 0.04 0.05
0.1 0.06 0.07
0.2 0.13 0.14
0.3 0.29 0.29
0.6 0.92 0.91
1 1 1
1000 0 0.03 0.04
0.1 0.06 0.09
0.2 0.24 0.28
0.3 0.59 0.61
0.6 1 1
1 1 1
Rejection rate for 1000 simulations
Type I error:
√
ψ22 = 0
βˆ43 = Bayes factor, M4 vs. M3
LR∗43 = ad-hoc RLRT, M4 vs. M3
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TABLE 3.6: Estimated Bayes factor, Bˆ43, for comparing M4 versus M3
Favor M3 Favor M4
m
√
ψ22 < 0.1 0.1-0.33 0.33-1 1-3 3-10 > 10
100 0 0 0 95 5 0 0
0.1 0 0 95 4 1 0
0.2 0 0 93 6 1 0
0.3 0 0 91 6 1 1
0.6 0 0 73 16 6 4
1 0 0 34 22 16 27
500 0 0 54 43 3 1 0
0.1 0 50 43 6 1 0
0.2 0 37 50 9 4 1
0.3 0 17 54 14 7 8
0.6 0 1 7 10 12 70
1 0 0 0 0 0 100
1000 0 0 85 12 2 0 0
0.1 0 74 19 4 2 1
0.2 0 47 28 11 7 6
0.3 0 16 23 15 16 28
0.6 0 0 0 0 1 99
1 0 0 0 0 0 100
Table includes the percent of times that the estimated
Bayes factor fell into the respective categories
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TABLE 3.7: Model posterior means and 95% credible interval
Parameter Posterior Mean 2.5% 97.5 %
β0 3329 3294 3363
β1 (Black) -40 -74 -7
β2 (Hisp) 14 -25 56
β3 (Asian) -57 -91 -24
β4 (Other) -2 -80 75
β5 (Gest)
∗ 284 278 289
β6 (Gest
2) -63 -71 -54
β7 (Previous birth) 105 99 111
β8 (Female) -120 -126 -115
β9 (Smoke) -165 -186 -143
β10 (Deprivation)
∗ -16 -23 -9
β11 (Age 26-30) 53 45 60
β12 (Age 31-35) 72 64 80
β13 (Age 36-40) 84 75 94
β14 (Age > 40) 76 60 92
β15 (Foreign) 11 3 18
β16 (Wtgain)
∗ 183 175 190
β17 (Wtgain
2) 49 40 58
β18 (Wtgain
3) -35 -41 -30
∗ Estimates for a 2 sd increase
All estimates given in grams
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FIGURE 3.1: Posterior means and 95% credible intervals of random intercepts
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FIGURE 3.2: Estimated change in infant birth weight by gestational age and maternal weight
gain
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TABLE 3.8: Frequency counts for ancestry by race
Region Ancestry White Black Hispanic Asian Other Total
Non-Hisp U.S. White Non-Hisp U.S. White 24749 0 0 0 0 24749
N Africa Morocco 203 21 0 4 0 228
Egypt 347 0 0 7 0 354
Other N Africa 65 44 0 4 0 113
Subsaharan Africa Nigeria 3 410 0 3 0 416
Ghana 2 450 0 0 0 452
Guinea 0 256 0 0 0 256
Senegal 1 206 0 1 0 208
Gambia 0 177 0 0 0 177
Ivory Coast 0 161 0 0 0 161
Mali 2 187 0 0 0 189
Other W Africa 5 219 0 1 0 225
Central-East-Southern Africa 38 283 0 4 0 325
E Asia China 25 13 0 5506 0 5544
Hong Kong 0 0 0 36 0 36
Taiwan 1 0 0 65 0 66
Korea 8 2 0 784 0 794
Japan 9 3 0 352 0 364
Other E Asia 19 3 0 51 0 73
SE Asia-Pac Islands Vietnam 6 4 0 13 0 23
Malaysia 0 0 0 78 2 80
Philippines 22 9 0 646 0 677
Other SE Asia 12 5 0 151 0 168
SC Asia India 8 56 0 1374 7 1445
Bangladesh 30 20 0 1190 0 1240
Pakistan 40 10 0 960 0 1010
Afghanistan 65 2 0 70 0 137
Iran 96 0 0 2 0 98
Other SC Asia 149 3 0 148 0 300
Non-Hisp Caribbean Jamaica 5 2076 0 14 0 2095
Haiti 6 1269 0 0 0 1275
Trinidad and Tobago 12 1140 0 283 0 1435
Grenada 0 220 0 3 0 223
Barbados 0 175 0 0 0 175
St Vincent 0 160 0 0 0 160
Antigua and Barbuda 0 118 0 0 0 118
St Lucia 1 142 0 1 0 144
Virgin Islands 2 40 0 0 0 42
Other Non-Hisp Caribbean 16 956 0 13 0 985
Hisp Caribbean Dominican Republic 0 0 8426 0 1 8427
Puerto Rico 0 0 7997 0 3 8000
Cuba 0 0 192 0 0 192
Mexico Mexico 0 0 6585 0 0 6585
S America Guyana 0 0 1785 0 73 1858
Ecuador 0 0 3053 0 0 3053
Colombia 0 0 1239 0 1 1240
Peru 0 0 521 0 0 521
Brazil 0 0 178 0 0 178
Argentina 0 0 198 0 0 198
Venezuela 0 0 181 0 0 181
Other S America 0 0 283 0 0 283
C American Honduras 0 0 740 0 23 763
El Salvador 0 0 640 0 0 640
Guatemala 0 0 397 0 13 410
Panama 0 0 226 0 0 226
Belize 0 0 109 0 0 109
Nicaragua 0 0 114 0 0 114
Other C America 0 0 59 0 0 59
African American African American 62 12323 0 12 6 12403
American Indian American Indian-Eskimo-Aluet 5 18 0 0 12 35
Other Ethnicity Other Ethnicity 59 344 0 137 7 547
Other US Born Hispanic Other US Born Hispanic 0 0 1356 0 0 1356
Total 26073 21525 34279 11913 148 93938
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TABLE 3.9: Posterior means of ancestry random intercepts, and predicted means by race
Region Ancestry bˆ1j yˆwhite yˆblack yˆHispanic yˆAsian yˆOther
Non-Hisp U.S. White Non-Hisp U.S. White 42 91 . . . .
N Africa Morocco 98 147 107 . 90 .
Egypt 24 73 . . 16 .
Other N Africa 60 109 69 . 52 .
Subsaharan Africa Nigeria 86 135 95 . 78 .
Ghana 23 72 32 . . .
Guinea -16 . -7 . . .
Senegal -30 19 -20 . -38 .
Gambia -91 . -82 . . .
Ivory Coast -83 . -74 . . .
Mali -65 -16 -55 . . .
Other W Africa 28 77 37 . 20 .
Central-East-Southern Africa 34 83 43 . 26 .
E Asia China 32 81 41 . 24 .
Hong Kong -45 . . . -53 .
Taiwan 22 71 . . 14 .
Korea 28 77 37 . 20 .
Japan -65 -16 -56 . -73 .
Other E Asia 83 132 93 . 75 .
SE Asia-Pac Islands Vietnam -54 -5 -45 . -62 .
Malaysia 9 . . . 1 55
Philippines -29 19 -20 . -37 .
Other SE Asia 40 89 49 . 32 .
SC Asia India -62 -13 -53 . -70 -16
Bangladesh -128 -80 -119 . -136 .
Pakistan -27 22 -18 . -35 .
Afghanistan 84 133 93 . 76 .
Iran -25 24 . . -33 .
Other SC Asia 59 108 68 . 51 .
Non-Hisp Caribbean Jamaica 5 54 15 . -3 .
Haiti 16 64 25 . . .
Trinidad and Tobago -22 26 -13 . -31 .
Grenada -2 . 7 . -10 .
Barbados -3 . 6 . . .
St Vincent 35 . 45 . . .
Antigua and Barbuda -54 . -45 . . .
St Lucia 34 83 43 . 26 .
Virgin Islands -43 6 -34 . . .
Other Non-Hisp Caribbean -7 41 2 . -15 .
Hisp Caribbean Dominican Republic -8 . . 55 . 38
Puerto Rico -33 . . 30 . 14
Cuba 20 . . 84 . .
Mexico Mexico 13 . . 77 . .
S America Guyana -150 . . -87 . -104
Ecuador 21 . . 84 . .
Colombia 29 . . 92 . 76
Peru 108 . . 171 . .
Brazil 26 . . 89 . .
Argentina 51 . . 114 . .
Venezuela -32 . . 31 . .
Other S America 66 . . 129 . .
C American Honduras 4 . . 67 . 50
El Salvador 20 . . 83 . .
Guatemala 10 . . 73 . 57
Panama -49 . . 14 . .
Belize -35 . . 28 . .
Nicaragua -15 . . 48 . .
Other C America -55 . . 8 . .
African American African American -12 36 -3 . -20 34
American Indian American Indian-Eskimo-Aluet 47 96 56 . . 93
Other Ethnicity Other Ethnicity 11 60 20 . 3 58
Other US Born Hispanic Other US Born Hispanic -13 . . 51 . .
bˆ1j is the posterior mean of the random intercept for ancestry j
yˆ is the predicted mean for a subject with gestational age = 39.3 weeks, NDI=0, male infant,
maternal weight gain = 31.2 lbs, no previous births, non-smoker,< 25 years old, born in the U.S.
Estimates given in grams; ’.’ denotes no observed subjects in the category
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TABLE 3.10: Posterior means of ancestry random intercepts with CI’s, with nativity
Region Ancestry bˆ1j LL UL N %Fgn
Non-Hisp U.S. White Non-Hisp U.S. White 42 9 73 24749 29
N Africa Morocco 98 44 155 228 97
Egypt 24 -26 73 354 94
Other N Africa 60 -7 126 113 99
Subsaharan Africa Nigeria 86 41 133 416 98
Ghana 23 -19 66 452 100
Guinea -16 -69 35 256 100
Senegal -30 -85 26 208 100
Gambia -91 -151 -35 177 99
Ivory Coast -83 -145 -24 161 100
Mali -65 -123 -8 189 99
Other W Africa 28 -26 82 225 98
Central-East-Southern Africa 34 -13 82 325 95
E Asia China 32 3 62 5544 95
Hong Kong -45 -134 44 36 97
Taiwan 22 -56 100 66 94
Korea 28 -10 67 794 93
Japan -65 -114 -19 364 92
Other E Asia 83 10 159 73 74
SE Asia-Pac Islands Vietnam -54 -151 41 23 100
Malaysia 9 -65 83 80 97
Philippines -29 -69 10 677 90
Other SE Asia 40 -18 99 168 95
SC Asia India -62 -99 -27 1445 94
Bangladesh -128 -173 -86 1240 100
Pakistan -27 -63 8 1010 98
Afghanistan 84 22 148 137 98
Iran -25 -95 46 98 92
Other SC Asia 59 11 108 300 100
Non-Hisp Caribbean Jamaica 5 -24 34 2095 95
Haiti 16 -17 48 1275 90
Trinidad and Tobago -22 -53 8 1435 96
Grenada -2 -55 51 223 99
Barbados -3 -62 54 175 95
St Vincent 35 -24 96 160 100
Antigua and Barbuda -54 -120 11 118 97
St Lucia 34 -27 96 144 100
Virgin Islands -43 -128 42 42 95
Other Non-Hisp Caribbean -7 -42 26 985 89
Hisp Caribbean Dominican Republic -8 -38 19 8427 81
Puerto Rico -33 -63 -4 8000 20
Cuba 20 -37 76 192 26
Mexico Mexico 13 -15 41 6585 96
S America Guyana -150 -199 -105 1858 96
Ecuador 21 -10 51 3053 91
Colombia 29 -6 63 1240 83
Peru 108 63 156 521 92
Brazil 26 -32 85 178 94
Argentina 51 -5 106 198 88
Venezuela -32 -91 24 181 95
Other S America 66 15 119 283 93
C American Honduras 4 -35 41 763 90
El Salvador 20 -21 59 640 92
Guatemala 10 -36 55 410 92
Panama -49 -105 4 226 74
Belize -35 -104 33 109 83
Nicaragua -15 -83 51 114 96
Other C America -55 -135 25 59 80
African American African American -12 -38 13 12403 12
American Indian American Indian-Eskimo-Aluet 47 -42 136 35 3
Other Ethnicity Other Ethnicity 11 -28 50 547 43
Other US Born Hispanic Other US Born Hispanic -13 -49 21 1356 3
bˆ1j = posterior mean of the random intercept with 95% credible interval (LL,UL)
%Fgn = percent born outside the U.S.
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CHAPTER 4
Analyzing Correlated Longitudinal and
Survival Data in Clinical Trials Using
Multivariate Time-to-Event Methods
4.1 Introduction
Many clinical trials evaluate the efficacy of a treatment on correlated longitudinal and time-to-
event outcomes. For example, consider a randomized clinical trial evaluating the effectiveness
of a treatment drug versus a control in 2,000 patients with a chronic respiratory disorder. The
investigators recorded the time to death within 3 years of randomization, as well as repeated
measurements at 6 month intervals of respiratory lung function FEV, or postbronchodilator
forced expiratory volume at 1 second. Because these patients suffer from a chronic condition,
lung function is expected to deteriorate over time and ultimately result in death. Clearly,
lung function and survival are expected to be highly correlated. There are well-established
methods for analyzing these longitudinal and survival outcomes separately, including the linear
mixed model for longitudinal data (Laird and Ware, 1982) and the Cox proportional hazards
model for survival data (Cox, 1972). However, the analysis of these longitudinal and survival
outcomes separately may be inefficient or even inappropriate when the longitudinal variable is
correlated with the survival endpoint (Guo and Carlin, 2004). Such approaches ignore important
information in the other outcome as well as potentially informative dropout in the longitudinal
process. This has led to a growing literature on jointly modeling distributions of correlated
longitudinal and survival endpoints.
There are many reasons to consider a joint model of longitudinal and event outcomes. Such
reasons include describing the trajectory of the longitudinal process over time subject to infor-
mative censoring and how this is affected by baseline predictors; determining how the probability
of an event outcome is influenced by the longitudinal process; evaluating whether the longitudi-
nal process can be used as a surrogate endpoint for the event outcome; or making predictions of
future event times for subjects who are censored. Joint models generally base inference on the
joint distribution of the longitudinal and survival outcomes (Wulfsohn and Tsiatis, 1997; Hen-
derson et al., 2000; Tsiatis and Davidian, 2001; Lin et al., 2002; Guo and Carlin, 2004; Tseng
et al., 2005, and more recently Elashoff et al., 2007; Dang et al., 2007). For more complete re-
views of joint modeling methods, see Hogan and Laird (1997b), Tsiatis and Davidian (2004), Yu
et al. (2004), and Ibrahim et al. (2001). Although joint models may be conceptually appealing,
they can be computationally demanding, difficult to implement, and may require specialized
software (Hogan and Laird, 1997b). Many of the joint model approaches make strong paramet-
ric assumptions regarding the longitudinal and survival processes (Tsiatis and Davidian, 2004;
Yu et al., 2004). These assumptions may not be obvious and can be difficult to validate.
We propose a strategy that uses multivariate time-to-event methods to evaluate effects of a
treatment or baseline predictor on both longitudinal and survival outcomes simultaneously. We
first create multiple time-to-event endpoints based on the survival and longitudinal outcomes.
These endpoints are defined as time to reach various thresholds in the longitudinal outcome
or death, whichever comes first. We then use semiparametric and nonparametric methods to
evaluate the treatment effect on these multivariate time-to-event outcomes. Our approach is
straightforward to implement for a randomized clinical trial using standard software (SAS) and
makes minimal or no assumptions regarding underlying distributions. More specifically, the
multivariate time-to-event methods that we utilize include the Wei-Lin-Weissfeld method (Wei
et al., 1989) and nonparametric analysis of covariance (NPANCOVA) with logrank scores as
defined by Tangen and Koch (Tangen and Koch, 1999b). Although these multivariate approaches
are well-established methods, they are typically applied in settings in which multivariate events
are clearly defined. These events are usually distinct outcomes (e.g. time to relapse or time to
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death) or repeated events of the same kind (e.g. time to hospitalization). Our contribution in
this paper is to apply the multivariate time-to-event methods to longitudinal and survival data
simultaneously. In Section 2 we introduce the multivariate methods used in our approach. In
Section 3 we present simulation studies. In Section 4 we apply our method to a clinical trial
involving chronic lung disease and conclude with a discussion in Section 5.
4.2 Application of Multivariate Time-to-Event Methods
4.2.1 Wei-Lin-Weissfeld Method
Suppose there areM time-to-event outcomes. To apply the method of Wei et al. (1989) (referred
to as the WLW method), one fits a marginal Cox proportional hazards model for each of the M
events
λmi(t) = λm0(t) exp{x′iβm}, (4.1)
in which βm = (βm1, . . . , βmp)
′ is the vector of parameters for the mth marginal model, x′i is a
vector of baseline predictors, and λmi(t) is the hazard for subject i proportional to the baseline
hazard λm0(t). Let β = (β
′
1, . . . ,β
′
M)
′ be the vector of all parameters and βˆ = (βˆ′1, . . . , βˆ
′
M)
′
be the maximum partial likelihood estimates from all M models. Wei et al. (1989) showed
that the asymptotic distribution of βˆ is normal with mean β and variance V , in which an
estimator Vˆ of the variance is a function of the score residuals and information matrix (see
Appendix). Given the asymptotic normal distribution of βˆ and variance estimate Vˆ , it is
straightforward to construct a model-averaged log hazards ratio to summarize the treatment
effect. Let βe = (β1e, . . . , βMe)
′ represent the vector of parameters for the marginal treatment
effect (e indexes the experimental or treatment effect). Wei et al. (1989) suggested estimating
a model-averaged log hazards ratio using the estimate
θˆ = C ′βˆe, (4.2)
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with C = (1′M Vˆe
−1
1M)
−1Vˆe
−1
1M and Vˆe equal to the estimated covariance matrix of βˆe (con-
structed from the appropriate elements of Vˆ ). This estimator was proposed as the optimal
estimator because it has the smallest asymptotic variance among all linear estimators. A test
statistic for testing whether the average log hazards ratio is equal to 0 can be constructed as
Z2 =
(C ′βˆe)2
C ′VˆeC
, (4.3)
which follows an asymptotic chi-square distribution with one degree of freedom. In SAS version
9.1 one can obtain this test directly using the procedure PROC PHREG (see SAS documen-
tation) or by fitting the marginal models and constructing the appropriate covariance matrix
using the “dfbeta” residuals. These residuals are equivalent to the product of score residuals
and the information matrix (see Appendix).
4.2.2 Nonparametric ANCOVA
Logrank scores are a set of values which are used in nonparametric testing procedures for com-
paring the survival times of two or more groups with possible censoring (Peto and Peto, 1972;
Koch et al., 1985). These scores are centered about zero starting with 1 and decreasing as
endpoints lengthen (see Appendix). For M time-to-event outcomes, one can compute logrank
scores for each of the M events separately to obtain M vectors of logrank scores. One can
then use multivariate nonparametric ANCOVA to evaluate a treatment effect on all outcomes
simultaneously adjusting for relevant covariables (Tangen and Koch, 1999b; Tangen and Koch,
1999a). This method uses weighted least squares methods to produce an estimated treatment
effect βˆ and corresponding variance estimate Vˆβˆ, in which βˆ is the estimated mean difference in
logrank scores between the treatment groups (see Appendix). This model restricts the vector(s)
of differences between means for the covariates to zeros on the basis of randomization. One can
use (4.2) to obtain an average difference in logrank scores between treatments (averaged across
the M events) and its corresponding test statistic as given by (4.3). This approach is straight-
forward to conduct in statistical software packages. SAS macros are available to compute the
logrank scores (please contact authors) and to perform multivariate nonparametric ANCOVA
for comparing two treatment groups (Zink and Koch, 2002).
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4.2.3 Defining the Multivariate Outcomes
We define M thresholds or cutpoints of interest in the longitudinal outcome and use these
cutpoints to construct (M+1) “threshold endpoints”. We define the firstM threshold endpoints
as time to the mth cutpoint or terminating event (e.g. death), whichever comes first. The final
threshold endpoint is defined as time to the terminating event. Subjects who do not experience
a threshold event in the study are considered censored. For example, consider the study of
chronic lung disease with FEV threshold events at ≤ 1300ml, ≤ 1010ml, and ≤ 740ml. Suppose
three subjects have FEV values and time of death as given in Table 4.1. For subject 1, the first
threshold event is observed at 18 months, the second at 24 months, and the third and fourth at
26 months. For subject 2, all four threshold events are censored at 36 months. For subject 3,
the first threshold event is observed at 6 months, and threshold events 2,3,4 are observed at 11
months.
We note that various definitions of the thresholds are possible depending on the clinical
relevance. For example, one could define the first M threshold endpoints as time to reach
a certain longitudinal value that is sustained for at least (say) three observations or death,
whichever comes first. The definition of these thresholds should be tailored toward the clinical
application such that the interpretations of the threshold endpoints are clinically relevant. Our
application is most relevant to studies in which there exists non-reversible deterioration in the
longitudinal process subject to censoring due to the survival endpoint.
We implicitly make assumptions in both the WLW and logrank approaches. For the WLW
approach, we assume that the observed time to reach a given threshold event has an underlying
continuous nature and that the hazards ratio for reaching an event is constant across time for
each predictor. We also assume that there is a log-linear relationship between the independent
variables and the underlying hazard function. For the logrank approach, essentially the only
assumption is that the patients are randomized to their respective treatment groups. The
logrank approach makes no modeling assumptions and does not require a continuous failure
time. Both approaches also make the assumption that censoring is independent of treatment
and is noninformative.
In a regulated clinical trial with correlated longitudinal and survival outcomes, it is often not
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known a priori whether the primary hypothesis should be based on the longitudinal or survival
outcome. The power of a survival analysis would increase with a larger number of events,
which would also be associated with increasing (informative) dropout and decreasing power for
a longitudinal analysis. Conversely, one has increasing power in the longitudinal process as
missing data due to terminating events decreases, implying fewer events and decreasing power
in the survival process. Even in cases in which the amount of missing data is predictable, it may
be unknown which process is likely to have greater sensitivity to treatment differences.
Our method is attractive in such situations, as one can incorporate our multivariate approach
in the study protocol with the understanding that it can lead to increased sensitivity to treatment
differences compared to the standard longitudinal and survival approaches and at worst should
lead to a “second best” approach. For example, consider a study in which a survival analysis
may have much greater sensitivity to treatment differences than a longitudinal analysis. Because
the multivariate approach incorporates information from each of these processes, it is reasonable
to expect the multivariate approach to have sensitivity to treatment differences somewhere in
between these two extremes. The same argument applies in the case in which the longitudinal
analysis has much greater sensitivity to treatment differences than the survival analysis. By
specifying the multivariate approach as the primary analysis a priori, one can reduce the risk of
selecting the outcome with the least sensitivity to treatment differences and have a reasonably
good chance of selecting the approach with the greatest sensitivity to treatment differences, as
shown in simulation studies in Section 3.
4.3 Simulation Studies
We conduct two simulations to evaluate the performance of our multivariate approach (using the
WLW or logrank strategy) relative to standard approaches using either of the longitudinal or
survival outcomes separately and to the joint model approach of Henderson et al. (2000). Our
proposed approach is most useful in settings with a small to moderate treatment effect on both
the longitudinal and survival outcomes and fairly large samples sizes (e.g. ≥ 300 per group). If
the treatment effects were known to be large a priori in both of these processes, there would be
little need for our method.
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We first simulate the longitudinal data with a trend over time for the mean and a random
intercept inducing an exchangeable correlation structure. We then generate terminating events
using a piecewise exponential model at fixed time points. The hazards function depends on
treatment, baseline covariates, and the population mean of the longitudinal variable for a given
interval. In the second simulation, we simulate the longitudinal data in the same format as
the first simulation, but we simulate deaths based upon subjects reaching a pre-determined
threshold. When subjects reach this threshold, the probability of death is set to 60% for each
observed Yij below the threshold. We compare the models based on power and Type I error.
Wei et al. (1989) proposed an “optimal” estimator βˆ that weights the marginal estimates by
the inverse of the covariance matrix. In our approach, one will observe a greater number of events
for earlier cutpoints, causing the “optimal” estimator to place more weight on the estimates from
the earlier cutpoints than on the later cutpoints. However, in many studies one may expect a
greater treatment effect in the later cutpoints. Hence we consider a modified WLW approach
that weights the parameter estimates of the respective events using a specified contrast matrix,
potentially weighting estimates from the later events more heavily compared to the weighting
of the “optimal” estimator. Let βˆe be the vector of treatment effects from the marginal Cox
models for the respective threshold endpoints and Vˆe be the corresponding covariance matrix.
In the case of four events, we define a contrast matrix C2 = (0.25, 0.25, 0.25, 0.25)
′ to weight the
treatment effects from the various threshold endpoints (time to 1st cutpoint or death, time to
2nd cutpoint or death, time to 3rd cutpoint or death, and time to death). This contrast weights
each estimate equally, placing more emphasis on estimates from the later events as compared
to the optimal estimator of Wei et al. (1989). We then compute the test statistic as shown in
(4.3). We denote this approach as WLW2 and use WLW1 to denote the WLW approach using
the optimal estimator.
4.3.1 Comparing Methods
Let Yij be the longitudinal response of subject i at observation j, for i = 1, . . . , n and j =
1, . . . , ni. Additionally, let yi0 be the baseline value of the observed response (the longitudinal
response at randomization) and xi be the treatment indicator. Let Ti denote the time to death
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of the ith subject, and Zi = min(Ti, Ui), in which Ui is a censoring time for survival of patient
i. In both simulation setups we compare the following methods:
• WLW1: The standard WLW approach using the optimal estimator of Wei et al. (1989),
i.e. C1 = (1
′
4Vˆe
−1
14)
−1Vˆe
−1
14.
• WLW2: The modified WLW approach with C2 = (0.25, 0.25, 0.25, 0.25)′.
• LR: The multivariate logrank analysis using nonparametric ANCOVA based on the test
statistic with equal weights, i.e. C2 = (0.25, 0.25, 0.25, 0.25).
• Cox: A Cox proportional hazards of the form
λi(t) = λ0(t) exp(γ1xi + γ2yi0), (4.4)
in which λi(t) is the hazard of subject i at time t, λ0(t) is an unspecified baseline haz-
ard function at time t, and γ1 and γ2 are parameters indicating treatment and baseline
measurement effects, respectively. To account for tied event times, we use both the ap-
proximation of Efron (1977) and the discrete logistic likelihood.
• LM1: A linear mixed model (with missing data due to failure) evaluating the treatment
main effect,
Yij = β0 + bi0 + β1tij + β2xi + β3yi0 + εij, (4.5)
in which tij is the observation time for subject i and observation j, β0 is a model intercept,
bi0 is a random subject intercept, and εij is the residual error. We assume εij ∼N(0, σ2)
independent of bi0 ∼N(0, ψ).
• LM2: A linear mixed model with time as a class variable (i.e. using indicator variables for
each time point) and a time by treatment interaction. The treatment effect is evaluated
at the last time point in which at least 50% of the subjects have an observed response.
Observations are discarded for the later time points with fewer than 5% observed data,
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as this would not allow for precise estimates of the time effect and treatment by time
interaction at these time points.
• Hen: A joint model based on the method of Henderson et al. (2000) using SAS code from
Guo and Carlin (2004). The longitudinal process takes the form of (4.5) and the time to
event Ti follows an exponential distribution with hazard function
λi = exp{γ0 + γ1xi + γ2yi0 + γ3bi0}, (4.6)
in which γ0 determines the baseline hazard function and γ1, γ2, and γ3 indicate the effect
of the treatment, baseline measurement, and random coefficient, respectively. The longi-
tudinal and survival processes are linked through the random coefficient bi0. A joint test
H0 : β2 = γ1 = 0 will test for a treatment effect in both the longitudinal and survival
processes simultaneously. This joint model assumes an exponential distribution on the
hazards function, i.e. a constant hazard over time. Use of a Weibull distribution, allowing
the hazard to vary over time, led to an inflated Type I error rate (data not shown).
As an alternative to the logrank approach, Tangen and Koch (1999b) discuss using nonpara-
metric ANCOVA on the Wilcoxon scores (Gehan, 1965). However, Wilcoxon scores tend to give
more weight than the logrank test to early failures and relatively less weight to later failures
(Prentice and Marek, 1979), and thus this method had decreased power in our setting (results
not shown).
4.3.2 Simulation One
To generate the longitudinal data, we set n = 600 and sample ε ∼ N(0, 1), bi0 ∼ N(0, 1), and
calculate
Yij = bi0 + β1tij + β2tijxi + εijz, (4.7)
in which β1 = (0,−0.2,−0.5) and β2 = (0, .01, .02, .03, .04, .05) in different settings, with
xi ∼Bernoulli(0.5) and tij = j for j = (1, . . . , 10). We calculate a baseline value yi0 = bi0 + εij
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to be used as a predictor in model fitting. We then generate the survival data using a piecewise
exponential model with hazard function
λij = exp(γ0 + γ1E(Yij) + γ2xi) (4.8)
for the interval (j − 1, j], in which E(Yij) is the expected value of the longitudinal outcome,
γ0 = −2, γ1 = −0.5, and γ2 = (0,−.05,−.10,−.15) over the simulations. For subject i with
death in the interval (j − 1, j], we set Yij and all subsequent Yij to missing. We generate 5,000
datasets and calculate Type I error rates and power at the α = 0.05 significance level. The
threshold endpoints for the simulation are defined as time to the 1st, 2nd, and 3rd quartiles of
the individual minimum longitudinal values or time to death, whichever comes first.
Figures 4.1-4.2 display the predicted longitudinal mean and survival probabilities for β1 =
(0,−0.5), β2 = (0.02, 0.05), and γ2 = (0,−0.15), which represent a range of the parameter
settings. Figure 4.1 shows that the treatment differences under consideration in the longitudinal
measures are not very large. The survival probabilities shown in Figure 4.2 also show relatively
small treatment effects. This is mainly due to the fact that we have a large sample size, and
any moderate to large treatment effect would be easily detectable by a linear mixed model or a
Cox model.
With the exception of Henderson’s joint model, which was overly conservative, all methods
consistently preserved the Type I error rate at 0.05. In general, the WLW approach had slightly
greater power than the logrank approach, but the difference was very minimal. With minimal
sensitivity to treatment differences in the longitudinal process (β2 = 0, 0.01), the Cox model
had the greatest power, followed by the multivariate methods and then the linear mixed models.
For cases with no direct treatment effect on survival (i.e. γ2 = 0, though treatment indirectly
impacts survival through γ1), the linear mixed model LM generally had the greatest power,
followed by the multivariate methods and then the Cox model. Generally, for cases in which
the longitudinal and survival processes displayed somewhat equal sensitivity to treatment differ-
ences, the multivariate methods had greater power for detecting a treatment effect than either
the Cox or linear mixed models. Also, the modified (weighted) WLW approach (WLW2) had
greater power than WLW1. The performance of Henderson’s joint model varied over the simula-
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tions. It generally had less power than the multivariate approaches for β1 = (−0.2,−0.5) (more
longitudinal dropouts induced by failure), and greater power than the multivariate approaches
for β1 = 0 (fewer longitudinal dropouts).
Figure 4.3 displays the power of the various methods for detecting a treatment effect for
β1 = (0,−0.5), β2 = (0.02, 0.05), and γ2 = (0,−0.15). For cases in which treatment does not
directly impact survival (γ2 = 0), the linear mixed models LM1 and LM2 have the greatest
power, followed by the multivariate approaches, and then the Cox model. For datasets with
greater sensitivity to treatment differences in the survival process (γ2 = −0.15), the multivariate
approach and Cox model have about equal power, while the linear mixed models LM1 and
LM2 have the least power. Henderson’s joint model is very competitive compared to the other
methods in the case of little missing data (β1 = 0) but has fairly low power with increased
missing data (β1 = −0.5) in the longitudinal process due to death.
4.3.3 Simulation Two
The second simulation generates the longitudinal data in the same manner but simulates deaths
based on an increased probability of death upon reaching a pre-determined threshold rather than
assuming the piecewise exponential model. We set the probability of death equal to 0.6 at all time
points with Yij < −2.5. For subject i with death event at time j, we set Yij and all subsequent Yij
to missing (and manage the patient as death at time j). Note in this setup, a subject may have
technically died in the interval (j − 1, j] but may not have an observed death until time j. We
sample 5,000 datasets and calculated Type I error rates and power at the α = 0.05 significance
level. We use the same parameter values as simulation one, except β2 = (0, .02, .03, .04, .06, .08)
and β1 = (−0.05,−0.15,−0.20,−0.25,−0.30,−0.40,−0.50,−0.70,−0.90,−1.4). One could view
the failure times for the terminating event as interval-censored because deaths can only occur
at j = (1, . . . , J). Hence we use the discrete logistic likelihood for the Cox survival model.
Figures 4.4-4.5 display the predicted longitudinal mean and survival probabilities for β2 =
(0.02, 0.05, 0.08) and β1 = (−0.05,−0.4,−0.9), which represent a range of the parameter settings.
As in the first simulation, the simulated treatment differences shown in Figures 4.4 and 4.5 are
relatively small due to our large sample size.
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With the exception of Henderson’s joint model, which again was overly conservative, all
methods consistently preserved the Type I error rate at 0.05. In general, the logrank approach
had slightly greater power than the WLW method, but the difference was minimal. For data
sets with small amounts of missing data in the longitudinal outcome due to failure, i.e. < 20%
(β1 ≤ −0.15), the linear mixed models performed best, followed by the multivariate methods
and then the Cox model. For data sets with 20% to 50% missing data (−0.15 ≤ β1 ≤ −0.5), the
multivariate approaches performed best, followed by the Cox model and then the linear mixed
models. For data sets with 50% to 70% missing data (−0.70 ≤ β1 ≤ −0.90), the multivariate
approaches again performed best, followed by LM1, the Cox model, and then LM2. For data
sets with greater than 70% missing data (β1 = −1.4), LM1 performs best followed by the
multivariate methods, LM2, and the Cox model. For data sets with > 70% missing data, the
linear mixed model LM1 had greater power than the Cox model, multivariate approaches, and
the linear mixed model LM2. One might expect the Cox model to perform best in this type
of setting (i.e. extreme amounts of missing data in the longitudinal outcome). However, given
the discrete sampling of our survival outcomes, most subjects experience death at time point
1 or 2, resulting in a large number of ties, and minimal sensitivity for detecting a treatment
effect in the survival process. Hence, in this simulation with extreme missing data, most of
the information regarding the treatment effect is contained in the longitudinal process. The
modified WLW approach (WLW2) again had greater power than WLW1. Henderson’s model
had less power than the multivariate approaches for all simulations except β1 ≤ −0.15 (little
missing data), with particularly low power (and a very conservative Type I error) when there
was a large amount of missing data due to failure.
Figure 4.6 displays the power of the various models of detecting a treatment effect for
β2 = (0.02, 0.05, 0.08) and β1 = (−0.05,−0.4,−0.9). For datasets with substantially greater
sensitivity to treatment differences in the longitudinal process compared to the survival process
(β2 = 0.05, β1 = −0.05), the linear mixed models perform best, followed by Henderson’s joint
model, the multivariate methods, and then the Cox model. In this simulation setup, there are no
examples in which the sensitivity to treatment differences is substantially greater in the survival
process than in the longitudinal process. For datasets with about equal sensitivity to treat-
ment differences in the survival and longitudinal processes, the multivariate methods generally
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perform better than both the Cox and linear mixed models, as well as Henderson’s joint model.
4.4 Application
We illustrate our method on the previously discussed clinical trial of 2,000 patients with a
chronic respiratory disorder. Due to reasons of confidentiality, these patients (1,000 treatment
and 1,000 control) are a random sample from the true study population, in which patients were
randomized to either treatment or control in permuted blocks with stratification by country and
smoking status.
In the original analysis, time to death within 3 years was chosen a priori as the primary
endpoint. We first evaluated the treatment effect on time to death using a Cox proportional
hazards model. We regressed the survival outcome on the following predictors: treatment,
baseline FEV, current smoking status (yes, no), age (< 55, 55-64, 65-74, ≥ 75), gender, body
mass index (< 20, 20-25, 25-29, ≥ 29), race (white, other), and geographical region (USA, Asia-
Pacific, Eastern Europe, Western Europe, other). Also, the exact days of death were available
for all patients with an event, resulting in very few ties with respect to event time. There were
139 deaths (13.9%) for patients on the treatment drug and 153 deaths (15.3%) for patients on
control. Survival data were available for all 2,000 subjects. Based on visual inspection of Kaplan-
Meier curves, there was no evidence to contradict the proportional hazards assumption. The
estimated hazard ratio for treatment versus control adjusting for covariates was 0.81 (p-value
= 0.07) with a 95% confidence interval of (0.64,1.02). An unadjusted log-rank test comparing
survival functions for the two treatment groups yields a test statistic of 0.84 with a p-value of
0.36, and a nonparametric ANCOVA approach adjusting for covariates yields a mean difference
in log-rank scores of -.026 with a p-value of 0.12. Hence these standard analyses with survival
as the primary endpoint result in non-significant results at the α = 0.05 level.
We analyzed the longitudinal outcome FEV using a linear mixed model (LM2) with the
same predictors as the Cox model, but also including time (6, 12, 18, 24, 20, and 36 months)
and a treatment by time interaction. The observation time was regarded as a class variable
using indicator variables for each observation time. We included a random intercept to account
for the intra-subject correlation. There were 297 subjects who did not have at least one FEV
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measurement post-randomization in the 3 year period, of which 80 were dead at 3 years. A total
of 8,372 observations from 1,703 subjects were available for this longitudinal analysis. 68% of
these patients had observed FEV measurements at the 3 year mark, and 18% of the observations
were missing across all possible (1703× 6) measurements, mostly due to death. The treatment
by time interaction term was not significant at the α = 0.05 level (p-value = 0.10 with 5 df), but
the estimates did show a trend for larger treatment differences as time increased. We evaluated
the treatment difference at the last observation time (3 years), at which the greatest treatment
difference was expected, resulting in an estimated difference of 60.5ml (p-value ≤ 0.0001) with
a 95% confidence interval of (34.0, 87.0) for subjects on treatment versus control. This result is
clearly signficant at the α = 0.05 level, and leads to the conclusion that treatment is associated
with higher FEV at 3 years.
We implemented the multivariate approaches to evaluate both outcomes simultaneously,
adjusting for baseline FEV, current smoking status, age, gender, body mass index, race, and
region. FEV measurements post randomization range from 210ml to 4,030ml with a median of
1,180ml. We defined three cutpoints based on the quartiles of the individual minimum FEV
measurements. This results in four threshold endpoints: time to FEV ≤ 1, 300ml or death, time
to FEV ≤ 1, 010ml or death, time to FEV ≤ 740ml or death, and time to death. Although
we could have required subjects to maintain FEV values below a cutpoint for two or more
observations to observe a threshold event, it is clinically relevant in this example to simply
define a threshold event as one observed FEV value below a given cutpoint (or death). For
subjects with no FEV measurements and death (or censored) times greater than 130 days,
we censored the first three threshold events at 130 days, the earliest time at which an FEV
measurement was recorded.
The estimated differences in logrank scores are -0.050, -0.047, -0.035, and -0.026 for the four
threshold events, respectively. The average difference in logrank scores for treatment versus
control using multivariate nonparametric ANCOVA is -0.040 (p-value = 0.005) with a 95%
confidence interval of (-0.068, -0.012). The goodness of fit statistic is 16.7 with 14 degrees of
freedom (p-value = 0.27), showing lack of evidence for imbalance of covariates at randomization
between treatments. Based on the logrank approach, we conclude that the treatment drug is
associated with smaller logrank scores and extended survival times for reaching a threshold event
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compared to control.
The respective marginal hazards ratios for the WLW model are 0.89, 0.84, 0.80, and 0.81.
Using the optimal estimator, the WLW1 hazards ratio is 0.87 (p-value≤0.0001) with a 95% CI of
(0.81,0.93). The modified estimator WLW2 results in a hazards ratio of 0.83 (p-value=0.0004)
with a 95% confidence interval of (0.75, 0.92). Based on the WLW approach, we conclude that
the treatment drug is associated with lower hazard of reaching a threshold event compared
to control, and hence is simultaneously associated with larger values of FEV and a decreased
probability of death.
The results of our proposed approach versus the Cox and linear mixed model are not sur-
prising based on our simulation results. In these data, we have a moderate to strong association
between the treatment drug and FEV and moderate missing data (18% among those with lon-
gitudinal measurements, or 30% among all 2,000 patients). This leads to a very small p-value
evaluating the longitudinal outcome. The sensitivity to treatment differences is much smaller
in the survival process compared to the longitutinal process and results in a non-sigificant p-
value for the survival endpoint. Because the WLW approach incorporates information from
both processes, in this situation we would expect it to have sensitivity to treatment differences
somewhere in between that of the longitudinal and survival approaches.
The investigators of this study had prior evidence of a strong treatment effect on FEV
and conducted this study specifically to evaluate the treatment effect on mortality. However,
had it been the case that the investigators did not know which outcome was more sensitive to
treatment differences a priori, a better approach may have been to specify either the logrank
or WLW approach as the primary analysis, which would hedge their planning with respect to
selecting the endpoint with the greatest sensitivity to treatment differences.
4.5 Discussion
Our simulation studies show two examples in which the multivariate methods are shown to have
good properties compared to standard approaches. One distinction in the first simulation setup
is that the data are generated in two extreme circumstances. First, there are many examples
in which the sensitivity to treatment differences is large in the longitudinal process, but very
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small in the survival process. Second, there are many examples in which the sensitivity to
treatment differences is large in the survival process, but very small in the longitudinal process.
In both extreme cases, the multivariate methods consistently have performance in between
longitudinal or survival methods alone. The multivariate methods generally do best relative
to the separate methods when there is a somewhat equal sensitivity to treatment differences
in both the longitudinal and survival processes. The second simulation does not have similar
extreme differences in sensitivity due to the larger correlation between the longitudinal and
survival processes.
In comparing the multivariate approaches to the joint model approach of Henderson et al.
(2000), we observed greater power for the multivariate methods for most simulations with moder-
ate missing data due to failure. In addition, in many simulations Henderson’s approach had less
power than both the linear mixed model and the Cox model. Based on simulation evidence, the
multivariate methods have better overall performance, make fewer distributional assumptions,
and are easier to implement than Henderson’s joint model.
The modified contrast matrix in WLW2 provided better performance than WLW1 in both
simulations. Although results are not shown here, we also implemented the weighted inverse
matrix C1 on the logrank method and found that the simple contrast matrix C2 resulted in
greater power. Additionally, we investigated several alternatives for the contrast matrix in
both multivariate approaches, including C3 = (0.30, 0.25, 0.25, 0.20), C4 = (0.35, 0.3, 0.2, 0.15),
C5 = (0.35, 0.35, 0.30, 0), and C6 = (0.6, 0, 0.4, 0), and found that the performance of the WLW
and logrank approaches did not change much compared to the results based on C2. In particular,
the small variations observed in power were more likely to occur in the WLW approach than
in the logrank approach. Hence, in the context of our simulations, our methods are not overly
sensitive to the specification of weights (excluding the weighted inverse matrix C1) and one can
use a smaller number of cutpoints in the longitudinal process (M = 1, 2 resulting in 2 or 3
threshold endpoints) to achieve a similar result.
Both the WLW and logrank approaches had very similar performance in terms of power and
Type I error. In general, the logrank method had slightly less power than the WLW model in
the first simulation and slightly greater power than the WLW model in the second simulation.
The logrank approach makes fewer assumptions than the WLW approach, but the analysis
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cannot evaluate effects of covariables or treatment by covariables interactions. Also, the logrank
estimated treatment parameter (i.e. mean difference in log ranks) only applies to populations
which have the same distributions for covariables as the study population. The interpretation
of the hazards ratio in the WLW approach may be more appealing than the corresponding
parameter estimate from the logrank approach. Additionally, the WLW approach allows one to
evaluate effects of covariables by treatment interactions, and the estimated treatment parameter
is generalizable to populations which might not have similar distributions for the covariables.
For a more thorough discussion of the advantages and disadvantages of nonparametric ANCOVA
versus a modeling procedure, see Koch et al. (1998). Their proposed strategy is to specify the
non-parametric analysis (e.g. logrank) as the primary evaluation of the treatment effect and to
use the statistical model (e.g. WLW) as a supportive analysis.
The WLW approach assumes that failure time (in this case time to a threshold event) is con-
tinuous. However, because longitudinal measurements are usually taken at set time points, there
is some ambiguity as to whether the continuous time assumption is satisfied for the threshold
endpoints. For cases in which the exact time of the terminating event is known, most ties in the
WLW model will be due to the longitudinal process (i.e. time to cutpoint). If one views time to
longitudinal cutpoint as interval-censored, then time to reach a threshold event may be viewed
as a combination of a continuous failure time and an interval-censored time. For cases in which
the terminating event is observed only at the time the longitudinal measurement is taken, then
time to a threshold event may be regarded as interval-censored. Hence the continuous failure
time assumption required by the WLW may not be satisfied. However, our simulations did not
show adversity for Type I error. One can still justify the WLW approach by taking the view that
time to the terminating event and time to the longitudinal cutpoints are continuous outcomes.
This is not unreasonable, especially when the exact time to terminating event is known and the
time between longitudinal measurements is small.
Guo and Lin (1994) proposed a discrete version of the WLW approach for interval-censored
data. Other discrete extensions of multivariate survival analysis include Kim and Xue (2002)
and Goggins and Finkelstein (2000). However, these methods are not easily implemented in
standard statistical software packages and are therefore not currently practical alternatives.
One could use a discrete logistic model with generalized estimating equations to account for the
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repeated events. We attempted to implement this model in our simulations but found that the
Type I error rate was conservative for some settings and inflated in other settings, perhaps due
to the large number of parameters in the model, as it requires an estimate for each interval and
threshold as well as the interaction between interval and threshold (data not shown).
Although the WLW method is well suited for multivariate survival data with different types
of events, some have criticized the WLW method in settings with recurrent events data. In
such settings, an individual is not at risk for the (k + 1)th event until the person experiences
the kth event. However, the WLW method includes an individual in the risk set for each event
from time zero until the individual has the event. This may cause the regression estimates
to be overestimates of the regression parameters (Kelly and Lim, 2000). Others have argued
against this criticism, claiming that the WLW method is appropriate for recurrent events data
as long as the parameter estimates are interpreted correctly (Metcalfe and Thompson, 2007).
In the context of our method, the threshold events represent progressively greater levels of
deterioration or death, but are not recurrent events such as those discussed in Kelly and Lim
(2000). Although an individual cannot experience the (k+1)th threshold event without having
experienced the kth event, these events can happen simultaneously. Hence an individual is at
risk for the (k + 1)th event even without having had the kth event. This implies the criticisms
of the WLW method for recurrent events data are not directly applicable to our method.
Our multivariate methods mainly address situations in which there exists attrition or non-
reversible deterioration in the longitudinal process subject to censoring due to the survival
endpoint. Our proposed strategy is very attractive in situations in which the best primary
outcome is not known a priori. Choosing a multivariate approach as the primary analysis
would ensure that the study does not choose a primary endpoint with the least sensitivity to
treatment differences, and may result in greater sensitivity to treatment differences than either
of the longitudinal or survival approaches separately.
The example in this article is based on random samples of a real clinical trial that was con-
ducted to compare three treatment arms versus a placebo for patients with chronic obstructive
pulmonary disease. The background, design, results, and interpretation of this trial are reported
by Calverley et al. (2007). Our methods are applicable to other studies with similar types of
data.
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TABLE 4.1: Individual FEV measurements
Observation time in months
Subject 6 12 18 24 30 36 Time of death
1 2500 1800 1100 900 - - 26
2 2000 1900 1800 1700 1650 1600 -
3 1200 - - - - - 11
Table gives FEV values at each observation time and time of death
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FIGURE 4.1: Simulation One: Longitudinal predicted mean
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FIGURE 4.2: Simulation One: Survival probabilities
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FIGURE 4.3: Simulation One: Power
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FIGURE 4.4: Simulation Two: Longitudinal predicted mean
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FIGURE 4.5: Simulation Two: Survival probabilities
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FIGURE 4.6: Simulation Two: Power
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CHAPTER 5
Discussion
We have presented methods for testing random coefficients in the linear mixed model, and more
generally multilevel linear models, using approximate Bayes factors. Our method incorporates
default prior distributions on the random coefficients that are shown to have good frequentist
properties and large-sample consistency. A major contribution of our method is the ability
to test multiple random coefficients simultaneously, and to do so with relative computational
efficiency. Our method does not involve computationally expensive MCMC algorithms, and
only requires a maximization algorithm and numerical second derivatives. In multilevel linear
models, our method is applicable to models with nested, non-nested, or cross-nested random
coefficients. Hence our method is a practical and useful approach for testing random coefficients
in multilevel linear models.
We also have proposed a straightforward approach for evaluating a treatment effect in cor-
related longitudinal and survival outcomes. Our method mainly addresses situations in which
there exists attrition or non-reversible deterioration in the longitudinal process subject to cen-
soring due to the survival endpoint. Simulations studies show that this method consistently
performs either best or second best compared to standard survival or longitudinal methods
alone. Our method is particularly attractive in clinical trial settings in which the primary anal-
ysis must be specified a priori. Our method is straightforward to implement, makes limited to
no assumptions, and is a practical alternative for analyzing correlated longitudinal and survival
endpoints.
APPENDIX A
Testing random effects in the linear
mixed model using approximate Bayes
factors
A.1 Marginal distributions for testing a random intercept
The marginal distributions in Sections 2.2.1 and 2.3.2 can be derived from the integral
p(Y |M (a)k ) =
∫ ∫ { n∏
i=1
∫
p(yi|ζ(a)k , bi, σ2)pi(bi)dbi
}
pi(σ2)dσ2pi(ζ
(a)
k )dζ
(a)
k (A.1)
=
∫ ∫ { n∏
i=1
p(yi|ζ(a)k , σ2)
}
pi(σ2)dσ2pi(ζ
(a)
k )dζ
(a)
k
=
∫ ∫
p(Y |ζ(a)k , σ2)pi(σ2)dσ2pi(ζ(a)k )dζ(a)k
=
∫
p(Y |ζ(a)k )pi(ζ(a)k )dζ(a)k .
Amultivariate t-distribution for a random vector x is typically denoted as x(p×1) ∼ tp(d,µ,Σ),
in which
p(x) = Γ
(
d+ p
2
)
(pid)−p/2|Σ|−1/2
Γ(d/2)
{
1 +
1
d
(x− µ)′Σ−1(x− µ)
}− d+p
2
. (A.2)
In (A.2), p is the dimension of x, d is the number of degrees of freedom, µ is the non-
centrality parameter, and Σ is the covariance matrix. In order to express the marginal dis-
tributions p(Y |ζ(a)k ,M (a)k ) in the form of (A.2), we must express the models in terms of the
vector Y = (y′1 . . . ,y
′
n)
′.
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For the ANOVA model in Section 2.2.1, we can write M
(1)
1 in terms of Y as
M
(1)
1 : Y = µ1m + λWb+ ε, (A.3)
in which 1m is a (m×1) vector of ones,W is a (m×n) block diagonal matrix of (1n1 , . . . ,1nn), b =
(b1, . . . , bn)
′, and ε = (ε′1, . . . , ε
′
n)
′. It can then be shown that (Y |µ, λ,M (1)1 ) ∼ tm(2v, µ1m, wvΣ(1)),
in which Σ(1) = (Im + λ
2WW ′). Similarly, M0 can be expressed in terms of the vector Y as
M0 : Y = µ1m + ε. (A.4)
It can then be shown that (Y |µ,M0) ∼ tm(2v, µ1m, wv Im). It is also straightforward to show
that (Y |µ, φ,M (2)1 ) ∼ tm(2v, µ1m, wvΣ(2)), in which Σ(2) = (Im+ e2φWW ′). For large datasets,
the covariance matrix Σ may be too large to handle computationally in a mixed model setting.
Hence it is preferable to express the multivariate t-distribution in terms of the subject-specific
(independent) covariance matrices Σi, as shown in equation (6)
A.2 Marginal distributions for testing a random slope
For the linear mixed model in Section 2.3.2, M
(a)
0 can be expressed in terms of the vector Y as
M
(a)
0 : Y =Xβ +Z0W
(a)
0 b0 + ε, (A.5)
in whichX = (X ′1, . . . ,X
′
n)
′ is a (m×p) design matrix, Z0 is a (m×q) block diagonal matrix of
(Z0,1, . . . ,Z0,n), b0 = (b
′
0,1, . . . , b
′
0,n)
′ is a (nq× 1) vector of all random effects, ε = (ε′1, . . . , ε′n)′,
W
(1)
0 = In⊗ (Λ(1)0 Γ0) andW (2)0 = In⊗ (Λ(2)0 Γ0) are (nq×nq) matrices, in which ⊗ denotes the
right Kronecker product (whereby the matrix on the right multiplies each element of the matrix
on the left). We can express M
(a)
1 in terms of the vector Y as
M
(a)
1 : Y =Xβ +Z1W
(a)
1 b1 + ε, (A.6)
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in which Z1 is a block diagonal matrix of (Z1,1, . . . ,Z1,n), b1 = (b
′
1,1, . . . , b
′
1,n)
′, ε = (ε′1, . . . , ε
′
n)
′,
W
(1)
1 = In ⊗ (Λ(1)1 Γ1), and W (2)1 = In ⊗ (Λ(2)1 Γ1). It can then be shown that
p(Y |β,λ(a)k ,γk,M (a)k ) ∼ tm(2v,Xβ, wvΣ(a)k ), in which Σ(a)k = (Im + ZkW (a)k W ′(a)k Z ′k). As with
testing a random intercept in the ANOVA setup, the covariance matrix Σ
(a)
k may be too large
to handle computationally in a mixed model setting.
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APPENDIX B
Analyzing Correlated Longitudinal and
Survival Data in Clinical Trials Using
Multivariate Time-to-Event Methods
B.1 The Wei-Lin-Weissfeld Method
Wei et al. Wei et al. (1989) showed that
βˆ ∼˙ N(β,V ), (B.1)
in which V is estimated by
Vˆ =

Vˆ11 Vˆ12 . . . Vˆ1M
Vˆ21 Vˆ22 . . . Vˆ2M
...
...
. . .
...
VˆM1 VˆM2 . . . VˆMM

. (B.2)
The estimated covariance matrix Vˆ is composed of the sub-matrices
Vˆmm′ = (RmAˆm)
′(Rm′Aˆm′), in which Aˆm is the inverse of the information matrix andRm is the
matrix of score residuals for event outcome m. Conveniently, the quantity RmAˆm is common
output in most software package and is known as the matrix of “dfbeta” residuals. The “dfbeta”
residuals represent the approximate change in a parameter estimate when the ith observation
is omitted. It follows that the asymptotic covariance matrix of βˆ can be obtained as a function
of the “dfbeta” residuals.
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B.2 Nonparametric Analysis of Covariance with Logrank Scores
Let nj be the number of observations at risk at the beginning of the jth interval,
nj =

N, j = 1
N −∑k(nk0 + nk1), k = 1, . . . , (j − 1) and j > 1, (B.3)
in which N is the sample size, nk0 is the number of censored observations in the kth interval,
and nk1 is the number of observed endpoints in the kth interval. Then the logrank scores for
the jth interval are
Cjd = d−
∑
k
(nk1/nk), k = 1, . . . , j, (B.4)
in which d = 1 for observed endpoints and d = 0 for censored endpoints.
Suppose we are interested in comparing two treatments for M logrank outcomes adjusting
for p covariates. Let treatment i have sample size ni, mean response y¯i of dimension (M × 1)
and a mean of covariates x¯i of dimension (p× 1). Let d = (y¯1 − y¯2) and u = (x¯1 − x¯2). We fit
the model
E [f ] = E
 d
u
 =̂
 IM
0(p×M)
 βˆ =Xβˆ (B.5)
using weighted least squares with weights based on the covariance matrix V0. Under H0,
V0 =
n1 + n2
n1n2(n1 + n2 − 1)

2∑
i=1
ni∑
k=1
 (yik − y¯)(yik − y¯)′ (yik − y¯)(xik − x¯)′
(xik − x¯)(yik − y¯)′ (xik − x¯)(xik − x¯)′

 (B.6)
in which y¯ and x¯ are means for all patients with treatments ignored. Additional covariance
estimates are possible under the alternative hypothesis of a treatment difference Tangen and
Koch (1999b), Tangen and Koch (1999a). The weighted least squares estimator βˆ is obtained
from
βˆ = (X ′V −10 X)
−1X ′V −10 f (B.7)
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and its estimated variance is given by
Vˆβˆ = (X
′V −10 X)
−1. (B.8)
A criterion for departures from (B.5) in terms of random imbalances takes the form
Q = (f − fˆ)′V −10 (f − fˆ) (B.9)
in which fˆ = Xβˆ. The statistic Q approximately has a chi-square distribution with p degrees
of freedom and assesses the amount of random imbalance in the covariates at randomization.
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